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ABSTRACT
RNA interference (RNAi) is a phenomenon in which RNA molecules elicit
potent and sequence-specific post-transcriptional gene silencing. Nucleic acid chemical
modifications have been incorporated to improve their pharmacological properties.
Despite numerous developments in chemical modifications for increased stability,
safety, and efficiency of these therapeutic agents, they still face challenges of spatial
and temporal targeting. One potential targeting strategy uses photocaging techniques,
which involves the covalent attachment of photolabile compounds to the effector NA
species that blocks bioactivity until exposed to near UV-light. This work demonstrates
that fully-2’-fluorinated nucleic acids (FNAs) can elicit RNAi and that these effectors are
resistant

to

sugar-specific

enzymatic

digestion.

1-(4,5-dimethoxy-2-

nitrophenyl)diazoethane (DMNPE) was used to cage NA oligonucleotides, including
FNAs for controlling RNAi. Photo-control over RNAi was demonstrated in cell culture
and developing zebrafish embryos. Caging also afforded additional protection against
nuclease digestion. High doses of siFNAs were toxic to fish embryos, as characterized
by a developmental delay and increased mortality rate. Caging siFNAs rendered the
effectors inert and eliminated the observed toxicity in the developing embryos. Building
on the success of caging chemically-modified siFNAs through random phosphate
alkylation, a strategy for the site-specific incorporation of an amine-based cage postsynthetically was developed. To demonstrate the feasibility of directed post-synthetic
base caging, a base-caged ATP was generated and tested for photo-activation
capacity. A novel cage group, 4,5-dimethoxy-2-nitrobenzylamine, was synthesized and
used for the conversion of chloropurine riboside triphosphate and the corresponding

xii

free nucleoside. Base-caged ATPs were inactive until photoexposure to 365nm light.
Additionally, these compounds did not demonstrate competitive inhibition of protein-ATP
interactions, as previously described for γ-phosphate caged ATP. For the site-specific
incorporation of caged nucleobase derivatives, a strategy relying on amine-reactive
convertible nucleotides was developed for positional substitution using 2-nitrobenzyl
amine cage compounds. These convertible nucleotides can be incorporated during
custom solid-phase synthesis, and may provide a reactive target for the presented
amine-based cage compounds.

Caging RNAi effectors will allow for spatial and

temporal targeting of a controlled dose release of gene silencing agents, which has
potential applications for wet-bench assays, probing developing biological systems, and
potentially targeted therapeutics.

xiii

CHAPTER 1
Introduction
1.1

Purpose and Significance
The primary aim of this work was to develop a method to induce RNAi

activity with an external trigger. To achieve this goal, photo-caging technology was
applied to RNAi effectors to control gene silencing activity using light. Photo-caging
refers to the attachment of photosensitive compounds to a biomolecule to transiently
alter its activity until the caged biomolecule is exposed to light of an appropriate
wavelength and intensity to remove the adducts (further defined in section 1.3.1). It
was originally hypothesized that caging various forms of dsRNA would be adequate to
control their activity. However, phosphate backbone photo-caging was found to be
chemically incompatible with stabile RNA polymers (see section 2.3). Therefore, it was
necessary to develop 100% chemically modified RNA mimics that successfully elicit
RNAi and are compatible with the caging strategy for controlling activity. This body of
work demonstrates that these chemically modified siRNAs function as potent RNAi
effectors, and the attachment of multiple cage compounds on each strand results in
transiently inert small interfering duplexes.

Exposure to light of the appropriate

wavelength and sufficient energy restores the biological response to these compounds
in vitro, in cell culture, and in vivo. These results demonstrate the potential utility of
caged RNAi effectors by incorporating several simultaneous modes of control for gene
silencing. Using the caging strategy, the inert RNAi effector can be delivered globally
to a biological system of interest without eliciting a response. In this scenario, a phototrigger can be used to induce gene silencing in a desired region of three-dimensional
space and/or at a specific time interval, post delivery.
1

In addition to this spatial-

temporal control, the extent of activity can be controlled using assorted doses of light
energy.

This level of control has potential future applications in the areas of

developmental knockdown investigations, tissue specific gene silencing, and single cell
gene silencing for experimental and therapeutic modeling purposes.
A secondary aim of this work was to explore chemical means of
incorporating a caging group into an RNAi effector in a site-specific manner. The
method described above uses a reactive intermediate for covalent attachment to the
nucleic acid in a batch-style reaction, resulting in caging at random sites on the
effector. Towards the aim of site-specific incorporation, a caging group with modified
attachment chemistry was generated and tested for its ability to bind an adenosine
residue on the nucleobase. Nucleoside model studies indicate that this attachment
scheme is possible through a nucleophilic substitution of chlorine on 6-chloropurine
riboside (see chapter 5). This scheme was expanded to generate base-caged ATP,
which unlike γ-phosphate caged ATP, does not act as a competitive inhibitor for
proteins that associate with ATP.

Future studies will attempt to use this caging

strategy for incorporating an amine-attached caging compound on an internal
nucleobase through substitution utilizing a convertible nucleoside. Caging at a sitedirected location may allow for complete inhibition of activity using a single cage
compound and a more efficient photo-activation of the RNAi effectors, resulting in a
binary on-off behavior profile. Caging offers the ability to modulate RNAi activity in
terms of spatial and temporal resolution and as a means for light-dependant dosing of
RNAi intensity, which has applications in developmental investigations of biological
systems and therapeutic targeting

2

1.2

RNA Interference
RNA interference (RNAi) refers to a highly specific, potent, and naturally

occurring post-transcriptional silencing of protein expression initiated by RNA. The first
evidence of this mechanism emerged from studies attempting to genetically enhance
the violet pigmentation in petunias (Napoli, Lemieux et al. 1990; van der Krol, Mur et
al. 1990). The overexpression of the pigment gene unexpectedly resulted in a null
phenotype.

A related observation was seen in fungal systems where an over-

expressed transgene retarded gene expression at the post-transcriptional level
(Romano and Macino 1992). However, it took nearly a decade to discover that dsRNA
is the foundation of this post-transcriptional gene silencing (PTGS) mechanism (Fire,
Xu et al. 1998). The breakthrough experiment showed that the introduction of dsRNA
was far more efficient in silencing a complementary target gene than either sense or
antisense strands individually. This dsRNA-induced PTGS mechanism was coined
RNAi. RNAi and its discovery have received a series of highly-acclaimed recognitions
including Science magazine’s 2002 Breakthrough of the Year, Fortune Magazine’s
2003 Biotech’s Billion Dollar Breakthrough, and has earned Andrew Fire and Craig
Mello the 2006 Nobel Prize in Physiology or Medicine. This praise is well-deserved as
the field of RNAi matures and the significance of this discovery in being realized.
However, the use of RNAi for therapeutics still faces several hurdles that are
discussed in the following sections. A detailed review of the RNAi mechanism along
with advancements in RNA chemical modifications and current therapeutic
development is given in the following sections to adequately identify these obstacles,
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describe current technologies to improve the pharmacological effectiveness of RNAi,
and to identify candidate positions for optimal photo-caging of RNAi effectors.

1.2.1

Known Mechanism of RNA Interference
The RNAi pathway has been extensively studied in various eukaryotic

organisms. It is an active process which requires ATP at several stages to induce
gene silencing. Although there are numerous differences in these pathways across
various plants and animals, the basic mechanism seems to be well conserved. For
this universal model, small double stranded RNAs (dsRNAs) act as the crucial
substrate for the initiation of RNAi. The sources of these dsRNAs can vary widely,
which is discussed in the following paragraph. Once introduced to the cytoplasm,
these small RNAs associate with several proteins to form the RNA-Induced Silencing
Complex (RISC) (Hammond, Bernstein et al. 2000). The nucleoprotein complex is
then activated by one or several ATP-dependant processes that are not yet well
understood. It is theorized that this activation process includes the unwinding of the
siRNA for target recognition. However, to date a conserved ATP-dependant helicase
has not been identified. Once activated, RISC recognizes the mRNA target and either
clips it at a specific location, physically blocks its translation, or sequesters it to a
processing body (p-Body) organelle. Although the general process can be described
in a relatively straightforward manner, the full process is complex due to a high number
of variations, unidentified factors, and downstream processes.

For simplicity, the

entire mechanism with an emphasis on the siRNA pathway will be broken down into 1)
siRNA generation, 2) RISC assembly, 3) RISC maturation, 4) RISC targeting

4

interaction and mRNA degradation, and 5) downstream chromatin remodeling. Each
of these sub-processes is described below.

siRNA introduction
RLC loading (optional)
RISC assembly

RISC
maturation

target
recognition

target
cleavage
and
release
mature
RISC
recycling
Figure 1.1: RNAi mechanism. RISC components illustrate how RNA
and proteins associate with each other. Stages include siRNA
generation, siRNA recognition and RISC assembly, RISC maturation,
and target mRNA cleavage
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1.2.1.1

Small Interfering RNA Generation
SiRNAs can be generated through several natural and synthetic methods.

As was done in this work, siRNAs can be generated synthetically or enzymatically in
vitro and then delivered to the cells or embryos in an active form. In most organisms,
the introduction of long double-stranded RNA (dsRNA) prompts the enzymatic
digestion of the RNA into 21-30nt length siRNAs. The highly conserved enzyme that
performs this digestion was named Dicer and belongs to the RNAse III family of
enzymes (Hammond, Bernstein et al. 2000; Bernstein, Caudy et al. 2001; Elbashir,
Lendeckel et al. 2001). This pathway is not utilized for RNAi in mammalian cells
because they mount a global protein kinase response as a viral protection mechanism,
which results in cellular apoptosis (Williams 1997; Gil and Esteban 2000). However,
Dicer is still a critical component to the RISC pathway and is present in mammalian
systems. In addition to linearized dsRNA, Dicer can process stem-loop structures to
produce siRNAs. This has enabled the ability to introduce transgenic short hairpin
RNAs (shRNAs) that are processed by Dicer to induce RNAi.

One of the more

profound discoveries that arose from RNAi studies was the existence of hundreds of
endogenous stem-loop RNAs called microRNAs (miRNAs), which are theorized to play
a major role in genetic regulation (Lee, Feinbaum et al. 1993; Ruvkun 2001). These
miRNAs originate from non-coding regions of the genome in the form of a long primary
transcript known as pri-miRNA. These are processed in the nucleus into the shorter
stem-loop structures (pre-miRNA) and exported to the cytoplasm where they are
processed into their mature form.

Although siRNAs and miRNAs are functionally

similar, small structural differences of these effectors elicit different RNAi pathways.
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1.2.1.2

RISC Assembly
Once in the cytoplasm, small RNAs are assembled into RISC. This is a

process in which siRNAs or miRNAs interact with a series of cellular proteins to form
active complexes for target recognition and regulation. The most important factor for
active RISC is the assembly of siRNAs with the argonate (AGO) family of proteins.
These are the only small binding proteins which have been found in all variations of
functional RISC to date. Several studies have shown that when some AGO proteins
are complexed with siRNA a functional core RISC can be formed, which drives mRNA
degradation in vitro and in vivo (Martinez, Patkaniowska et al. 2002; Liu, Carmell et al.
2004; Rand, Ginalski et al. 2004). AGO proteins contain several conserved domains,
that are critical for siRNA binding and RISC activity. The PAZ domain is located within
a hydrophobic cleft and contains a series of aromatic and positively charged residues
that enable a strong recognition of the negative charges on the siRNA 3’-end 2nt
overhangs (Song, Liu et al. 2003). AGO proteins also contain a Mid domain, which is
characterized by a deep basic pocket.

Studies have suggested that this domain

interacts with the 5’-end monophosphate of the guide RNA (Parker, Roe et al. 2004;
Song, Smith et al. 2004; Ma, Yuan et al. 2005; Rivas, Tolia et al. 2005; Yuan, Pei et al.
2005). The final region of interest is the conserved PIWI domain, which is between the
Mid and PAZ domains. This section contains a motif that is similar to those found in
the RNAse H family of endonucleases, suggesting that AGO proteins possess catalytic
activity (Yang and Steitz 1995; Parker, Roe et al. 2004; Ma, Yuan et al. 2005; Parker,
Roe et al. 2005; Yuan, Pei et al. 2005). However, not all AGO proteins contain a
catalytically active PIWI motif. For instance, 8 AGO proteins have been discovered in
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humans, which are evenly split into 2 subfamilies: PIWI and eIF2C containing AGOs
(Sasaki, Shiohama et al. 2003). Among the non-PIWI containing proteins, only one,
hAGO2, demonstrates catalytic ability (Liu, Carmell et al. 2004; Meister, Landthaler et
al. 2004; Rivas, Tolia et al. 2005). An understanding of this family of proteins may
allow for the design of siRNAs that can enter functionally different RNAi pathways.
Additionally conserved requirements among all AGO variants may provide insight into
potential caging sites that will disrupt all RNAi processes.
In some RISC systems, other protein factors are required for RISC assembly
and RNAi activity. Not only are there variations among different organism species but
there are various pathways within single organisms.

One example comes from

Drosophila melanogaster, one of the most extensively studied systems, where two
dicer proteins (Dcr-1 and Dcr-2) have distinct functions (Bernstein, Caudy et al. 2001;
Liu, Rand et al. 2003; Lee, Nakahara et al. 2004; Okamura, Ishizuka et al. 2004;
Pham, Pellino et al. 2004). Dcr-1 is responsible for miRNA production while Dcr-2 is
required only for siRNA production and therefore it is not required for normal fly
development (Lee, Nakahara et al. 2004; Okamura, Ishizuka et al. 2004).

In this

system, siRNAs are loaded into a RISC loading complex (RLC) which is comprised of
Dcr-2 and a double-stranded RNA binding protein, R2D2, before associating with
AGO2 (Pham, Pellino et al. 2004; Tomari, Du et al. 2004; Tomari, Matranga et al.
2004; Tomari and Zamore 2005). One interesting phenomenon is that R2D2 and Dcr2 bind asymmetrically to the siRNA, where R2D2 associates to the more stable end
(Tomari, Matranga et al. 2004). This could be taken into account when designing
siRNAs to ensure that the antisense strand is preferentially retained in RISC. The RLC
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factors are gradually displaced once AGO2 has been recruited, leaving behind only the
core RISC components, AGO2 and siRNA. Observations in the human system of
siRNA-based RISC assembly seem to share many similarities with Drosophila. It has
been shown that human Dicer forms a complex with TAR RNA binding protein (TRBP)
(Chendrimada, Gregory et al. 2005; Haase, Jaskiewicz et al. 2005). Following this
binding, siRNA is added to the assembly forming a Dicer-TRBP-siRNA complex. In
this system, TRBP is required for recruiting hAGO2 to the complex for RISC formation.

1.2.1.3

RISC Maturation
The process of generating a mature RISC containing the single-stranded

RNA effector is not yet well understood.

It is known that the maturation process

requires ATP in vitro (Nykanen, Haley et al. 2001).

Initial models rely on an

unidentified ATP-dependant helicase in the immature RISC or RLC to remove the
carrier strand.

This theory is supported by the fact that several DEAD-box RNA

helicases, which are ATP dependant, are involved in the RNA pathway in different
organisms (Dalmay, Horsefield et al. 2001; Tabara, Yigit et al. 2002; Yan, Mouillet et
al. 2003; Cook, Koppetsch et al. 2004; Tomari, Du et al. 2004; Kim, Gabel et al. 2005).
In this proposed mechanism it is unclear whether helicase unwinding occurs in the
RLC or simultaneously with AGO protein displacement of the RLC cofactors.

More

recent models suggest the RLC transfers the siRNA to the AGO protein, and in a
process that is analogous to mRNA enzymatic processing, the passenger strand is
cleaved. Once cleaved, the two halves of the passenger strand are ejected so that
RISC is free to repeat the processed on another mRNA target (Matranga, Tomari et al.
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2005; Miyoshi, Tsukumo et al. 2005; Leuschner, Ameres et al. 2006). The ejecting
process is likely an ATP dependant process that is equivalent to releasing digested
target mRNA and recycling of RISC.

Additionally, if ATP is required for strand

separation, there is nothing to suggest that this is a helicase independent process.

1.2.1.4

RISC Targeting and mRNA Degradation
There are two functional categories of mature RISC: those that initiate

cleavage of the target and those that only participate in translational arrest. Cleavage
the mRNA target by RISC is determined by three factors. First, only an AGO protein
that contains an active endonuclease motif in the PIWI domain can cleave target
mRNA (Liu, Carmell et al. 2004; Parker, Roe et al. 2004; Baumberger and Baulcombe
2005; Parker, Roe et al. 2005). If a non-catalytically active AGO protein is used, a
non-cleaving RISC is formed. Secondly, a high degree of complementarity is needed
between the incorporated strand of siRNA with the target (Chiu and Rana 2002).
Lastly, the scissile phosphodiester bond of the mRNA must be directly accessible to
the active endonuclease motif in the PIWI domain (Parker, Roe et al. 2004; Parker,
Roe et al. 2005; Yuan, Pei et al. 2005).

Only a fraction of all the AGO proteins

identified contain a catalytically active motif, such as the human hAGO2 (Liu, Carmell
et al. 2004; Meister, Landthaler et al. 2004; Meister and Tuschl 2004; Rivas, Tolia et al.
2005) or dAGO1 and dAGO2 in Drosophila (Meister and Tuschl 2004). The catalysis
of AGO “slicer” activity is dependant on divalent cations such as Mg2+ and Ca2+
(Schwarz, Tomari et al. 2004; Rivas, Tolia et al. 2005). The location of cleavage is
predetermined by RISC at the phosphodiester bond on the mRNA across from the
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location between the nucleotides 10 and 11 from the 5’-end of the guide RNA,
regardless of siRNA size (Elbashir, Lendeckel et al. 2001; Elbashir, Martinez et al.
2001; Haley, Tang et al. 2003; Rivas, Tolia et al. 2005).

The hydrolysis of this

phosphodiester linkage yields 3’-hydroxyl and 5’-phosphate termini on the cleavage
products (Elbashir, Martinez et al. 2001; Martinez and Tuschl 2004).
Proper base-pairing is not only important for target recognition but is critical
for RISC-directed cleavage. A strong association between the guide RNA strand and
the target mRNA seems to correlate to more efficient target cleavage (Chiu and Rana
2003; Tang, Reinhart et al. 2003; Martinez and Tuschl 2004; Yang, Li et al. 2005).
However, there does seem to be some mismatch tolerance as certain locations of
partial complementarities can lead to mRNA cleavage. In nearly all cases of base
mismatching, target cleavage is reduced. The exception to this rule is the first base on
the 5’end. A point mismatch at this location increases the observed target cleavage in
vitro (Rhoades, Reinhart et al. 2002; Haley, Tang et al. 2003; Lewis, Shih et al. 2003;
Tang and Zamore 2004; Ma, Yuan et al. 2005), presumably by facilitating release of
the processed target. Other than this location, mismatches on the 5’-half of the guide
strand are less tolerated than those on the 3’-half (Haley, Tang et al. 2003; Martinez
and Tuschl 2004). It has also been suggested that the A-form RNA helix is required
for RISC activity (Chiu and Rana 2002; Chiu and Rana 2003). Since there are 11
base-pairs per turn in the A-form helix, a mismatch in the first 9 or 10 nucleotides of
the guide strand may disrupt the helix and cause the resulting loss of activity.
The preferred association between the AGO protein with the guide RNA
occurs with the 5’-end phosphate anchored in the basic pocket motif of the Mid-PIWI
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domain and the 3’-end bound to the PAZ-domain (Parker, Roe et al. 2004; Ma, Yuan et
al. 2005; Yuan, Pei et al. 2005). This directs the region containing the active slicer
motif between the Mid-PIWI and PAZ domains, and the interaction with the guide
strand likely restricts this region so that the hydrophilic side of this domain is positioned
toward the solution (Ma, Yuan et al. 2005). Once bound to the target, a conformational
change occurs to bring the scissile phosphodiester bond of the target into the
catalytically active region (Ma, Yuan et al. 2005; Parker, Roe et al. 2005). The actual
cutting of the target mRNA is not ATP dependant, but the release of the cleaved
products does require ATP and likely also requires an ATPase/RNA helicase (Hunter
2000; Nykanen, Haley et al. 2001; Haley, Tang et al. 2003; Rivas, Tolia et al. 2005). In
the circumstance of a non-catalytic RISC, knockdown may occur either through
blockade of protein translation or by sequestering mRNA targets to cytoplasmic
processing bodies (P-bodies) that are sometimes co-localized with mRNA decapping
and degradation proteins (Bagga, Bracht et al. 2005; Ding, Spencer et al. 2005;
Fillman and Lykke-Andersen 2005; Jabri 2005; Liu, Valencia-Sanchez et al. 2005;
Pillai, Bhattacharyya et al. 2005; Rehwinkel, Behm-Ansmant et al. 2005; Sen and Blau
2005).

1.2.1.5

Downstream RNAi Processes
RNA-dependant epigenetic chromatin remodeling was first discovered in

1994 in a plant system (Wassenegger, Heimes et al. 1994).

This phenomenon

occurred in response to the integration of viral cDNA into the host genome. It was
observed that the replicating foreign sequence triggered methylation of homologous
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DNA copies. It was later shown that this process is dependant on short RNA strands
that are generated from processing the replicated dsRNA, suggesting Dicer activity
(Zilberman, Cao et al. 2004). This RNA-dependant DNA-methylation was found to be
highly specific in that methylation is limited to the region of RNA-DNA complementarity
(Wassenegger 2000; Aufsatz, Mette et al. 2002). In addition to plants, RNAi mediated
chromatin remodeling was also studied in S. Pombe, a species of yeast.

It was

observed that small RNAs, which were generated from the centromeric repeat regions
of chromosomes, eventually caused a silencing of these regions (Reinhart and Bartel
2002). The existence of a nucleus RISC that contains small RNAs and the AGO1
protein provided the first biochemical evidence of RNAi activity in the nucleus
(Motamedi, Verdel et al. 2004; Noma, Sugiyama et al. 2004). It was subsequently
found that Dicer, RNA-dependant RNA-polymerase, and a specific histone methyl
transferase are also required to establish heterochromatin in S. Pombe centromeres
(Volpe, Kidner et al. 2002; Hall, Noma et al. 2003; Volpe, Schramke et al. 2003).
Unlike the plant system, chromatin methylation in yeast spreads several kilobases from
the initially targeted region (Hall, Shankaranarayana et al. 2002; Schramke and
Allshire 2003). Although more extensively studied in the plant and yeast systems,
RNAi-related chromatin remodeling has been identified in human cells (Bayne and
Allshire 2005). The phenomenon of RNA-mediated epigenetic genome modification
demonstrates the utility of RNAi as an intrinsic defense mechanism to foreign genetic
material from viral or transposable element sources, as well as suggesting a potential
RNAi role in developmental processes.
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1.2.2

Chemical Modifications to siRNAs
Although siRNAs utilizing chemical modifications have been used determine

intramolecular RNA structural requirements that are necessary to elicit RNAi and to
elucidate certain protein nucleic acid interactions, most of these studies aim to improve
the pharmacological properties of siRNAs. For in vitro, cell culture, and some in vivo
models, the efficacy of unmodified siRNAs is sufficient. However, the development of
robust RNAi drugs faces several challenges including; chemical stability in
physiological environments, improved bio-distribution, improved cellular delivery, and
targeting of disease tissues.
chemical modifications.

This section reviews the current literature on siRNA

Several excellent reviews are also available (Dorsett and

Tuschl 2004; Manoharan 2004; Zhang, Du et al. 2006).

1.2.2.1

Terminal Modifications
The termini of siRNAs have different structural requirements related to how

they interact with RISC components (refer to section 10.2.1 for a detailed description).
The structural studies of the interactions between the PAZ and MID domains of AGO
proteins with siRNAs complement studies in which terminally-modified RNAi effectors
were tested for silencing ability. For example, it is known that a 5’-phosphate on the
antisense, or guide strand, is required for siRNA recognition and RISC formation from
both crystallography studies of AGO proteins and from incorporating modifications on
siRNAs to disrupt the RNAi pathway (Nykanen, Haley et al. 2001; Martinez,
Patkaniowska et al. 2002; Schwarz, Hutvagner et al. 2002; Parker, Roe et al. 2004;
Song, Smith et al. 2004; Ma, Yuan et al. 2005; Rivas, Tolia et al. 2005; Yuan, Pei et al.
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2005). Despite the progress made in the understanding of the RNAi pathway, different
studies relating to terminal modification of siRNA often yields varying results. One of
the modified termini that yields the most inconsistent reports with respect to RNAi
tolerance is the 3’-antisense end. Structural studies of siRNA recognition by AGO
proteins suggests that the 2-nt 3’-antisense over hang is necessary for proper RISC
formation and stability (Lingel, Simon et al. 2003; Song, Liu et al. 2003; Yan, Yan et al.
2003; Ma, Ye et al. 2004). Therefore, modifications to this location should reduce
RNAi activity.

Indeed, both 2-hydroxylethylphosphate and 2’-O,4’-C-ethylene

thymidine modifications to this location abolished all RNAi activity (Hamada, Ohtsuka
et al. 2002).

Other siRNA chemical modification examples, however, have

demonstrated that silencing activity is retained when this terminal is modified with
larger substitutions such as 3’phosphate-aminopropyl, 3’-puromycin, 3’biotin, or
fluorescent chromophores (Chiu and Rana 2002; Schwarz, Hutvagner et al. 2002;
Harborth, Elbashir et al. 2003). There is even a case in which the 3’-2nt overhang of
the antisense strand was eliminated and the resulting blunt ended siRNA that exhibited
RNAi activity in mammalian cell culture (Czauderna, Fechtner et al. 2003)
siRNAs tolerate terminal modifications on both ends of the sense strand
(Chiu and Rana 2003; Czauderna, Fechtner et al. 2003; Harborth, Elbashir et al. 2003;
Davidson, Harel et al. 2004; Lorenz, Hadwiger et al. 2004; Muratovska and Eccles
2004; Morrissey, Blanchard et al. 2005). This is expected since this strand is not
retained in the active RISC effector, and as long as the siRNA forms a proper duplex
structure for RISC formation, RNAi will likely be uninterrupted. These locations are the
most exploited with respect to improving cellular delivery. For example, cholesterol
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and lipid conjugates to the sense strand 5’-terminal nucleotide allow increased delivery
to liver cells (Lorenz, Hadwiger et al. 2004; Soutschek, Akinc et al. 2004). In a similar
strategy, end-conjugation to proteins that promote endocytosis has also demonstrated
successful siRNA delivery and effective RNAi (Davidson, Harel et al. 2004; Muratovska
and Eccles 2004). Another example employs an acid-labile linker to generate siRNA
micelle complexes that are transported by triggering cell-surface receptors and
subsequently released into the intracellular environment through pH-dependent
breakdown (Oishi, Nagasaki et al. 2005).

Although this end-conjugation strategy

addresses increased delivery of siRNAs to cells, this technique has primarily been
evaluated in liver cells when applied to in vivo models since the RNAi effectors are
localized in this tissue after being introduced systemically.
Modification of the 5’-end of the antisense strand is the least tolerated by the
RNAi pathway. It has been consistently demonstrated the phosphate at this location is
required for RNAi. More specifically, the 5’-phosphoester bond must not be disturbed
if silencing is to occur (Nykanen, Haley et al. 2001). An unmodified hydroxyl can be
phosphorylated, but if this location is blocked by any conjugate attached the oxygen,
RNAi will be abolished (Elbashir, Martinez et al. 2001; Martinez, Patkaniowska et al.
2002; Schwarz, Hutvagner et al. 2002). Conjugation that retains 5’-phosphate does
not eliminate the necessary phosphoester and is generally tolerated. Several studies
have demonstrated that silencing ability is retained after conjugation of a bulky linker to
the phosphate (Schwarz, Hutvagner et al. 2002; Harborth, Elbashir et al. 2003). In
fact, a photolabile linker at this location has shown to decrease but not eliminate RNAi
activity (Nguyen, Chavli et al. 2006; Shah and Friedman 2007). The residual activity
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was explained by an isomer that partially exposes the negative charge of the
phosphate to the MID domain of the AGO protein (Shah and Friedman 2007). This
allows for RISC recognition of the 5’-end, even when a large conjugate is attached to
the phosphate.

1.2.2.2

Backbone Modifications
Backbone modifications have a history in providing NA stability and chemical

resistance to degradation and enzymatic digestion that predates RNAi. This review is
limited to the use of these chemical substitutions for synthetic siRNA knockdown. A
recent review of chemical modifications to antisense and ribozyme therapies provides
a more detailed record of these applications (Kurreck 2003). Since a great deal of
knowledge was generated studying the effects of backbone modifications on DNA
antisense therapies, only the most successful candidates have been investigated for
RNAi. The most widely used phosphate modification in siRNA is the phosphorothioate
(PS). The PS modification consists of a sulfur substitution in place of one of the
nonbridging oxygen within the phosphate backbone.
PS substitutions were first used in siRNAs in 2000 (Parrish, Fleenor et al.
2000), shortly after the discovery of RNAi. Studies on RNAs with PS substitutions
used sparingly do not report adverse affects on silencing ability (Padilla and Sousa
2002; Braasch, Jensen et al. 2003; Holen, Amarzguioui et al. 2003), but extensive
modification can result in cytotoxicity (Amarzguioui, Holen et al. 2003; Holen,
Amarzguioui et al. 2003).

One of the more heavily cited studies also showed a

decreased silencing ability of phosphorothioated compared to unmodified siRNA
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independent of cytotoxicity (Chiu and Rana 2003). Alternatively one study reported
that if certain locations were modified, RNAi activity would actually increase (Li, Mao et
al. 2005). In addition to the aforementioned research, several incidences of the PS
modification being used in conjunction with other types of chemical modifications and
conjugations have been reported (reviewed by (Manoharan 2004; Zhang, Du et al.
2006)).
Another, less common, modification that has generated some recent
enthusiasm is the boranophosphate substitution. These modifications consist of BH3
substitutions of one of the non-bridging oxygen molecules of the phosphate backbone.
NAs with these modifications have demonstrated nuclease stability (Hall, Wan et al.
2004; Hall, Wan et al. 2006), increased hydrophobicity (Shaw, Sergueev et al. 2000),
and minimal toxicity (Hall, Burnham et al. 1993). Relative to PS modified siRNAs of
the same sequence, boranophosphates used for partial modification showed the ability
to increase the level of silencing activity (Hall, Wan et al. 2004).

Single-stranded

boranophophate-siRNAs were also able to enter the RNAi pathway and not operate
under a translational arrest pathway alone (Hall, Wan et al. 2006). This is appealing
as it is demonstrated in chapter 2 that fully modified 2’-fluoro RNAs were unable to
elicit single-stranded RNAi. This suggests that single-stranded RNA recognition by
RISC components may involve an intermediate factor that requires the 2’-hydroxyl
instead of identifying the negative charge of the phosphate. Although this modification
shows promise, it should be noted that all boranophosphate RNAi studies have been
conducted by the same research group and further studies are needed.
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1.2.2.3

Base Modifications
Surprisingly, nucleobase chemical modifications have not been extensively

studied in siRNAs. Base modifications that have been attempted thus far include 5’bromo uracil, 5’-iodo uracil, 2,6-diaminopurine, N3-methyl-uridine, inosine, and 5-(3aminoallyl) (Parrish, Fleenor et al. 2000; Chiu and Rana 2003). In general, each of
these substitutions reduced RNAi activity to varying degrees. To complement reports
on nucleobase substitution are studies that have investigated single base
mismatching. A recent comprehensive investigation was carried out by systematically
inserting a single base mutation at all locations of the siRNA target site (Du, Thonberg
et al. 2005). This study provides insight into which locations are most sensitive to
mismatches. Additionally, it was discovered that the identity of the mismatch also
influenced silencing ability.

Reduction in silencing activity caused by single base

mismatches varied depending on which nucleobase was inserted as the mismatch.
This study differed from others which inserted point mutations into the siRNA rather
than the target (Boutla, Delidakis et al. 2001; Holen, Amarzguioui et al. 2002;
Amarzguioui, Holen et al. 2003).

However, the results of these two substitution

techniques were consistent. Together, these studies suggest that complementarity in
the central region of the siRNA is the most critical for efficient RNAi activity, whereas
mismatches at the terminal ends are better tolerated.

1.2.2.4

2’ Modifications
Modifications to the 2’-hydroxyl of RNA have been widely utilized in siRNAs.

These substitutions are generally well tolerated by the RNAi pathway because the 2’-
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hydroxyl is not necessary for RISC recognition or target cleavage (Chiu and Rana
2003). Additionally these modifications increase the chemical and enzymatic stability
of the NAs, relative to unmodified RNA.

For these reasons, many chemical

substitutions at this location have been evaluated for RNAi activity and improved
resistance to nuclease degradation.
2’-O-Methoxyethyl (2’-MOE) modifications had previously shown promise for
antisense applications due to their enhanced blood stability and adequate retention of
activity (reviewed by (Kurreck 2003)). Therefore, they seemed likely candidates for
introduction into siRNAs.

However, pervasive use of this modification is not well

tolerated by the RNAi pathway, suggesting that the cumbersome side chain interferes
with the process. In the central region of the duplex across from the cleavage site, it
appears that the size of a 2’-substitution is inversely proportional to the level of RNAi
activity of the effector (Chiu and Rana 2003; Prakash, Allerson et al. 2005). The 2’MOE modification was also not tolerated on the on either end of the antisense strand,
but RNAi activity was maintained surprisingly well when this modification was used on
either end of the sense strand (Prakash, Allerson et al. 2005). Another study showed
favorable results by increasing end duplex stability with several 2’-MOE modifications
on each side of the siRNA (Vickers, Koo et al. 2003).

Despite the potential for

improved stability, these studies suggest that this modification reduces RNAi efficiency
and can only be used sparingly.
Initial studies using 2’-O-methyl (2’-OME) substitutions demonstrated
unfavorable results with respect to maintaining RNAi efficiency (Elbashir, Martinez et
al. 2001; Chiu and Rana 2003).

However, the use of this modification has

21

subsequently been studied in great detail (reviewed by (Manoharan 2004; Zhang, Du
et al. 2006)). Like other bulky modifications, 2’-OME nucleotides can only be used
sparingly.

Heavy utilization results in a decrease in silencing activity, presumably

through disruption of the major groove of the RNA A-type helix (Chiu and Rana 2003).
This study that gradually increased the number of 2’-OME substitutions determined
that four nucleotide substitutions per strand are well tolerated. Additionally, limited use
of this substitution appears to increase RNAi ability, presumably through increase
duplex stability and/or improved resistance to enzymatic digestion (Czauderna,
Fechtner et al. 2003). The benefits obtained by using a small number of the 2’-OME
modification in a siRNA have made this substitution popular for use in siRNAs with
combinations of various chemical modifications.
Locked nucleic acids (LNA) are a family of ribose modified compounds in
which the 2’-oxygen is bridged to the 4’-carbon, locking the ribose in the C3’-endo
conformation.

LNAs have been studied in detail to determine their nuclease

resistance, duplex stability, and RNAi functionality (Braasch, Jensen et al. 2003;
Jepsen and Wengel 2004; Elmen, Thonberg et al. 2005).

End-modification using

LNAs is tolerated well on all but the 5’-end of the antisense strand. In another example
of a comprehensive evaluation, a single LNA substitution was evaluated at each
location of the antisense strand of an otherwise active siRNA (Elmen, Thonberg et al.
2005). This study identified four locations that resulted in a significant loss of silencing
activity, which comprised of the 5’-end, nucleotide 10, nucleotide 12, and nucleotide
14. However, these positional effects were only tested on a single siRNA sequence.
As with other bulky modifications, extensive use of these modifications results in a loss
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of RNAi activity. It was proposed that this decrease might be a result of increased
thermal stability and a reduction in helicase unwinding ability (Elmen, Thonberg et al.
2005).

However, 2’-fluoro substitutions result in a similar thermal stability without

diminishing silencing capacity (see chapter 2).

Even with the limitations of LNAs,

careful placement of this modification can improve the properties of the resulting
siRNAs for use in in vivo systems.
Of all the chemical modifications tested, deoxy-2’-fluoro (2’-F) modifications
seem to be the best-tolerated alteration with respect to retaining the silencing activity
of unmodified siRNAs. These substitutions have several characteristics that make
them ideal for RNAi applications.
groove

without

inhibiting

duplex

Fluorine is small enough to fit within the minor
recognition

by

certain

proteins,

and

the

electronegativity of the halide reinforces the A-type helix through the preferred C3’endo ribose pucker conformation (Guschlbauer and Jankowski 1980; Chiu and Rana
2003).

In addition to not disrupting the global structure of a RNA duplex, 2’-F

substitutions increase thermal stability of the modified NAs when annealed to DNA or
RNA (Kawasaki, Casper et al. 1993; Yazbeck, Min et al. 2002).

2’-F modified

oligonucleotides and siRNAs have also demonstrated improved resistance to
enzymatic degradation relative to their unmodified counterparts (reviewed by
(Manoharan 2004; Zhang, Du et al. 2006)). Several studies have shown similar levels
of RNAi elicited between unmodified siRNA and these synthetic counterparts that
contain fluorine on every pyrimidine (Braasch, Jensen et al. 2003; Chiu and Rana
2003; Harborth, Elbashir et al. 2003; Layzer, McCaffrey et al. 2004; Manoharan 2004;
Soutschek, Akinc et al. 2004). Sullenger and colleagues showed that 2’-F pyrimidine-
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modified siRNAs and unmodified siRNAs have similar activity over a range of
concentrations and silencing durations (Layzer, McCaffrey et al. 2004).

Chiu and

Rana compared silencing potency of various siRNA modifications and found that
siRNA completely modified with 2’-F pyrimidines and 2’-H purines showed only a 50%
decrease in knockdown ability relative to an unaltered siRNA counterpart (Chiu and
Rana 2003).

In addition to improving resistance to enzymatic degradation while

maintaining silencing efficiency, 2’-modifications have been shown to reduce off-target
effects normally observed following siRNA delivery (Jackson, Burchard et al. 2006;
Cekaite, Furset et al. 2007).

Until recently, 2’-F modified purine phosphoramidite

building-blocks for solid phase synthesis were unavailable.
aforementioned studies investigated pyrimidine only 2’-F NAs.

Therefore, the
Chapter 2

demonstrates the first use of fully-modified 2’-F siRNAs generated through synthetic
and enzymatic methods. Alternatively, 2’-deoxy-2’fluoro-β-D-arabinonucleic acid
modifications, in which the 2’-flouro is inverted, have been used to partially modify
siRNA and successfully induce RNAi (Dowler, Bergeron et al. 2006). The combination
of these results suggests that the 2’-OH is not necessary for RNAi, but changes at this
location that either alter the global duplex structure or disrupt the minor groove can
abolish interference.

Therefore, this modification is ideal for either global 2’-F

substitution or for use in conjunction with other chemical modifications for the
development of efficient and persistent RNAi effectors.
The combination of several types of chemical modifications into a single
siRNA molecule is becoming increasingly common in efforts to improve the
pharmacological efficacy of RNAi.

Bhat and colleagues demonstrated that fully-

modified duplexes which included 2’-F pyrimidine nucleotides and 2’-O-methyl purine
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nucleotides actually increased RNAi efficiency, and in one case they achieved a 500fold increase in silencing ability (Allerson, Sioufi et al.). The grouping of these two
modifications is popular in studies that utilized more than one type of chemical
substitution (Allerson, Sioufi et al. 2005; Morrissey, Blanchard et al. 2005; Morrissey,
Lockridge et al. 2005; Prakash, Allerson et al. 2005; Kraynack and Baker 2006). In
one of the more heavily modified examples, Morrissey and colleagues (Morrissey,
Blanchard et al. 2005) created a siRNA targeting hepatitis B that contained 2’-deoxy,
2’-F, 2’-O-ME, PS, and 3’-5’-inverted deoxy-abasic substitutions. Combining these
types of modifications may improve efficacy and effector half-life, but it may also
provide means to achieve targeted delivery or inducible activity with the use of
alternative modifications such as receptor ligands or caging compounds conjugated to
the stabilized siRNAs.

1.2.3

Current RNAi Therapeutic Developments
RNAi has demonstrated potent gene silencing in laboratory studies, making

it an exciting alternative approach for treating a wide variety of medical conditions.
The strategy of repressing protein translation with NAs has several advantages over
small molecule pharmaceuticals. Most notably is the flexibility and ease of targeting
the specific gene that is causing a pathological state. There are a whole host of
diseases in which the protein responsible has been identified, but no compound has
been developed for effective treatment. Using RNAi and antisense techniques, several
sequences could be developed for the specific disease-causing gene or allele, and
candidate effectors could be generated in sufficient quantities for evaluation in a matter
of days once the problem gene is identified.
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Despite these benefits and general

optimism surrounding this technology, few examples exist of siRNA being tested
clinically in humans.

In addition to the fact that RNAi is still a relatively young

technology, the primary reason that RNAi drugs are rare is the inability to overcome
the problems of biodistribution, siRNA stability, cellular delivery, and tissue targeting,
as discussed in the prior sections. For this reason, all clinical trials to date rely on
localized delivery of the siRNA-based drugs.
Three companies are currently in the process of conducting clinical trials of
RNAi drugs.

Acuity Pharmaceuticals (recently merged with Froptix Corp. and

eXegenics, Inc.) was the first to begin a phase I clinical trial for a siRNA drug in
November of 2004. This siRNA targets the gene for vascular endothelial growth factor
(VEGF) to halt angiogenesis in the macula. Up-regulation of this gene is one of the
major factors in causing wet age-related macular degeneration (AMD).

The drug,

called bevasiranib, is delivered intra-ocularly to stop the progression of the disease.
This drug was also the first to reach the milestone of a double-blinded phase II study in
July of 2005. Although it is not yet on the market, Acuity has reported positive results
relating to halting the disease progression and maintaining safety.

SiRNA

Therapeutics (recently acquired by Merck & Co.) has also completed phase I trials
using a siRNA drug, Sirna-027, targeting wet AMD.

In addition, they are moving

rapidly toward clinical trials of a hepatitis C targeting siRNA, Sirna-034.

Lastly,

Alnylam Pharmaceuticals have developed a siRNA drug, ALN-RSV01, which targets
nucleocapsid protein to prevent viral replication against respiratory syncytial virus
(RSV). Phase I clinical trials for this compound began in December of 2005, and a
human experimental infection model was initiated in November of 2006. However, to
achieve RNAi by systemic delivery, some of the technologies discussed in the prior
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section will need to be applied. Indeed, many of these techniques have been adopted
outside of academia. A strong commercial contingent is actively pursuing techniques
that will improve the pharmacological potential of siRNAs.
The development of delivery systems is of paramount importance to the
successful generation of RNAi therapeutics. Several companies have adopted a lipidmediated approach to this problem. Silence Therapeutics (formerly SR Pharma) has
developed siRNA-lipoplexes that function very similar to cationic liposomes that are
used to transfect cell culture. In addition to complexing the NAs with a lipid delivery
system, this company has developed a siRNA structure that is blunt-ended and
contains alternating 2’-modifications to impart enzymatic stability.

A similar lipid

approach has been adopted by SiRNA Therapeutics in which lipid nanoparticles are
used to physically encase the effector for delivery. For both of these cases, the siRNA
complexes are endocytosed and then released intracellularly. A more tissue-specific
version of this strategy was developed by Calando Pharmaceuticals. In their strategy,
siRNAs are end-conjugated to a polymer, which are complexed into nanoparticle
structures. These polymers have the ability to target specific cell surface receptors
and induce endocytosis.

Nastech Pharmaceutical Company Inc., has taken this

cellular targeting strategy one step further to promote siRNA delivery specifically at
tight junctions of epithelial and endothelial cells. High-throughput screening is used to
identify compounds that interact with these tight junctions and then candidate
compounds are used as carriers for delivery of siRNAs. Nastech also uses siRNA
sequences that are screened for natural enzyme resistance and replaces ribouracil
with ribothymine to reduce off-target silencing through improved hybridization
properties. Due to the known enzyme susceptibility of siRNAs and the complications
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associated with global and specific cellular delivery, it is reasonable to assume that
systemic application of RNAi drugs will require the combination of several
technological advancements.
If the hurdles associated RNAi drugs are overcome, the therapeutic
applications are nearly limitless. Three of the most important areas of RNAi potential
applications include antivirals, treatments for neurodegenerative disorders, and cancer
therapies. For example, the development of vaccines is severally limited when the
virus of interest proves to be highly mutagenic. RNAi offers the alternative of targeting
highly conserved regions of the genome, as opposed to targeting viral surface
antigens. Examples of viruses that may one day be treatable with RNAi drugs include
influenza, hepatitis C, and HIV. As aforementioned, Alnylam has already completed
phase I clinical trials with a siRNA against RSV, a viral target. Alnylam is also working
with Medtronic toward a technology that would allow for local delivery of siRNAs to
treat neurodegenerative diseases via an implantable infusion pump.

As a final

example, Calando is expected to file a new drug application for a cancer targeting
siRNA, CALAA-01.

Despite the guarded optimism for RNAi drugs, they are

fundamentally untested in therapeutic applications.

In order to truly estimate the

impact of RNAi, more validation in human trials are necessary.

1.3:

Caging

1.3.1:

Definition and Historical Perspective
Traditional chemical modulators of biological processes are unable to

achieve the necessary spatiotemporal control required for some experimental
investigations and targeting for therapeutics. One strategy to achieve this control is to
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develop compounds whose activity is dependant on a conditional trigger.

Light

exemplifies an ideal external trigger for inducing mechanisms with extraordinary spatial
and temporal resolution. Light-induced activation of biological molecules is typically
accomplished by first rendering the molecule of interest inert through conjugation of a
photoprotecting group, or “caging”, which can later be removed by exposure to an
appropriate light source. Caging is very specific term, which describes the use of a
photolytic chromophore for the rapid release of a biologically active substrate (Kaplan,
Forbush et al. 1978).

The covalent attachment of a photosensitive compound

produces a photo-caged compound when the attachment of this group blocks native
biochemical or biological activity and the blocked activity can be restored by light
treatment. Therefore, the term “caged,” in this context, is descriptive of the photoactivation property and does not refer to physical trapping of the inactivated substance
within a crystal lattice or shell. For the purposes of this work, the term caging is more
narrowly defined.

Caging refers to the covalent attachment of one or multiple

chromophores to a biomolecule, and the attachment of the caging compound(s) must
alter the normal biological activity of the substrate. In nearly all cases, it is desired that
the caged molecule is functionally inert. Attachment of the cage and inactivation of the
biomolecule must be transient and reversible in the presence of the appropriate
incident light. This restriction eliminates stable photo-responsive elements, such as
biological photoswitches (Reviewed by (Mayer and Heckel 2006)). Finally, the photoresponsive biomolecule must not be naturally occurring. Although the definition of
caging requires that the photochemistry be used to release a biochemically active
substrate, the initial findings by Kaplan and colleges was inspired by earlier reports in
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which photolabile residues were used as protecting groups in synthetic chemistry for
carboxylic acids, alcohols, amines, ketones, or phosphates (reviewed by (Pillai 1980)).
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Figure 1.3: 2-Nitrobenzyl γ -phosphate caged ATP and photolytic release

Classically, caged compounds have been used to study the time course of
cellular responses induced by a millisecond step increase in the intracellular
concentration of a bioactive compound of interest. As aforementioned, Kaplan et al.
(Kaplan, Forbush et al. 1978) was the first to apply this type of photochemistry to
release an inducer to a biological system, the Na:K ion pump from erythrocytes (e.g.
ATP, Fig. 1.3). Time course experiments using caged compounds have been used to
study a wide range of biological processes in vitro and in vivo, including studies of cell
motility, muscle fibers, active transport proteins, biological membranes and other
intracellular responses (reviewed by (McCray and Trentham 1989; Pelliccioli and Wirz
2002; Mayer and Heckel 2006; Ellis-Davies 2007)). Applications of cage groups have
expanded beyond their beginnings in organic synthesis and step increases in
concentration of biological inducers to play an important role in the inactivation of
macro-biomolecules. While the early biochemical studies were limited to evaluating
the time course of brief biological responses in vitro and in situ, caged macromolecules
afford control to a broad range of wet-bench and potentially therapeutic applications.
Examples of caged macromolecules include proteins, neurotransmitters, fluorophores,
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lipids, and nucleic acids (Mayer and Heckel 2006; Ellis-Davies 2007). Photoprotected
species can be dispersed throughout the biological target without eliciting the normal
bioactivity, which is a major advantage over conventional methods for substrate
release. Additional benefits of this strategy include control over the local concentration
and spatial distribution, and the temporal release of the effector can be varied from
seconds to nanoseconds (Givens, Weber et al. 1998).
In order to be effective in biological systems, cage compounds must exhibit
various characteristics to achieve the desired response while avoiding unwantedeffects (reviewed by (Mayer and Heckel 2006; Ellis-Davies 2007; Tang and
Dmochowski 2007)). The chromatic properties of the caged species must allow for
efficient and non-toxic substrate release. Therefore the cage should have both a high
extinction coefficient at non-damaging wavelengths, corresponding to strong light
absorption characteristics, as well as a high quantum yield, which dictates energy
conversion efficiency. For applications in which a rapid biological response is being
measured, the rate at which the product is released through dark-reaction
intermediates may also be a significant factor. The caged molecule should be water
soluble and resistant to hydrolysis in order to be properly utilized under aqueous
conditions in physiological pH ranges.

Additionally, the caged molecule and the

released byproduct(s) should be physiologically inert to avoid potentially toxic sideresponses. Lastly, in order to progress beyond proof-of-concept studies, the mode of
covalent attachment between the cage and biomolecule should be relatively simple,
reproducible, and cost efficient. Although many caging systems adequately adhere to
these characteristics, no single cage exhibits the ideal properties for all categories.
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Many types of caging groups have been developed in efforts to improve the
aforementioned properties. However, most of these are simple conjugations to already
known photoprotecting groups. For instance, nitrobenzyl derivatives are often adorned
with electron donating functional moieties to achieve a hyperchromatic absorbance
shift into the near UV-light range (Aujard, Benbrahim et al. 2006).

Nitrobenzyl

derivatives are the most extensively studied of all the caging groups and were selected
for this study. A review of caging groups for nucleic acids is presented in the following
section.

1.3.2

Common Cage Groups
The number of incidences in which photoprotection groups have been used

to cage biomolecules has been rapidly expanding since ATP was first caged by Kaplan
in 1978.

For the purposes of this study, emphasis is placed a general review of

various categories of cage compounds while providing periodic examples of
applications. Although the experimental section of this work only utilizes one of these
caging groups, an understanding of available alternatives is paramount to future works
that may improve upon this body of work.

1.3.2.1

2-Nitrobenzyl Caging Group
The 2-nitrobenzyl (2-NB) caging group and its derivatives are the most

widely utilized cage molecules to date, and therefore are the best characterized
(Goeldner and Givens 2006). The pervasiveness in the literature in not necessarily an
indicator that this caging group has ideal photochemical properties or is the easiest to

32

use via synthetic or biochemical methods, but rather its’ widespread use first type of
cage compound applied to biological systems. Kaplan’s pioneering work using caged
ATP for controlling the NA:K pump utilized 2-NB cages from this category (Kaplan,
Forbush et al. 1978). They were also the first used to study millisecond time-scale
induction of the actin-myosin response to photolysed caged ATP (McCray, Herbette et
al. 1980; Goldman, Hibberd et al. 1982). The basic structure that defines the group is
a benzyl structure with an ortho-located nitro substitution. Variants of this structure
commonly include substitutions directly on the carbon ring and/or alternative
attachment chemistry on the methyl group (fig. 1.4a).
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Figure 1.4: 2-nitrobenzyl derivatives
Cage compounds in the 2-NB family of can be further subdivided based on
different substitutions at positions 4 and 5 as well as the exocyclic linker, as illustrated
in figure 1.4a.

Common subdivisions include 2-nitrobenzyl (NB) (fig. 1.4b), 4,5-

dimethoxy-2-nitrobenzyl (DMNB) (fig. 1.4c), 1-(2-nitrophenyl)ethyl (NPE) (fig. 1.4d), 1-
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(4,5-dimethoxy-2-nitrophenyl)ethyl (DMNPE) (fig. 1.4e), and α-carboxy-2-nitrobenzyl
(CNB) (fig. 1.4f). The driving motivation for developing derivatized forms of the cage
compound is to improve either the rate or efficiency of photolysis. Generally, electron
donating ring substitutions result a hyperchromatic absorbance shift, allowing
photolysis at longer wavelengths that are less damaging to biological systems.
However, these substitutions often significantly reduce the efficiency of photolysis
(Aujard, Benbrahim et al. 2006; Goeldner and Givens 2006).

Benzylic carbon α-

substitutions presumably affect the C-H bond at the site of attachment in the excited
state, which may affect the rate of hydrogen transfer that forms the aci-nitro
intermediate, illustrated below (Goeldner and Givens 2006).

However, the decay

process of 2-NB photo-cleavage is complex, and the rate constants at each stage
depend heavily on pH, make up of the media or buffer, the nature of the substrate, as
well as derivations to the cage compound (Il'ichev, Schworer et al. 2004).
The currently theorized mechanism of 2-NB photolysis begins with the
delivery of a photon that can be absorbed by the chromophore and induces an excited
state. Both singlet and triplet excited states have been identified and either state may
cause the hydrogen transfer to form the Z-nitronic acid (aci-nitro), which is converted to
the E-isomeric form (Yip, Sharma et al. 1985; Yip, Wen et al. 1991; 2006).

The

resulting aci-nitro compound is a long-lived intermediate and with several possible
isomeric forms, as aforementioned. It is the E,E isomer that spontaneously forms the
cyclic benzisoxazole that will ultimately lead to substrate release. This structure is
converted to hemi-acetyl intermediate, which is then further hydrolyzed to the 2nitrosobenzylcarbonyl and the released biomolecule (Walker, Reid et al. 1988; Corrie,
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Barth et al. 2003; Il'ichev, Schworer et al. 2004) (Goeldner and Givens 2006). The
nitroso byproduct has historically been theorized to be potentially reactive and toxic to
biological systems. However, there are only a few incidences of complications related
to this byproduct reported in the literature (Kaplan, Forbush et al. 1978; Zhang, Buchet
et al. 2004) and subsequent work suggests that the conclusions of these studies were
not accurate (Goeldner and Givens 2006).
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Figure 1.5: Proposed photolytic mechanism of 2-nitrobenzyl

1.3.2.2

p-Hydroxyphenacyl Caging Group
The p-hydroxyphenacyl group (pHP) is a relatively new category of caging

compounds. Although it was first utilized in photo-reactions in 1962 (Anderson and
Reese 1962) and identified as a potential photolabile protecting group by releasing
glycine in 1973 (Sheehan and Umezawa 1973), it was only about a decade ago that
this family of compounds was utilized as a caging group for biomolecules. Much like
the original 2-nitrobenzyl caging of ATP by Kaplan, this group was also exploited by
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Givens and Park to generate photo-released ATP (Givens and Park 1996; Park and
Givens 1997). Despite their recent entry into the caging field, these compounds have
been met with enthusiasm and are often included in biocaging review articles
(Pelliccioli and Wirz 2002; 2006; Mayer and Heckel 2006).
As dictated in the name, the general structure of the pHP group consists a
phenyl ring with an acyl attachment chemistry and a hydroxyl in the para-position. The
acyl functional group attachment allows for several attachment schemes such as
carbonyls, acyl halides, esters, and more. Other substitutions can be made at the
meta-positions on the phenyl ring. Electron donating groups at these positions cause
a hyperchromatic shift, but they also drastically reduce the quantum yield of the photoreaction (Conrad, Givens et al. 2000).

In contrast, electron-withdrawing ring
O
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HO
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6

X

1

2
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Figure 1.6: p-hydroxyphenacyl cage group
substitutions tend to increase the quantum yield (Goeldner and Givens 2006).
Interestingly, the withdrawing substitutions have little affect on the absorption spectra.
Figure 1.6 illustrates the basic structure of the pHP cage group.
The photo-release mechanism of the pHP cage is not as well understood as
the 2-NB group, but a general proposed chemical pathway has been proposed. The
initial photon-induced excitation creates a singlet excited state of the phenolic ring.
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This is then converted to a triplet state prior to substrate release (Conrad, Givens et al.
2000). Deprotonation of the excited compounds results in an anion oxide intermediate.
The proton transfer from the caged species to the solvent is supported by a strong
dependence on solution pH for uncaging (Goeldner and Givens 2006). The anion form
of the caged species is believed to undergo substrate release as the rate limiting step
as illustrated in figure 1.7 (Goeldner and Givens 2006). However, this process is
currently considered to be speculative.

The resulting intermediate is believed to

undergo hydrolysis and reprotonization to form p-hydroxyphenylacetic acid (pHPA).
Other proposed mechanisms hypothesize direct substrate cleavage from the triplet
excited state (not shown) (Goeldner and Givens 2006). These mechanisms would
allow for O-methyl or alkylether groups at the para-position, since deprotonization is
not required. In addition, the cage intermediate following substrate release may be in
equilibrium with an anion oxide isomer. Other exceptions to the proposed mechanism
include an example in which caged carboxylic esters photo-released directly from the
singlet state (Zhang, Corrie et al. 1999; Zhang and Taylor 1999) and that an attempt to
identify the spirodienedione intermediate through TRIR were unsuccessful (Pelliccioli
and Wirz 2002).
Substrates caged by pHP include but are not limited to ATP (Givens and
Park 1996; Park and Givens 1997), phosphates (Park and Givens 1997; Conrad,
Givens et al. 2000), and various amino acid based structures (Givens, Jung et al.
1997).

These studies indicate that the pHP cage group is capable of desirable

quantum yields, rapid photo-release, acceptable solubility and stability in aqueous
conditions, and non-toxic photo products. In addition to the favorable aspects of these
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compounds, several drawbacks were also identified. Most notably, these compounds
do not absorb well for wavelengths above 320 nm (Pelliccioli and Wirz 2002). As
aforementioned, derivations on the ring structure can improve the absorption
properties, but this causes in a drastic decrease in quantum yield.
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Figure 1.7: p-hydroxyphenacyl proposed photolytic mechanism
1.3.2.3

Coumarinyl Caging Group
The coumarinyl group was first recognized as a potential photoprotection

group in 1984, when a (coumarin-4-yl)phosphate ester was found to be photosensitive
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(Givens and Matuszewski 1984). It was nearly a decade later before this chemical
group was evaluated as alternative cage compounds for the 2-NB group (Furuta,
Torigai et al. 1993). These compounds typically possess high absorption coefficients,
fast photo-release kinetics, and large two-photon excitation cross-sections (Pelliccioli
and Wirz 2002; 2006). The strong absorption properties of these compounds (εmax
typically from 4,000 to 20,000 M-1cm-1) make up for relatively poor quantum yields of
photo-release (Goeldner and Givens 2006).

Another property of these cage

compounds is a strong fluorescence signal. The emission spectra may overlap with
common fluorescent probes, which limits the use of coumarin derivatives in certain
biochemical assays.

Despite this minor limitation, the coumarinyl group has

demonstrated practical photochemical properties along with a wide diversity of
derivatization possibilities.
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Figure 1.8: The coumarinyl cage group
The base structure of this group is a derivatized coumarin, as the name
indicates.

Coumarins consist of two fused six-member rings, one of which is an

oxygen containing heterocyclic ring with an adjacent carbonyl group (figure 1.8).
Attachment is in the meta-position in reference to the ring-bound oxygen. A methyl

39

functionality lies between the bound substrate and the coumarin. Ring-substitutions at
C6 and C7 are commonly used to red-shift the absorption maxima.

Ring

derivatizations can also be used to improve membrane permeability and water
solubility. In addition to these substitutions, the nature of the bound substrate can
have a significant effect on the photochemical properties of cage release.

The

coumarinyl group can be subdivided into several groups consisting of; 7-alkoxy, 6,7dialkoxy, 6-bromo-7-alkoxy, and 7-dialkylamino (reviewed by (Goeldner and Givens
2006)).

Figure 1.8 illustrates these sub-classifications in reference to the base

structure.
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A photo-release mechanism was proposed from the studies of various
coumaryl-caged phosphates (Schade, Hagen et al. 1999; Eckardt, Hagen et al. 2002;
Hagen, Frings et al. 2003).

In this scheme, photo-activation results in an excited

singlet state, followed by heterolysis or homolysis and subsequent electron transfer at
the site of substrate attachment. The unstable cationic released cage is then trapped
by the solvent. Figure 1.9 demonstrates this mechanism. Alternatively, studies of
coumarinyl-caged amines suggested a slightly different mode of photo-release, shown
in figure 1.9b (Sarker, Kaneko et al. 1997; Sarker, Kaneko et al. 1998; Schoenleber
and Giese 2003).

Photo-excitation results in electron-donor dependent homolytic

cleavage and the formation of a radical anion intermediate.
The coumarinyl group has successfully been used to cage phosphates,
carboxylates, carbonyls, alcohols, amines, and sulfonates (reviewed by (Goeldner and
Givens 2006)). Generally, the photo-kinetic properties of these compounds and the
flexibility for creating various coumarin derivatives are desirable. Despite the success
of this group used for in vitro assays, only a few examples in biological systems exist.
However, these studies have also yielded positive results. In fact, one of the first
examples of a coumarinyl-caged macromolecule used in a biological system was a
Bhc-caged mRNA for photo-induction of gene expression (Ando, Furuta et al. 2001;
Ando, Furuta et al. 2004).

1.3.2.4

Benzoin Caging Group
The benzoin group was first reported in 1971, where 3’,5’-dimethoxybenzoin

caged acetate was released upon photoexposure (Sheehan and Umezawa 1973).
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This

study

reported

a

clean

photolysis

reaction

yielding

acetate

and

dimethoxybenzofuran at an exceptionally high quantum efficiency (Φ = 0.64).
Although various other derivatives have been tested, the two most common forms
include the unsubstituted and the 3’,5’-dimethoxy benzoins (reviewed by (Pelliccioli
and Wirz 2002)). The general structure of these compounds is depicted in figure 1.10,
along with the general photo-release scheme. A detailed figure on the photo-release
mechanism is not shown do to the high degree of disagreement in several proposed
mechanisms. It is likely that the nature of the substrate and the attachment chemistry
have a profound effect on the mode of photo-release. Several studies demonstrate
quenching of photo-release by the addition of piperylene or naphthalene, indicating
that photolysis occurs through the excited triplet state (Sheehan and Umezawa 1973;
Rajesh, Givens et al. 2000). These quenchers facilitate vibration relaxation of the
excited state, and they function through the triplet state since it is less energetic.
However, studies of different benzoin-caged substrates demonstrated a lack of
susceptibility to quenching(Sheehan and Umezawa 1973; Pirrung and Shuey 1994),
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Figure 1.10: The benzoin cage group
suggesting different photolytic pathways. Proposed mechanisms of photolysis include
heterolytic dissociation and cation formation through the singlet state (Rajesh, Givens
et al. 2000), formation of a strained bicyclic intermediate that breaks down to release
the substrate (Sheehan and Umezawa 1973), and triplet state heterolytic cleavage to
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form an ion pair followed by elimination through ring closure (Cameron, Willson et al.
1996).
Benzoin cage compounds typically exhibit high quantum yields and fast
release kinetics, (Sheehan, Wilson et al. 1971; Corrie and Trentham 1992; Givens,
Athey et al. 1993; Pelliccioli and Wirz 2002). However, there are several drawbacks to
this cage group. It has a strong absorption coefficient, but this occurs in the 300 nm
range (Pelliccioli and Wirz 2002). Radiation of this wavelength is not tolerated by
biological systems. Additionally, these compounds exhibit strong fluorescence, limiting
their use for some fluorescence-based in vitro assays (Pirrung and Shuey 1994).
Finally, these compounds are highly hydrophobic and reduce the solubility of the
bounds substrate in physiological conditions. An attempt to develop a water soluble
derivative using bis(carboxymethoxy) substitutions reduced the photolytic yield (Rock
and Chan 1998).

1.3.3

Caging of Nucleic Acids
Examples of caged nucleic acids (NAs) are much less abundant and more

recent when compared to other categories of caged compounds, such as smallmolecule metabolites and proteins. This is surprising given that the original model for
caged biomolecules was based on nucleotides such as caged-ATP (Kaplan, Forbush
et al. 1978). Additionally, the potential utility of caging NAs is readily apparent since
they participate in a variety of biochemical reactions that are inherently dependent on
structure. Although earlier examples of caged NAs exist, the first study in which caged
DNA was used in a cellular system did not occur until 1999 (Monroe, McQuain et al.
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1999; Monroe, McQuain et al. 1999). In this work, plasmids encoding for GFP or
luciferase were caged with DMNPE-groups in bulk based on diazo attachment to
nucleotide phosphates. Using this strategy, the authors were able to demonstrate
photo-induced transgene expression. Despite this three-decade gap from caged ATP
to caged DNA use in biological systems, this study ignited interest in the field by
demonstrating the utility of caging NAs.
Prior to the 1999 study by Haselton and colleagues, there were several
examples of caged NAs being used for chemical or enzymatic applications in vitro.
Photoprotection groups offer alternatives for NA synthesis. Caging has been used for
microarray oligonucleotide synthesis (McGall, Labadie et al. 1996) and as an
alternative nucleobase protection for solid-phase synthesis (Alvarez, Vasseur et al.
1999). This technique has also been used to control the self annealing of a hairpin
(Ordoukhanian and Taylor 1995) and the hybridization of an oligonucleotide to its
complement (Ghosn, Haselton et al. 2005).

Caging compounds have also been

employed by Meldrum et al. to study DNA repair kinetics (Meldrum, Chittock et al.
1998). This study was an extension of their earlier work in which radiolabeled cagedATP was used to study the same phenomenon (Meldrum, Shall et al. 1990). The first
example of a nucleic acid with a caged compound inserted at a precise location was
demonstrated by Chaulk and Macmillian (Chaulk and MacMillan 1998). In this study
the authors prepared a 2’-O-caged phosphoramidite for insertion into a full-length RNA
oligonucleotide.

They prepared a ribozyme target that was caged at the site of

catalytic cleavage and demonstrated protection of the RNA substrate until
photoexposure. These authors expanded on this original work to disrupt splicesome
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and polymerase activity using the site-specifically caged NA strategy (Chaulk and
MacMillan 2001). Responding to requests from the scientific community, Chaulk and
MacMillian have recently published detailed protocols for their technique (Chaulk and
MacMillan 2007). This 2’-hydroxyl caging strategy was later adopted by Pitsch for the
development of alternative conditions for synthesizing RNA (Pitsch, Weiss et al. 1999).
In addition to these early studies, there is a large body of literature relating to photoinduction of strand breaks using photosensitive adducts (Reviewed by (Mayer and
Heckel 2006)).
Chaulk and MacMillian used a de novo synthetic process to cage RNA on
the 2’-hydroxyl while Monroe et al. used a batch-style reaction to achieve random
attachment to the phosphate backbone, or “statistical caging”. The latter was also
adopted to cage mRNA and plasmid DNA using a derivatized coumarin caging group
(Ando, Furuta et al. 2001; Ando and Okamoto 2003). Through this strategy, Ando et
al. were able to control transcription of the mRNA in a zebrafish model. Interestingly,
the caged mRNA appeared to be surprisingly stabile. This contrasts with our results,
in which caging of double-stranded RNA resulted in fragmentation of the target (see
section 1.4), presumably through a 2’-hydroxyl attack at the phosphotriester (Breslow
and Xu). The same approach which caused hydrolysis of the dsRNA was used to
produce

1-(4,5-dimethoxy-2-nitropheynl)ether

Rangarajan et al. 2005).

(DMNPE)

caged

siRNAs

(Shah,

In both incidences of statistical RNA backbone caging

reported in the literature, the caged RNA effectors demonstrated reduced activity
relative to their respective controls, which was partially restored by exposure to 350365nm light. In an effort to reduce the leak activity, improve the efficiency of photo-
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induction, and avoid RNA hydrolysis, two groups have separately expanded on caged
siRNA by incorporating a single photolabile group onto the 5’ terminal phosphate of the
siRNA antisense strand (Nguyen, Chavli et al. 2006; Shah and Friedman 2007).
These studies are discussed in further detail in chapter 3.

Briefly, Nguyen et al.

demonstrated that these caged siRNA had very little activity until silencing was
efficiently restored with light. Small leak activities were explained by N-1 contaminants
from the synthesis process, in which the cage-containing terminal nucleotide was
missing. Shah and Friedman disputed this interpretation since their data shows a
significant higher leak RNAi activity in the caged state. Their interpretation was that
the RISC components have the ability to interact with the remaining non-bridging
phosphate-bound oxygen, allowing some RNAi to proceed.
Significant progress has been made in recent years toward site-specific
caging of nucleic acids.

A review of the studies above suggests that in order to

achieve a binary, “on-off behavior”, for caged NAs, control over positioning of the
caging group is necessary. The original work by Chaulk and MacMillian was limited to
only adenosine residues that are caged on the 2’-hydroxyl. However, the design of a
caged NA for various effectors will require more flexibility.
expanded the 2’-O-caging to include the other bases.

Pitsch and colleagues

However, other work has

attempted to include the caging species on the nucleobases. The first example of a
caged nucleobase appeared in 1992, where a caged adenosine derivative was used
for self-replication but was not incorporated into an oligonucleotide (Hong, Feng et al.
1992). The first example of a caged base within an oligonucleotide came in 2004 and
was also an adenosine derivative (Ting, Lermer et al. 2004). This study used a non-
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traditional photoactive C8 thioether-linkage to control DNAzyme activity. Shortly after
this study, the 2-nitrobenzyl caging moiety was used for all bases. A 2-nitrobenzyl
group to cage the O4-position of thymine and the resulting NAs were used to disrupt
T7 polymerase (Krock and Heckel 2005) and control aptamer activity (Heckel and
Mayer 2005). This same team also caged the guanine nucleobase in order to control
aptamer activity by controlling G-quadruplex structure formation (Mayer, Krock et al.
2005). At nearly the same time, another group presented NPE caged guanine to study
tertiary folding kinetics of RNA (Wenter, Furtig et al. 2005).

Almost immediately

following these studies, Höbartner and Silverman produced a complete set of NPE
base-caged RNA residues (Hobartner and Silverman 2005). This offers a great deal of
design flexibility to researched developing caged oligonucleotide effectors. However,
these compounds are still significantly limited in two ways. First, generation of the
caged precursors requires considerable chemical expertise and is a limiting factor for
many biologists. Second, since the caging groups are non-substituted 2-nitrobenzyl
cage groups, uncaging requires photoexposure in a range of wavelengths that is
damaging to biological systems.
Dmochowski and colleagues.

One final example of base caging comes from
This group has created a 25nt oligonucleotide

containing a cytosine with a nitrobenzyl linker that is further conjugated to a
fluorescence quencher (Tang and Dmochowski 2005).

An adjacent nucleotide

contains a fluorophore, which emits a fluorescent signal upon photo-release of the
quencher. They used this cage attachment chemistry to control RNAse H mediated
digestion through hairpin loop caging (Tang and Dmochowski 2006).
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1.3.4

Special Considerations

1.3.4.1

Two-Photon Excitation
One of the newest frontiers in caging technology is the application of the

two-photon excitation (TPE) strategy, first applied by Webb and colleagues (Denk,
Strickler et al. 1990). The time required to produce an excited electron state when a
chromophore absorbs a single photon is on the order of 10-15 s-1 (Ellis-Davies 2007).
TPE occurs when two photons of half the necessary energy are absorbed within this
time-frame, or “simultaneous” absorption.

The probability for the simultaneous

absorption of two photons is proportional to the square of the incident light intensity
One-photon
uncaging

Two-photon
uncaging

Figure 1.11: One versus two-photon uncaging. Brackets and shading depict the
region of efficient uncaging.
and the two-photon absorption cross-section, measured in units of Göppert-Mayer (1
GM = 10-50 cm4·s·photon-1) (Göppert-Mayer 1931; Pelliccioli and Wirz 2002). This
strategy has several advantages over single-photon uncaging. Since the excitation is
exponentially dependent on the incident light intensity, much greater three-dimensional
control over substrate release can be achieved. Figure 1.11 illustrates that TPE is
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confined to a very small region near the focal point of the excitation laser. It has been
demonstrated that the spatial resolution of TPE can reach sub-femtoliter volumes
[Brown, 1999 #334; Brown, 1996 #335]. Another benefit of TPE is that it relies on IR
radiation for excitation. Light in this wavelength range is capable of deeper tissue
penetration and is less likely to cause damage to biological systems. Nevertheless,
photo-toxicity is response to TPE has been observed in biological systems when the
power of the incident laser exceeds 5 to 10 mW (Hopt and Neher 2001).

1.3.4.2

Convertible Nucleoside Approach
An alternative to generating phosphoramidites containing photolabile

protecting groups on the nucleobase or the ribose 2’-hydroxyl is post-synthesis
substitution of the oligonucleotide. For this technique to be affective, the protecting
groups used need to be stabile under the conditions of RNA solid-phase synthesis, but
they must also susceptible to some form of substitution for post-synthetic placement of
the cage compound. In an effort to generate cross-linked nucleic acid duplexes to
study DNA-protein interactions, a group led by Verdine developed a method for
incorporating reactive nucleotide analogs for post-synthetic substitution of NAs. They
named their technique “the convertible nucleotide approach” (Ferentz and Verdine
1992; Ferentz, Keating et al. 1993). Building on the foundation of successful postsynthetic modification, this group developed a complete set of convertible nucleotide
analogues for site-specific incorporation into DNA (Macmillan and Verdine 1990;
Macmillan and Verdine 1991; Erlanson, Chen et al. 1993; Ferentz, Keating et al. 1993)
and RNA (Allerson and Verdine 1995; Allerson 1996; Allerson, Chen et al. 1997). The
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Figure 1.12. Convertible nucleotide approach. Benzylamine used as a model for 2nitrobenzylamine mediated caging. A = convertible adenosine reaction, B =
convertible cytosine reaction, and C = convertible guanine reaction
conversion reaction requires a primary amine that is nucleophilic in nature and is
performed following oligonucleotide synthesis. In the case of convertible RNA, this
reaction is performed prior to 2’-deprotection. If a suitable cage compound containing
a nucleophilic amine is available, this process would be practical for biologists and
those in other disciplines whose focus is not on synthetic chemistry techniques.
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Although a number of amines were tested by Verdine’s group, the
attachment of a 2-nitrobenzyl group through the convertible nucleotide approach was
not attempted.

However this group did successfully demonstrate the conversion

reaction using benzyl amine (fig 1.12) (Allerson 1996). Recently, this same chemistry
was used to generate site-specifically modified siRNAs by reacting benzyl amine with
an internal convertible G (Puthenveetil, Whitby et al. 2006). Although the authors of
the latter study were using this technique to probe the cytokine response induced by
small RNA duplexes, this serves as a foundation for the use of this approach for sitespecifically modified siRNAs. This work demonstrates the use of this approach to
generate an internally N6-caged adenosine using 2-nitrobenzl amine and a novel 4,5dimethoxy-2-nitobenzyl amine.
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CHAPTER 2
Initial Feasibility Studies for Caging RNA
2.1

Determination of Caging Efficiency
Before experimental conditions of cage attachment to oligonucleotides could

be varied for optimization (described below), it was necessary to determine spectral
properties of the dimethoxy-2-nitorbenzyl product. The hypothesized position of cage
attachment for the reactive diazo-intermediate is on the negatively charged phosphate
of the NA.

This theory is based on common use of diazo chemistry to alkylate

phosphate groups in addition to previous caged nucleic acid examples (reviewed by
(Monroe and Haselton 2004)). Therefore, the expected product would be a phosphate,
which would likely have little effect on the absorbance spectrum of the NA. A simple
experiment was performed to determine the spectral properties of DMNPE-phosphate.
2-nitrobenzyl hydrazone cage precursor (5 mg) was activated in DMF (1 mL)
and filtered according to the protocol discussed below. A control was simultaneously
processed without the addition of the 2-nitrobenzyl hydrazone. Both the activated
diazo cage and process control (0.1 mL) were added to an excess of concentrated
phosphoric acid (15 mL). The process control was used to obtain baseline spectra at
various dilutions in deionized water.

Absorbance spectra for several dilutions of

reacted cage were obtained in triplicate, and extinction coefficients were determined
for A260, A355, and A500. The results (ε260 = 3064, ε355 = 4512, ε500 = 0 M-1cm-1),
were in agreement with previous studies (reviewed by (Monroe and Haselton 2004)).
Following a caging reaction, the isolated caged oligonucleotide products
were analyzed through spectroscopy to determine caging efficiency.
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Briefly, the

absorbance spectra of a caged products were measured from 230 to 500 nm. A500
was utilized as a standard to zero each measurement. A355 was used to calculate the
molar concentration of attached DMNPE. Once this concentration was known, the
absorbance at 260 nm due to this DMNPE was subtracted from the measured value.
The corrected A260 was used to calculate the molar concentration of the nucleic acid.
The degree of phosphate alkylation is reported as “caging efficiency”. This term is
descriptive of the percentage of the phosphate groups has reacted with the diazo 2nitrobenzyl.

For instance, an oligonucleotide with 20 monomers would have 19

phosphate groups, assuming the 5’-end is not phosphorylated.

For this sample

scenario, a 100% caged product would require a 19:1 molar ratio of oligonucleotide to
cage group in solution.

100*(A355)
(ε355DMNPE)

% Caging Efficiency =
(A260) -

(A355)(ε260DMNPE)
(ε355DMNPE)

(ε260NA) · (phosphates/NA)

Equation 2.1: Equation used to calculate the caging efficiency following removal of
all unreacted diazo cage compound. The numerator is used to determine the molar
concentration of attached cage. The denominator is used to calculate the molar
concentration of free phosphates using a corrected absorbance.

After UVA light exposure, the quantum yield (Φ) can be calculated for the
photolysis event. In this case, Φ refers to the number of photo-release events for each
photon absorbed by the cage molecule. Measuring this property requires an additional
purification step to remove any photo-released cage from the deprotected NA. With
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proper product purification and characterization of the incident light, Φ can be
calculated from analysis of the post-UVA light treated caged species and the predetermine absorbance properties of the cage molecule.
A355Caged - A355Caged

Quantum Yield (Φ) =

(ε355DMNPE) · L
Light Dose (J/cm2)
Area · LOG-1(ε355DMNPE · CDMNPE · L)
h · C(speed of light)
λ

Equation 2.2: Equation used to calculate Φ following photo-release. The numerator
is used to determine the molar amount of DMNPE removed by light treatment. The
denominator is used to calculate the number of photons absorbed by the caged
species.

2.2

Determination and Optimization of Caging Protocol
The cage attachment procedure was modeled after previous examples in the

literature (Monroe, McQuain et al. 1999; Ghosn, Haselton et al. 2005; Shah,
Rangarajan et al. 2005). Dimethoxy-2-nitorbenzyl hydrazone (5 mg) was dissolved in
an organic solvent and converted to the diazo-form using MnO2 (50 mg) for 20 minutes
at room temperature under agitation. The MnO2 was pelleted through centrifugation
and the supernatant was filtered through a prewetted diatomaceous earth column.
The resulting active cage solution was added to an aqueous solution of NA, buffered to
a desired pH. The reaction was shielded from light, and typically allowed to react at
4oC for 18 hours. Once complete, the unreacted cage was removed through size
exclusion chromatography using solvent resistant LH-20 sephadex (GE Healthcare
Bio-Sciences Corp., Piscataway, NJ). The product solution was then dried in vacuo
until most of the solvent was removed.
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Deionized water was used to bring the

concentrated solution to 500 μL. All remaining organic solvents, by products, and
unreacted cage molecules were removed through a nitrocellulose spin filter (YM3,
Microcon).

Table 1.1

Caging Efficiencies
efficiencies of Various
various NA
Caging
NA targets.
Targets.
NA type, base composition and pH are varied.
Caging Efficiency
No UV
+ 365 nm
Exposure Exposure

Sample Type

pH

DNA mixed sequence
DNA mixed sequence
DNA oligo dT
DNA oligo dT
FNA mixed sequence
Morpholino mixed sequence

5.5
8.0
5.5
8.0
5.5
5.5

46.7
4.0
41.5
6.4
36.2
18.3

13.4
1.6
9.3
1.4
12.4
4.3

Morpholino mixed sequence

8.0

7.2

4.9

In an effort to obtain purified products through a range of caging efficiencies,
several variables of the caging reaction were investigated. The following variables
were examined to determine their effect on the caging reaction: nucleic acid type
(DNA, RNA, PS, 2’-fluoro substituted NAs, morpholino), nucleobase composition,
concentration and molar excess of active diazo-cage, reaction duration, reaction
temperature, organic solvent, and pH of the aqueous buffer. Variables which affected
the efficiency of the cage reaction included pH, relative molar excess of active cage,
and type of nucleic acid target. PS NAs experienced the highest alkylation rate among
the samples tested. Morpholino oligonucleotides, which lack a phosphate backbone,
also showed cage attachment, albeit at a lesser rate. Since these polymers do not
contain any phosphates, this suggests that either a minimal degree of nucleobase
alkylation is possible or that a more specific reaction is occurring with the specialized
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backbone of this NA. Reaction with the backbone morpholinos is unlikely as they are
comprised of stable 6-membered morpholino rings bound by phosphorodiamidate
linkages. Sugar-modifications seemed to have little effect on the caging process, and
therefore DNA, RNA, and FNA all yielded equivalent efficiencies.

Reaction

temperature and reaction duration also had little effect on the outcome of the reactions.
This is likely because these reactions proceeded to completion in the timeframes that
were tested, even at 19oC. The organic solvent used to activate the cage hydrazone
also had little effect on caging reaction outcome. However, different organic solvents
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Figure 2.1: Caging efficiency by cage concentration and reaction temperature
required optimization of the purification process to prevent loss of the product and poor
reaction yields.

Altering base composition yielded somewhat inconsistent results.

However, it was evident from these preliminary studies that the sequence of the
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nucleic acid may have an unexpectedly robust influence on caging efficiency. Below
are results from two sample experiments that tested some of these variables.
In addition to developing a protocol to adjust the caging efficiencies for
various NA targets, improvements to caged product purification were also required.
Previous studies that utilized this caging technique targeted larger NAs such as
plasmid DNA or mRNA (Monroe, McQuain et al. 1999; Ando, Furuta et al. 2001). This
required fewer caging molecules to render the biomolecules inert, which allows for the
purification through phase separation. For hybridization disruption, oligonucleotides
seem to require a higher percentage of caged phosphates, which reduces the
hydrophillicity of the molecule and results in inefficient liquid-liquid extraction. Since
caging of the oligonucleotides alters the hydrophillicity and eliminates backbone
charge, separation based on these principles is challenging.

Size-exclusion

chromatography and filtration, two techniques based on molecular size, provided the
most reasonable alternative.

However, organic solvent contamination is often

incompatible with the materials used for these separation techniques. Additionally, the
crude product can not simply be dried to remove the organic solvents because the
unattached caging material will partially precipitate from the remaining aqueous
solution. Therefore, a solvent-resistant size-exclusion chromatography material, LH-20
sephadex, was used. The separation capabilities were tested for each organic solvent
used in the reaction (DMF, DMSO, acetonitrile). Figure 2.2 illustrates that separation
occurs well for solutions containing 30% or less acetonitrile in aqueous buffer. Any
new solvent system must be tested in this manner to ensure proper cage removal.
Once the solvent conditions were determined for adequate separation from the free
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cage, the system was also tested using spin filters at a relative centrifugal force of
500g. Preswollen LH-20 sephadex could be used in either a gravity or spin column,
and each technique had benefits and drawbacks. Gravity columns could handle a
larger load of material, but the process was slower and generated larger volumes that
required longer drying steps. Spin columns were very fast, but only a limited volume
could be added to the column bed. Additionally, the fixed angle rotor found in many
microtube centrifuges sometimes caused uneven elution of the product solution.
Following size-exclusion, the solutions were dried in vacuo until less than 25 μL of
solvent remained in order to remove most of the organic component. This solution
was brought to a volume of 500 μL with deionized water and applied to the cellulose
filtration system, YM3 amicon spin filters (Millipore, Billerica, MA). The product was
filtered several times by adding water to the filter and spinning to elute the unwanted

Figure 2.2: LH-20 sephadex resolution. Size-exclusion separation as a function of
% organic solvent. From left to right, loaded LH-20 sephadex was washed with
100%, 80%, 60%, 40%, 20%, and 0% organic solvent (acetonitrile). The panel on
the right illustrates the resolution of a spin filter eluted at 400Xg at 30% organic
solvent.
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material. This step removed any remaining organic solvents, removed any remaining
free cage contamination, and desalted the product. However, this step was particularly
sensitive to organic contamination, and improper handling before this step resulted in
poor yields. When performed properly, this cleaning protocol would consistently result
in caged NA recovery yields greater than 90%.
The final reaction conditions used to generate caged oligonucleotides that
were unmodified on the phosphate or the nucleobase are as follows. Dimethoxy-2nitorbenzyl hydrazone (5 mg) was dissolved in 1 mL of acetonitrile and activated using
MnO2 (50 mg) for 20 minutes at room temperature. If less efficiently caged products
were desired, several dilutions of the active diazo-cage were made following MnO2
removal. The nucleic acid was diluted to 500 ng/μL in BisTris buffer (50 mM Bis-TrisHCl, 1 mM EDTA, pH 5.5), and the active cage was added to achieve a final solution of
2:1 acetonitrile:water. The reaction was agitated at 4oC for 18 hours in the dark. At
this time, water was added to the reaction solution to obtain a 3:10 acetonitrile:water
concentration. A gravity column was packed with prewetted LH-20 sephadex and
washed with three column volumes using the appropriate solvent. The entire reaction
was added to the column and the eluent was collected. The column was washed with
3 X 200 μL using deionzed water to ensure all nucleic acid was eluted from the
column. The collected product was dried in a vacuum centrifuge until less than 25 μL
remained. This was added to 500 μL of water in a YM3 amicon spin filter, which was
spun at 12,000Xg for 100 minutes. Water was added (500 μL) twice and the spinning
elution was repeated each time. All eluents from this step were kept until the product
recovery was verified, and then they were discarded. YM3 filtration would typically
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yield 50 μL of an aqueous solution of the purified product. The product was measured
by spectroscopy to determine caging efficiency and product yield.

2.3

Caging of 700bp dsRNA
Initially it was proposed that caging of long double-stranded RNA would be a

feasible means to control RNAi by light. This has several benefits over caging small
RNAs. First, these targets can be generated more easily through in vitro enzymatic
methods. Secondly, this technique did not require the screening for active siRNA
sequences, as Dicer acts to digest these products into a pool of siRNAs. This process
can be carried out in vitro using a recombinant Dicer enzyme to generate siRNAs for
use in mammalian cell culture. Finally, caging at this stage offers another level of
control since the processing by Dicer is an additional protein-NA interaction that may
be disrupted.

However, this preliminary experiment allowed the identification of a

major design flaw in the original proposal.
The Dicer siRNA Generation Kit (Genelantis, San Diego, CA) provided all
the necessary materials for the initial experiment including: the dicer enzyme, a control
GFP reporter plasmid, T7 polymerase, and the appropriate PCR primers. PCR was
carried out according to the manufacturer instructions to generate a 700bp RNA
transcript. This dsRNA was subjected to the caging reaction using DMF as the organic
solvent. The product was analyzed by spectroscopy and DMNPE attachment was
verified. These products were further analyzed by capillary electrophoresis using the
Agilent 2100 Bioanalyzer lab-on-a-chip platform and the accompanying DNA 1000
reagent system [Agilent, Clara, CA], according to the manufacturer protocol. Figure
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2.3 shows the electropherograms of the resulting products as they relate to the 15bp
and 1500bp internal standard peaks. The process control RNA is detected at around
90 seconds, which corresponds to the expected migration time for a 700bp NA.
However, the caged sample elutes much sooner, at around 50 seconds. This shift
direction was unexpected since cage attachment should increase the migration time
through standard principles of electrophoresis. Indeed, photoexposure increased the
mobility of the caged species, suggesting removal of the cage groups.
These results indicate that caging RNA using phosphate alkylating diazo
cage compounds is possible, but it also results in fragmentation. RNA is known to be

Caged

Caged + Light

Control
Control
+ Light

Control
+ Light
Cage
+ Light

Figure 2.3: Capillary electrophoresis of caged 700bp dsRNA. Faster elution of caged RNA
indicated strand cleavage from the caging process.
susceptible to self-hydrolysis due to the presence of the 2’-hydroxyl on the ribose
moiety.

Additionally, RNA phosphotriesters have been shown to be particularly
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unstable in aqueous solutions (Breslow and Xu). This aqueous instability is due to the
2’-hydroxyl attack and cyclization of the 2’-3’ positions of the ribose, creating an
unstable intermediate.

Therefore internally caged nucleotides might be very

susceptible to scissile bond cleavage and degradation of the RNA.

Alternatively,

hydrolytic release of the cage molecule is a possibility. This experiment prompted a
search for a chemically stabilized RNA mimic and is the subject of Chapter 3.

2.4

Design of the siRNA for the pAcGFP Reporter System
Established siRNA design requirements were followed, such as maintaining

approximately 50% GC content of 21nt sense and antisense strands which hybridize to
yield 2nt, 3’ overhangs (Elbashir, Lendeckel et al. 2001).

The overhangs were

designed as UU on both strands, and a sequence was chosen so that the antisense
overhang was still homologous to the target gene. Additionally, the first nucleotide of
both the sense and the antisense transcripts was guanine since it is typically the first
addition by T7 polymerase (Donze and Picard 2002). This required the 19th nucleotide
of each transcript to be cytosine. Additionally, several sequence requirements were
necessary for endeavors into the site-specific incorporation of a cage species. The
most likely base for this site specific incorporation is adenosine because of its stability,
history of ATP experiments, possession of an exocyclic primary amine, and previous
caging of this nucleotide in the literature. Therefore, one adenosine was placed within
the first 5 nucleotides from the 5’-end and one was placed at the 11th nucleotide from
this end. These are considered as important sites for RISC recognition and mRNA
processed. The sequence of the GFP plasmid, pAcGFP-N1 (Clontech, Carlsbad, CA),
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used in knockdown experiments was searched for an appropriate target, which was
also subjected to a BLAST search to ensure no cross-reactivity with other known
genes.
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CHAPTER 3
2’-Fluoro Nucleic Acids Induce RNA Interference
3.1

Introduction
RNA interference refers to a highly specific, very potent, and naturally-

occurring post-transcriptional silencing of protein expression initiated by RNA (for
review, see (Tomari and Zamore 2005)). Since its discovery in 1998 (Fire, Xu et al.
1998), RNAi has drastically altered our understanding of gene regulation by
introducing a plethora of small regulatory RNA molecules.

These molecules are

termed small-interfering RNAs (siRNAs), small-hairpin RNAs (shRNAs), or microRNAs
(miRNAs), depending on their origin and specific structure (Elbashir, Lendeckel et al.
2001; Matzke and Matzke 2003). In addition to these variations, recent works show
that single-stranded RNA molecules (antisense siRNA) can elicit RNAi in mammals
(Martinez, Patkaniowska et al. 2002; Schwarz, Hutvagner et al. 2002; Amarzguioui,
Holen et al. 2003; Holen, Amarzguioui et al. 2003). A collection of proteins known as
the RNA-induced silencing compound (RISC) incorporate the siRNAs, which act as a
guide for sequence recognition and enzymatic degradation of target mRNAs in the
cytoplasm. Some intramolecular RNA structural requirements that are necessary to
elicit these various pathways and consequences with respect to siRNA design have
been described in recent studies.

A common focus of these works is chemical

modification of siRNAs to improve pharmacological efficacy. In order to develop useful
RNAi drugs, the siRNA must be efficiently delivered systemically, exhibit highly specific
knockdown of the target gene, and maximize the duration of silencing. For these
reasons, modifications have been made which optimize the lipophilicity of RNA,
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increase the stability of the duplex, and impart resistance to RNAses, respectively.
The relative successes and failures of these modifications have helped to identify
useful alterations that may be well-tolerated by the RNAi pathway.
Phosphate backbone and ribose modifications are widely used to increase
resistance of RNA to enzymatic degradation ((Elbashir, Lendeckel et al. 2001;
Amarzguioui, Holen et al. 2003; Braasch, Jensen et al. 2003; Chiu and Rana 2003;
Czauderna, Fechtner et al. 2003; Harborth, Elbashir et al. 2003; Dowler, Bergeron et
al. 2006) reviewed by (Manoharan 2004; Zhang, Du et al. 2006)).

In addition to

nucleases resistance other such modifications impart other desired characteristics
such as preference for a certain helix formation or increased thermal stability (Kurreck
2003; Manoharan 2003; Manoharan 2004). For this reason, many types of modified
siRNAs have been evaluated for their ability to elicit target mRNA degradation and
subsequent gene knockdown with highly variable results between studies. Other than
halide substitutions, modifications at the 2’ site have been problematic. O-methyls,
locked nucleic acids (LNAs), or other bulky substitutions can be used only sparingly
and are thought to protrude into the minor groove and disrupt RISC recognition of the
duplex (Braasch, Jensen et al. 2003; Chiu and Rana 2003; Czauderna, Fechtner et al.
2003).

Complete 2’-deoxy substitution, results in a conformational change of the

duplex to a B-type helix and does not exhibit RNAi activity (Chiu and Rana 2003). 2’Deoxy-2’-fluoro modifications seem to be the best-tolerated alteration with respect to
maintaining silencing activity (Manoharan 2003; Manoharan 2004). Unfortunately, 2’-F
substituted purines have been unavailable commercially until recently, so only
pyrimidine-modified siRNA mediated gene silencing has been attempted to date.
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Several studies have shown similar levels of RNAi elicited between wild-type siRNA
and these synthetic counterparts that contain fluorine on every pyrimidine (Braasch,
Jensen et al. 2003; Chiu and Rana 2003; Harborth, Elbashir et al. 2003; Manoharan
2003; Layzer, McCaffrey et al. 2004; Manoharan 2004; Soutschek, Akinc et al. 2004).
Sullenger and colleagues showed that 2’-F pyrimidine-modified siRNAs and
unmodified siRNAs have similar activity over a range of concentrations and silencing
durations (Layzer, McCaffrey et al. 2004). Chiu and Rana compared silencing potency
of various siRNA modifications and found that siRNA completely modified with 2’-F
pyrimidines and 2’-H purines showed only a 50% decrease in knockdown ability
relative to an unaltered siRNA counterpart (Chiu and Rana 2003). Interestingly, Bhat
and colleagues demonstrated that fully-modified duplexes which included 2’-F
pyrimidine nucleotides and 2’-O-methyl purine nucleotides actually increased RNAi
efficiency, and in one case they achieved a 500-fold increase in silencing ability
(Allerson, Sioufi et al. 2005).

The combination of several types of chemical

modifications into a single siRNA molecule are becoming increasingly common as
illustrated by a recent work by Morrissey and colleagues (Morrissey, Blanchard et al.
2005). Alternatively, 2’-deoxy-2’fluoro-β-D-arabinonucleic acid modifications, in which
the 2’-flouro is inverted, have been used to partially modify siRNA and successfully
induce RNAi (Dowler, Bergeron et al. 2006).

The combination of these results

suggests that the 2’-OH is not necessary for RNAi, but changes at this location that
alter either the global duplex structure or disrupt the minor groove can abolish
interference.

In addition to improving resistance to enzymatic degradation while

maintaining silencing efficiency, 2’-modifications have been shown to reduce off-target
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effects normally observed following siRNA delivery (Jackson, Burchard et al. 2006;
Cekaite, Furset et al. 2007). Since halide substitutions are thought to maintain the Atype helical structure by enforcing a C3’-endo sugar pucker confirmation (Guschlbauer
and Jankowski 1980; Chiu and Rana 2003) and they are not large enough to disrupt
the minor groove, siRNAs that contain 2’-F functional groups at every location may still
elicit potent RNAi. Although fully 2’F-modified nucleic acids have been generated and
evaluated for several characteristics which are crucial in antisense applications, these
compounds have not been evaluated for gene silencing in cells or in vivo (Kawasaki,
Casper et al. 1993). Replacing the hydroxyl at every location may also provide further
resistance to enzymatic degradation by nucleases and eliminate RNA degradation
through 2’-OH nucleophilic hydrolysis.
A mutated polymerase, originally developed for the ability to incorporate both
rNTPs and deoxy-counterparts, may provide a cost-effective method to generate fullyfluorinated siRNAs. Specifically, T7 with a mutation of tyrosine to phenylalanine at
position 639 (Y639F) eliminates discrimination at the 2’-location of the NTP substrate
by abolishing hydrogen bonding requirements (Sousa and Padilla 1995). Eliminating
the requirement for 2’-recognition might allow the polymerase to incorporate any 2’functional group that is not limited by steric hindrance. NTPs with small functional
group modifications at this location, such as amines and halides, are incorporated into
full length transcripts at differing efficiencies dependant on these steric limitations
(Padilla and Sousa 1999). Given that this enzyme has been used to incorporate 2’-F
modified pyrimidine NTPs at every location in full-length transcripts, its use may be
extended to generate a fully-fluorinated product.
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The potential benefits of fluorinated RNA with respect to RNAi stability have
prompted us to generate fully 2’-deoxy-2’-fluoro substituted nucleic acid (FNA) through
solid phase synthetic and in vitro transcription methods. Nuclease digestion assays
were performed to evaluate resistance to degradation compared to native RNA. We
have evaluated the ability of small interfering fluoronucleic acid (siFNA) to initiate
knockdown of a target gene in mammalian cell cultures. Additionally, these siFNAs
were evaluated for their silencing ability in both their duplex and single-stranded
antisense forms.

3.2

Materials and Methods

3.2.1

siRNA Design
Established siRNA design requirements were followed, such as

maintaining approximately 50% GC content of 21nt sense and antisense strands which
hybridize to yield 2nt, 3’ overhangs (Elbashir, Lendeckel et al. 2001). The overhangs
were designed as UU on both strands, and a sequence was chosen so that the
antisense overhang was still homologous to the target gene. Additionally, the first
nucleotide of both the sense and the antisense transcripts was guanine since it is
typically the first addition by T7 polymerase (Donze and Picard 2002). This required
the 19th nucleotide of each transcript to be cytosine. Using these design criteria, runoff
trasciption could be used to generate each strand in vitro. The sequence of the GFP
plasmid, pAcGFP-N1 (Clontech, Carlsbad, CA), used in knockdown experiments was
searched for an appropriate target, which was also subjected to a BLAST search to
ensure no cross-reactivity with other known genes.
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3.2.2

siRNA and siFNA Preparation
RNAs were generated in vitro using a T7 polymerase (Donze and Picard

2002) and using partial duplexes designed for run-off transcription. DNA templates
(Sense: 5’-AAGCGGATCTTGAAGTTCACCTATAGTGAGTCGTATTA-3’, Antisense:
5’-AAGGTGAACTTCAAGATCCGCTATAGTGAGTCGTATTA-3’,

T7

Primer:

5’-

TAATACGACT-CACTATAG-3’) were synthesized, desalted, and HPLC purified from
Alpha DNA (Montreal, Quebec, Canada). Equal molar ratios (75pMoles/μl) of each
template and the T7 primer oligonucleotide were annealed by bringing the solution to
95oC and slowly cooling to 4oC over 20 minutes. The RNAMaxx® in vitro transcription
kit (Stratagene, Cedar Creek, TX) was used according to manufacturer instructions to
generate each strand of RNA individually. FNA strands were generated using 2’FNTPs (purines from Trilink Biotechnologies, San Diego, CA, pyrimidines from
Epicentre, Madison, WI) and an alternate in vitro transcription kit, Durascribe®
(Epicentre, Madison, WI), which utilized a Y639F mutant T7 polymerase, R&DNA
Polymerase™ (Sousa and Padilla 1995; Padilla and Sousa 1999).

Final

concentrations of templates and NTPs were 50 ng/μl and 5 mM, respectively.
Transcription incubation times were extended from 8 hours for native unmodified RNA
generation to 48 hours for FNA generation. The transcription mixtures were treated
with DNAse I at a final concentration of 0.5units/ul overnight at 37°C to completely
digest the DNA template. The RNA/FNA products were then precipitated with sodium
acetate and ethanol, washed three times, and resuspended in nuclease-free water.
Additional purification of fluorinated products was carried out using Microcon YM-3
cellulose spin filters (Millipore, Billerica, MA) to remove possible early termination
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products under approximately 10nts in length.
determined by UV/VIS absorbance spectroscopy.

Product concentrations were
The 21-nt FNAs were also

chemically synthesized by University of Calgary Core DNA & Protein Services
(Calgary, AB, Canada).

Synthetic FNAs were PAGE purified and verified through

matrix-assisted laser desorption/ionization (MALDI) mass spectrometry. Homologous
strands at equal molar ratios were annealed as aforementioned to generate duplex
siRNA or siFNA.

3.2.3

Hybridization Analysis
Melting curves were measured for FNA duplexes, DNA duplexes, and

FNA/DNA hybrids to compare transcribed and synthetic FNA oligonucleotide
hybridization to the same target. For each case, complementary strands were brought
to equal molar concentrations of 4μM in a medium-salt buffer (100 mM NaCl, 10 mM
sodium phosphate, 0.1 mM EDTA, pH 7.5). The samples were annealed by heating to
95oC for 5 minutes and cooling to 4oC over 10 minutes, degassed under vacuum,
transferred to a quartz cuvette, and covered with 100μl of dimethylsiloxane to prevent
evaporation.

Melting experiments were conducted using an AVIV model 14DS

spectrophotometer (Lakewood, NJ).

OD260 was measured as a function of

temperature from 15oC to 90oC with a 2.5oC step. The samples were held at each
temperature for 2 minutes before absorbance reading were recorded.

Melting

temperature (Tm) values were calculated by determining the local maximum of each
melting curve’s first derivative.
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3.2.4

Nuclease Digestions
RNAse One™, an E. Coli derived RNAse, and an accompanying buffer

(Promega Corporation, Madison, WI) were used to evaluate nuclease resistance to
FNAs.

Equal molar ratios of single-stranded or duplex RNAs and FNAs were

suspended in optimal buffer and pH conditions as described by the manufacturer.
RNAse One™ was added to each solution to a final concentration of 0.5 unit/μl. The
digestion reactions were incubated overnight at 37oC. The products were evaluated
qualitatively by capillary electrophoresis on the Bioanalyzer 2100 Lab-Chip system
(Agilent Technologies, Wilmington, DE) using a custom protocol designed to evaluate
small oligonucleotides. The manufacturer loading buffer was replaced with a solution
of 200 nM N-Tris(hydroxymethyl)methyl-3-aminopropane sulfonic acid (TAPS) and 2
mM EDTA at pH 8.0-8.5 to eliminate the 15bp markers, which have similar mobility to
the experimental samples. With the exception of the loading buffer, a DNA 500/1000
electrophoresis chip was loaded according to the manufacturer protocol, but the chip
was run under the mRNA Nano programming conditions (provided within the
manufacturer’s software package) to obtain data within a useful range of short
migration times (<40 sec). The intensities for each electropherogram were normalized
to baseline fluorescence and are presented as a composite gel image.

3.2.5

Cell Culture and Transfection
BHK-21 (Baby Hamster Kidney) cells were cultured in reduced serum

Dulbecco’s

Modified

Eagle’s

Medium

(DMEM-RS)

(HyClone,

Logan,

UT)

supplemented with 3% heat inactivated fetal bovine serum (HyClone, Logan, UT) at
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37oC under 5% CO2 in a humidified chamber and regularly passaged at
subconfluence. Cells were seeded on 12 well plates (BD Biosciences, Franklin Lakes,
NJ) 18 hours prior to transfection at approximately 20K cells/cm2. Cotransfections of
pAcGFP-N1, and siRNA or siFNA were mediated with lipofectamine (Invitrogen,
Carlsbad, CA).

Transfection mixtures containing 0.1 μg of pAcGFP-N1, varying

amounts of siRNA or siFNA, and lipid (3:1 ratio of lipid with respect to total nucleic
acid) were assembled in 100 μl of reduced protein medium (OPTI-MEM®, Invitrogen,
Carlsbad, CA) and incubated at room temperature for 30 minutes. The plated cells
were rinsed with OPTI-MEM and 500 μl of OPTI-MEM was added to each well. The
transfection mixtures were added to the appropriate wells and the cells were incubated
at 37oC under 5% CO2 for 6 hours. The transfection media was then replaced with cell
culture media and the plates were incubated for 48 hours and harvested for expression
analysis.

3.2.6

Flow Cytometry RNAi Analysis
Transfected and control cell culture samples were harvested and fixed in

PBS suspension with 1% or 0.5% paraformaldehyde prior to GFP expression analysis
via flow cytometry. GFP fluorescence was collected at 530±15 nm (FL1), and cellular
auto-fluorescence was collected at a wavelength greater than or equal to 650 nm (FL3)
on a fluorescence activated cell sorter (FASC-Scan) cytometer (Becton Dickinson, San
Jose, CA) equipped with 488 nm excitation. For each sample, a maximum of 30,000
events were collected. Intact cells were gated on a FSC (forward angle light scatter)
versus SSC (90 degrees light scatter) dot plot. An FL1 versus an FL3 display of a
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GFP-negative control was gated and applied to all samples and analyzed to yield a
percentage of cell events in the GFP-positive region. This GFP-positive percentage for
each sample was normalized to an average of GFP-positive controls for the specific
set of experiments and expressed as a mean value ± standard error. In addition to
gating analysis, the linear mean of GFP fluorescence intensity was calculated using all
measured cell events.

3.2.7

Semiquantitative PCR Analysis
BHK-21 cells were co-transfected with 100ng of pAcGFP plasmid and the

aforementioned siRNAs or siFNAs as previously described. Each sample type: siRNA
(13.3 nM), two concentrations of siFNA (13.3 and 33.3 nM), positive control, and
negative control was generated in triplicate. At 48hrs post-transfection, the cells were
harvested and washed with PBS. Approximately 100,000 cells were fixed in 0.5% PFA
in PBS and evaluated by flow cytometry to determine GFP expression levels. Total
RNA was isolated from the remaining cells (approximately 400,000) using TRI Reagent
(Sigma, St. Louis, MO). The RNA isolate was treated with Turbo DNA-free (Ambion,
Austin, TX) to eliminate genomic and plasmid DNA contamination.

The yield of

isolated RNA was evaluated by OD260 and purity by OD260/OD280 using a Bio-Tek
Synergy HT multi-detection microplate reader (Bio-Tek Instruments, Inc., Winooski,
VT). The integrity of the RNA was evaluated by electrophoresis in a denaturing 0.8%
agarose slab gel and stained with SYBR GOLD (Invitrogen Molecular Probes,
Carlsbad, California). Each RNA isolate (500ng) was reverse transcribed with BD
Sprint PowerScript Pre-Primed Random Hexamer primers RT-PCR Kit (BD
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Biosciences, Palo Alto, CA), divided into single-use aliquots, and stored at -20oC.
Desalted primers for the knockdown target (GFP: forward primer, 5’-TAC AAC TAC
AAC GCC CAC AAT GT-3’; reverse primer, 5’-CAC GCT GCC ATC CTC GAT-3’) and
a control gene (GAPDH, glyceraldehyde-3-phosphate dehydrogenase: forward primer,
5’-TGG CAA AGT GGA TAT TGT CG-3’; reverse primer, 5’-AGA TGG ACT TCC CGT
TGA TG-3’) were synthesized (Integrated DNA Technologies, Coralville, IA). For realtime PCR, the following components were mixed: 12.5uL iTaq Sybr green supermix
with ROX (BioRad, Hercules, CA, USA), 3.5uL of PCR grade water, 2uL of both
forward and reverse primers at 10uM and 2.5uM for GAPDH and GFP, respectively,
and 5uL template cDNA diluted 100-fold. Non-template controls and a standard curve
(beginning with a non-diluted mixture of all cDNAs and including 5-serial 10-fold
dilutions of this mixture) were simultaneously run in conjunction with the experimental
samples using both primer sets. PCR was carried out using a Chromo4 Real-Time
PCR Detection System (Bio-Rad, Hercules, CA, USA). For all samples and primer
sets, the following thermal cycling conditions were used: incubation (50oC for 2 mins),
denaturation (95oC for 5 mins), 45 cycles of amplification and fluorescence
quantification (95oC for 15 secs followed by 60oC for 60 secs), and melting
fluorescence quantification (heating from 55oC to 95oC and measuring at 0.2oC stepintervals after holding for 0.02 secs).

Both GAPDH message levels and PCR

efficiencies (calculated via amplification slopes with Opticon Monitor 3 software) were
used to ensure the results for each sample were suitable for analysis.

Following

amplification, a representative GFP product was sequenced to ensure the correct
amplicon was generated.
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3.3

Results

3.3.1

FNA Generation
Synthetic sense and antisense FNA oligonucleotides were successfully

generated through solid phase synthesis at a 250nMole yield and verified by MALDI
and further purified by PAGE separation. Mass spectroscopy of these products prior to
PAGE purification gave primary peaks of 6693m/z and 6715m/z for the antisense and
sense strands, respectively. These values agree with the expected mass calculated
for each product. Extra peaks, which were only slightly discernable above background
noise, corresponded to base depurinations that occur as a result of MALDI, or the
presence of residual monovalent cations. UV/VIS absorbance spectroscopy was used
to determine the total amount of FNA generated for each transcription reaction. An
extinction coefficient was calculated for each product based on the sequence and
standard absorbance profiles for nucleic acids. Since 2’-Fluoro-2’deoxy-NTPs have
absorbance properties comparable to native NTPs (2’F-dATP, ε = 15,400 M-1cm-1, 2’FdGTP, ε = 13,600 M-1cm-1, Trilink Biotechnologies), the same extinction coefficients
were used for the RNA and FNA products. At 48 hours, an average of 83.9±7.4 μg
(n=8) of total product was generated in a typical 20 μl reaction volume. This was
comparable to manufacturer’s estimated yield of unmodified RNA generation using this
enzyme, which was 40-60μg for an equivalent reaction held for 4 hours.

PAGE

separation of the products followed by nucleic acid staining and comparison to
included standards indicated that full-length transcripts were present in addition to
some early termination products. An average of 28.7±8.9% (n=4) sample recovery
was obtained from Microcon spin filter purification.

75

PAGE results showed little

difference between single stranded and duplex FNA products (figure 3.2).

The

average yield of unmodified RNA using the RNAMaxx® in vitro transcription was
approximately 92±6.9 μg (n=6) for an 8 hour reaction of the same volume.

This

amount was in agreement with the manufacturer’s estimated yield.

2.3.2

Hybridization Analysis
Melting curves shown in figure 3.1 were measured to calculate the Tm of

various duplexes to assess the purity and accuracy of the transcribed products and
synthesized FNA. Synthetic FNAs exhibited the highest melting temperatures, with a

Figure 3.1: Melt-curve analysis of FNA hydridization. Nucleic acid hybridization
measured by absorbance as a function of temperature. The black line represents
the absorbance measurements at temperatures from 15oC to 95oC normalized to
the lowest reading of each sample. The dF/dT of these curves gives a local
maximum, representing the Tm of the duplex. The nucleic acid hybridization Tm
values are show as follows: A) DNA/DNA duplex (Tm = 65oC), B) DNA/Synthetic
FNA duplex (Tm = 72.4oC), C) Synthetic FNA/Synthetic FNA duplex (Tm = 89oC),
and D) DNA/Transcribed FNA duplex (Tm = 35oC).
FNA:FNA duplex Tm of 89oC and a FNA:DNA duplex Tm of 72.4oC. This increase in
melting temperature relative to the DNA duplex (Tm = 65oC) agrees with earlier findings
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that these modifications act to improve duplex stability (Kawasaki, Casper et al. 1993;
Yazbeck, Min et al. 2002). Conversely, when the transcribed FNA is hybridized with its
DNA complement, the duplex dissociates at approximately 35oC. This reduction in Tm
suggests that transcription products contain base incorporation errors and/or early
termination products.
3.3.3

Nuclease Digestions
Products of double-stranded and single-stranded synthetic FNAs following

digestion by both DNAse I and RNAse One® were analyzed by electrophoresis (figure
3.2) to qualitatively evaluate nuclease resistance.

Comparison of the digestion

products to the associated controls, which were not exposed to RNAse One® but

Figure 3.2: Capillary electrophoresis of nuclease treated RNAs and FNAs. All
species were originally treated with DNAse I following synthesis. Digested products
were treated with RNAse One® for 18 hours. Control samples were treated to
similar buffer and heating conditions in the absence of the ribonuclease. Lane L:
10bp Ladder, Lane 1: single-stranded transcribed FNA, Lane2: single-stranded RNA
control, Lane 3: single-stranded RNA digested, Lane 4: double-stranded RNA
control, Lane 5: double-stranded RNA digested, Lane 6: single-stranded FNA
control, Lane 7: single-stranded FNA digested, Lane 8: double-stranded FNA
control, Lane 9: double-stranded FNA digested
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otherwise processed identically to test samples, shows a striking difference between
native RNA and fluoro-modified species.

Unmodified single-stranded RNAs were

completely digested by nuclease treatment. Although duplex RNA is thought to be
considerably more resistant to nuclease digestion than single-stranded RNA, these
samples show a similar pattern in figure 3.2, which illustrates that siRNA was also
completely digested under the aforementioned conditions. Both the single-stranded
and the double-stranded digested FNAs were nearly indistinguishable from their
processed controls, suggesting that no nuclease degradation occurred.

3.3.4

RNAi of GFP Expression in Cell Cultures
GFP expression levels were normalized to the positive controls in the same

experimental plate for both the percent of cells gated and the fluorescence linear
mean. The siRNAs designed in this study were effective silencing agents, reducing
GFP expression at low concentrations. Native RNA that was synthesized through a
similar transcription reaction did not require purification, and knockdown of GFP was
evident at the lowest concentration evaluated (21.8±3.3% at 3.3 nM siRNA). SiFNAs
from custom synthesis were also able to reduce target gene expression at 3.3 nM.
Expression of GFP relative to the corresponding positive controls were 35.8±8.0%,
19.9±3.8%, 14.9±2.8%, 11.0±2.0%, and 8.1±0.8% for 3.3 nM, 13.3 nM, 33.3 nM, 66.7
nM, and 133.3 nM, respectively (figure 3.4 A). These levels were only slightly higher
than those for siRNA knockdown, indicating efficient silencing.

Preliminary

experiments with transcribed siFNAs were used to define a concentration range where
treatment effects were responsive to concentration and not due to non-specific toxicity
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phenomena. While these initial experiments spanned a concentration range of 3.3 nM
to 333.3 nM, the appropriate concentration range for evaluating effective transcribed

Figure 3.3: Brightfield and fluorescent images microscopy of cell cultures.
Transfected BHK-21 cells at 48 hours following transfection: A,B) Positive control,
C,D) siRNA knockdown, and E,F) siFNA knockdown.
siFNA mediated GFP suppression was narrowed to 33.3 nM to 133.3 nM.

The

concentrations in this range were evaluated in triplicate. Since siRNA and synthetic
siFNA were effective at lower concentrations, a single set of transcribed siFNA
knockdown experiments incorporating the full range from 3.3 nM to 333.3 nM was
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included to illustrate trends for comparative analysis. Expression levels relative to
positive controls were 70.4±3.0%, 36.2±2.7%, and 24.8±0.3% following filtered
transcribed siFNA knockdown at concentrations of 33.3 nM, 66.7 nM, and 133.3 nM,
respectively.

The FL1 (530±15 nm) fluorescence linear mean also suggests a

reduction in GFP levels following siRNA and siFNA treatment. Figure 3.4B illustrates
this reduction and the trend that synthetic siFNA is nearly equivalent to siRNA in
reducing total protein content, even at the lowest levels of effector concentration.
Since the enzymatic RNAi pathway can be elicited using single-stranded
antisense RNA in mammalian cells (Martinez, Patkaniowska et al. 2002; Schwarz,
Hutvagner et al. 2002; Amarzguioui, Holen et al. 2003; Holen, Amarzguioui et al.
2003), antisense FNA was evaluated for its silencing ability in the 33.3 nM to 133.3 nM
range. The single-stranded synthetic antisense FNA showed minimal silencing ability,
yielding approximately 88.2±1.3%, 81.0±1.6%, and 51.7±0.8% GFP expression levels
for 33.3 nM, 66.7 nM, and 133.3 nM, respectively. The single-stranded transcribed
antisense FNA has a similar silencing ability that is indistinguishable from the synthetic
FNA, yielding approximately 74.1±15.7%, 84.1±4.4%, and 62.5±0.7% GFP expression
levels for 33.3 nM, 66.7 nM, and 133.3 nM, respectively. In contrast, native antisense
RNA exhibited a lower level of GFP activity (approximately 32%) at the lowest
concentration studied (3.3nM, not shown) and then maintained between 15-20%
expression for the concentrations shown in figure 3.5.
Expression analysis was also supported by decreased mRNA levels following
siRNA or siFNA treatment, shown in figure 3.6. The siRNA GFP expression levels
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†

†

†

Figure 3.4: RNAi analysis of siRNA and siFNA in cell culture. A: Gated analysis of
cell population for GFP expression. Bars from light to dark represent scrambled
siRNA, transcribed siFNA, synthetic siFNA, and siRNA. Expression was normalized
to the average of GFP-positive controls. B: Cell mFI GFP expression analysis for
30,000 measured events. Grey bars represent synthetic siFNA and black bars
represent siRNA. Statistical differences between synthetic siFNA and siRNA for a
given concentration are denoted by the symbol † (Student’s t-test, p < 0.05)
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†

†

‡

Figure 3.5. RNAi analysis of antisense RNA and FNA in cell culture. FACS
fluorescence analysis of GFP expression in cells transfected with antisense siRNA,
synthetic antisense siFNA, and transcribed antisense siFNA at various
concentrations from light to dark, respectively. Expression was normalized to an
average of GFP positive controls. The symbol † denotes a significant differences
between antisense FNA and antisense RNA only. The symbol ‡ denotes a
significant difference between antisense FNA and antisense RNA and a significant
difference between the two antisense FNA populations (Student’s t-test, p < 0.05).

relative to the positive controls measured via flow cytometry were an average of 8.4%
for the triplicate samples, while the two siFNA averages were 28.3% and 16.8%. GFP
mRNA levels are reported as a ratio to GAPDH message measured in triplicate from
the same cDNA sample. The positive control illustrates the variability in transfection
efficiency of the pAcGFP, but also that this gene is highly expressed (32.8±18.5
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GFP:GAPDH).

This ratio is drastically reduced for the siRNA (0.16±0.05

GFP:GAPDH) and siFNA (5.77±1.61 and 3.36±1.77 GFP:GAPDH) samples.

†

Figure 3.6: Semiquantitative PCR analysis of RNAi knockdown of GFP vs GAPDH.
Levels of mRNA are reported as a ratio of GAPDH to GFP. Each category shown
as an individual bar represents three separate cellular experiments, which were
each measured in triplicate. The siRNA samples achieved an average GFP
knockdown of 91.6%. The two concentrations of synthetic siFNAs evaluated
reduced GFP expression levels at averages of 77.7% and 83.2%. The symbol †
denotes a significant difference between the siRNA and 77.7% siFNA knockdown
(Student’s t-test, p < 0.05). No statistical difference was observed between the
siRNA and 83.2% siFNA knockdown or between the two siFNA populations.
3.4

Discussion
In this investigation fully-modified 2’-deoxy-2’fluoro nucleic acids were

generated through transcription and solid phase synthesis, evaluated for their nuclease
resistance, and tested for knockdown activity in cell culture. FNA effectively induced
gene silencing in the duplex siFNA form but is much less effective as an antisense
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single-stranded oligonucleotide.

The findings presented here are in agreement with

earlier works using partially modified nucleic acids. The ability to incorporate these
modifications using standard synthesis techniques allows for the additional inclusion of
other types of alterations that may aid in drug delivery. The combined results suggest
that incorporation of the 2’-fluoro modification may be a useful approach to achieve
improved stability of RNAi-based therapeutics without sacrificing potency.

3.4.1

FNA Generation
FNAs for RNAi were successfully generated through both solid phase

synthesis and transcription. However, the quality of the product generated from each
method is markedly different.

Synthetic FNAs were shown to be the proper size

through mass spectroscopy and PAGE separation. Elevated melting temperatures of
these products illustrated strong association with the target sequence, indicating both
that FNAs form more stable duplexes and that base incorporation errors are not likely
in the synthetic products. The observed increase in Tm values that occur due to the 2’F
substitution are in agreement with previous work that evaluated partially and fully
modified oligonucleotides. The transcribed FNAs required further purification using
Microcon YM3 spin filters to remove any fragments under 10 nucleotides in length.
Approximately 70% of the product was not recovered, which suggests that a large
portion of the FNAs were shorter than the desired 21 nucleotides due to early
termination. This agrees with early characterizations of the Y639F T7 polymerase
regarding the abortive stage of polymerization, where it was found that the wild-type
and the mutant polymerase generate a large amount of early termination product in the
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2-8nt range (Sousa and Padilla 1995). Despite that the Y639F polymerase is able to
initiate DNA and RNA primer extension to a limited extent (Sousa and Padilla 1995),
extending the reaction to 48 hours did not yield a higher percentage of full length FNA
transcripts. Melting curve data reveals that the synthetic products have very different
hybridization behavior than the transcribed FNAs based on the difference in the Tm
values. The higher melting temperature of the synthetic FNAs suggests that custom
synthesis has a much lower error incorporation rate than the transcription method.
While the error incorporation rate of 2-F-NTPs is not known, Y639F T7 polymerase
does exhibit miscoding of rNTPs at a similar rate to the wild-type polymerase (Sousa
and Padilla 1995). Consequently, transcription base-coupling errors are expected and
will have a minimum incorporation rate that is equivalent to the wild-type polymerase.
Homopolymer assays to determine the error-rate of the mutant polymerase showed
that the incorporation of a complementary NTP was 184-fold greater than that for noncomplementary NTPs on a poly(dC) template (Sousa and Padilla 1995). Relative to
the poly(dC) template non-complementary base incorporation was approximately 5fold higher using a poly(dT) template (Sousa and Padilla 1995). Thus errors in base
incorporation would be expected at relatively high frequency, even if unmodified
nucleotides were used. Despite the higher inaccuracy rate, the transcribed FNAs were
still able to elicit RNAi.

As a result, the products are still useful and possess

appreciable benefits over custom synthesis techniques. Although currently the cost to
generate a given amount of FNA product is nearly equivalent for the two techniques,
enzymatic generation offers greater flexibility than custom synthesis.

Specifically,

transcription allows for the generation of several different siFNAs instead of only one
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sequence. This provides a technique for siFNA screening, the ability knockdown of an
array of targets, or the ability to validate the viability of a siFNA sequence before
pursuing custom synthesis.

3.4.2

Digestion Assays
Both the single-stranded and the double-stranded FNAs were resistant to

enzymatic digestion using DNAse I and RNAse One®, while both forms of unmodified
RNA were degraded completely under the same conditions.

While this does not

indicate invulnerability to all enzymatic degradation pathways, it does illustrate
improved nuclease resistance over unmodified RNA and DNA. Previous work with
pyrimidine 2’-deoxy 2’fluoro modified RNA has also shown improved stability in cell
lysate and plasma (Layzer, McCaffrey et al. 2004). However, since pyrimidine only
fluoro-modified nucleic acids still contain 2’-hydroxyls, they may still be susceptible to
sugar-specific endonuclease digestion. Some evidence of substrate degradation was
observed in pyrimidine-only 2’F modified RNA that was incubated for 60 minutes in cell
lysate (Chiu and Rana). Additionally, partially-modified siRNAs did not extend target
gene knockdown relative to the unmodified species (Layzer, McCaffrey et al. 2004).
Incorporating fluorine halides on every nucleotide could eliminate all possibility of 2’hydroxyl-mediated

enzymatic

digestion

or

degradation

through

spontaneous

intramolecular hydrolysis and may further improve the stability of single- and doublestranded siRNAs. The current GFP expression system in BHK cells is not conducive
to long-term suppression analysis due to the fact that the effector is diluted in the
rapidly proliferating cells. Future studies will explore the silencing duration of siFNAs

86

using a stably-transfected transient or inducible reporter gene in a system more
amenable to long-term gene expression analysis.

3.4.3 RNAi of GFP Expression in Cell Cultures
It was previously shown that RNAi does not require a 2’-hydroxl to be
present in the nucleic acid species, but it requires an unimpeded minor groove and an
A-type helical structure (Chiu and Rana 2003). Since fluorine is small enough to fit in
the minor groove and the electronegativity of the halide reinforces an A-type helix
structure through a preferred sugar pucker conformation (Guschlbauer and Jankowski
1980; Chiu and Rana 2003), fluoro-modifications are particularly well-tolerated by the
RNAi pathway. Our results indicate that siFNA can induce RNAi and the silencing
efficiency is nearly equivalent to the unmodified siRNA species. In fact, siRNA and
siFNA efficacy were only significantly different at the 66.7 nM and 133.3 nM
concentrations (Student’s t-test, p<0.05).

These results correlate well with

observations regarding RNAi activity of partially or pyrimidine only 2’F-modified
siRNAs, reported elsewhere (Chiu and Rana 2003; Layzer, McCaffrey et al. 2004).
One potential reason for the slight decrease in knockdown potency is that FNAs may
form more stable duplexes relative to RNAs. This could result in a duplex that is less
efficiently unwound by RISC.

The melting properties of the synthetic fluorinated

oligonucleotide duplexes suggest that this hypothesis may have merit. It is likely that
the RNAi pathway is able to overcome this obstacle since the dissociation of siRNA is
an ATP-driven process.

Additionally, it was observed through the course of this
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investigation that minor variations in the initial siFNA hybridization had a noticeable
effect on the silencing outcome.
One concern relating to the observed elevated melting temperatures of FNAs is
the potential loss of may loose some level of target specificity.

Kawasaki and

colleagues gave a detailed description of 2’F modifications with respect to increased
Tm and base pair specificity (Kawasaki, Casper et al. 1993).

In essence, they

demonstrate that uniformly- modified NAs maintain base-specificity relative to the
perfect complement. Since the 2’F modification results in a large Tm increase, the
annealing temperature may still be elevated with a single nucleotide mismatch pointmutation.

This could lead to off-target hybridization at physiological temperatures.

However it is doubtful that even one or two mismatches in a 21-mer oligonucleotide
would result in better complementarity to an off-target mRNA within the transcriptome
that has amenable secondary structure for hybridization.

Because the RISC

machinery must interact with the duplex siRNA and the antisense RNA/mRNA
complement along the silencing pathway, RNAi might still be disrupted by a single
mismatch within a siFNA molecule. Additionally, the improved duplex stability may
also allow the use of small interfering duplexes with a lower GC content to be used for
RNAi. In this study, no changes to cellular morphology, growth rate or housekeeping
gene expression were observed in response to siFNA treatment. This suggests that if
off-target silencing was occurring, the potential effect on the global expression profile
was not toxic for the sequence studied. Future endeavors exploring off-target effects
could test a series of mismatches at several locations on the sense and antisense
strands of the different effector sequences, and include more global measures of gene
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expression such as RT-PCR of multiple candidate off-targets or comprehensive
microarray analysis (Jackson, Burchard et al. 2006).
Transcribed FNA products displayed the least amount of silencing ability, which
is likely due to malformed siFNAs that arise from either early termination products or
more likely polymerase base incorporation errors. In the future, it may be possible to
improve the transcription efficiency by using a dual-mutated polymerase which has
been used to successfully incorporate 2’-O-methyl modified NTPs into full-length
transcripts (Padilla and Sousa 2002). Knockdown at higher concentrations of siFNA
were not evaluated due to potential transfection lipid toxicities. The upper limit was
determined in mock RNAi experiments using scrambled sequences over an extended
range of concentrations.

At the 333.3 nM concentration, GFP expression was

decreased in response to the scrambled siRNAs, indicating nonspecific effects.
Additionally, exposing cells to micromolar concentrations of siFNA in the absence of a
cationic lipid showed no signs of toxicity nor GFP reduction (data not shown).
Therefore, the observed decrease in GFP mRNA and protein expression by siFNA
treatment below 333.3 nM is believed to be the result of targeted gene knockdown.
Despite the typically rigid adherence to the characteristic siRNA structure
resulting from the processing of dsRNA by Dicer, recent work has demonstrated that
RNAi can be elicited by single-stranded antisense siRNAs (Martinez, Patkaniowska et
al. 2002; Schwarz, Hutvagner et al. 2002; Amarzguioui, Holen et al. 2003; Holen,
Amarzguioui et al. 2003).

Although the pathway of RNAi using single-stranded

homologues is not well-understood, evidence suggests that at least part of the
pathway is conserved among the duplex and antisense siRNAs (Holen, Amarzguioui et
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al. 2003). It has also been shown that antisense siRNAs are incorporated into RISC,
resulting in targeted RNA cleavage in mammalian cell extracts (Martinez,
Patkaniowska et al. 2002; Schwarz, Hutvagner et al. 2002) and in cell culture (Holen,
Amarzguioui et al. 2003). In contrast with the apparent similarities, antisense siRNA
shows lower activity and reaches peak levels earlier than compared to duplex siRNA
(Holen, Amarzguioui et al. 2003).

Duplex siRNA requires unwinding while still

associated with RISC, which may explain the delayed onset of gene silencing through
this RNAi pathway. The transient nature of the single-stranded knockdown could be
partially explained by its vulnerability to ribonucleases. Therefore, nuclease-resistant
modified antisense siRNA may have potential benefits over native unmodified
antisense siRNA. Fully fluorinated nucleic acids were initially thought to have ideal
properties to achieve single-stranded knockdown while improving stability of the
effecter molecule.
Because single-stranded antisense RNA is known to induce RNAi, antisense
FNA was also evaluated for its silencing ability. Given that this method does not
require delivery of a duplex knockdown agent, the negative affects of early termination
are thought to be lessened.

Surprisingly, the FNA antisense product shows no

significant silencing ability until higher concentration levels are reached, and in contrast
to RNA, antisense FNA silencing ability is greatly reduced.

Even though

misincorporation errors may be present in the transcribed FNAs, antisense products
may still hybridize to the target mRNA due to the increases the Tm by the 2’F
substitution. This FNA:RNA duplex with potential mismatch bulges may still participate
in translational arrest, which could explain the lack of difference observed between the

90

transcribed and synthetic antisense FNAs shown in figure 3.5.

For the siFNA

knockdown, these base misincorporation errors may hinder the ability for RISC to
recognize the duplex form of the transcribed product duplexes, explaining the larger
difference in silencing ability between transcribed and synthetic FNAs shown in figure
3.4. Since it is known that 2’-FNA:RNA duplexes do not induce RNAse H1 mediated
cleavage of the RNA strand (Yazbeck, Min et al. 2002), the slight reduction in GFP
expression caused by the single-stranded antisense products is likely due to minimal
levels of antisense translational interruption. 2’-Flouro substitutions in nucleic have
been shown to increase the melting temperature when hybridized to either DNA or
RNA complements (Kawasaki, Casper et al. 1993; Yazbeck, Min et al. 2002), and in
conjunction with improved stability, this supports the idea that some physical disruption
of protein synthesis in the cytoplasm may be possible. However, since single-stranded
antisense FNAs are inefficient in reducing GFP expression relative to siFNAs, the
mechanism of knockdown by duplex siFNAs is not likely to be simple antisense
translational arrest or FNA toxicity.

Rather, these results, in conjunction with the

finding that FNA:RNA duplexes do not act as substrates for RNAse H1, suggest that
siFNA GFP knockdown is mediated through the RNAi pathway.

3.5

Conclusions and Future Works
RNAi has quickly become one of the primary methods of genetic knockdown

and has experienced a rapid expansion in the number of exploited applications and
synthetic modifications.

In addition to its utility for a wide array of applications

conserved over a variety of organisms, the RNAi mechanism has proven to be
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remarkably complex. Previous works have illustrated the flexibility of RNAi to tolerate
certain chemical modifications into siRNA. By maintaining efficacy while imparting
other potentially beneficial properties, such as nuclease resistance and improved
cellular delivery, the possibility of using RNAi for therapeutic applications is within
reach. In fact, pharmaceutical companies have begun incorporating these types of
modifications into potential siRNA drugs, and some of these chemically-modified
siRNA therapeutic agents have already reached clinical trials (Sirna Therapeutics,
Alnylam, Acuity (Bourzac 2007)). Previous works which have incorporated halides in
the 2’-region of nucleic acids were limited due to the scarcity of modified guanine and
adenosine residues. Therefore this study investigated the efficacy of RNAi knockdown
using fully-fluorinated nucleic acids as small interfering RNAs. Despite the fact that
phosphoramidites which contain these modifications are becoming available with
increasing frequency, the custom synthesis of fully-fluorinated strands is still costprohibitive. For this reason, we also investigated the ability to generate FNAs through
transcription using a mutated polymerase. While the transcription technique does not
improve the overall cost effectiveness of FNA generation, it adds flexibility to produce
many siFNAs of distinctive sequences.

The FNAs showed improved enzymatic

stability in the presence of nucleases as demonstrated by a digestion assay. It has
also been shown here that fully-fluorinated nucleic acids can induce targeted gene
knockdown. Since the antisense FNA strand is much less potent than the duplex form,
the decreased genetic expression resulting from siFNA introduction is likely due to
enzyme mediated RNAi rather than simple translational blockade. Conversely, this
result suggests that single-stranded FNAs are not recognized by RISC due to the lack
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of antisense silencing. This may provide some insight into the recognition and binding
properties associated with RISC. Synthetic siFNAs resulted in more efficient silencing
than the corresponding transcribed species.

This is likely due to base-coupling

inefficiencies during transcription and/or early termination of the desired products.
Melting curve analysis supports the suggestion that transcribed FNAs contain errors. It
is possible that improvements in the transcription conditions or the use of a less error
prone polymerase may improve the efficacy and yield of this method.

93

CHAPTER 4:
Caging 2’-Fluoro Nucleic Acids for RNAi
4.1

Introduction
RNA interference (RNAi) refers to the post-transcriptional silencing of protein

expression that is initiated by specific small regulatory RNA molecules (reviewed by
(Tomari and Zamore 2005)). Several forms of these molecules have RNAi activity
including small-interfering RNAs (siRNAs), small-hairpin RNAs (shRNAs), or
microRNAs (miRNAs), where their classification depends on their origin and specific
structure (Elbashir, Lendeckel et al. 2001; Matzke and Matzke 2003).

RNAi has

gained attention in laboratory and therapeutic settings because siRNAs are generally
more potent regulators of gene expression than traditional antisense compounds
(Grunweller, Wyszko et al. 2003).

Although siRNAs are highly effective, RNA is

relatively unstable and susceptible to enzymatic digestion. In order to develop useful
RNAi drugs, the siRNA must be efficiently delivered either systemically or directly to
the intended tissue, exhibit specific knockdown of the target gene, and maximize the
duration of silencing. In the common effort of expanding the utility of siRNAs, many
have explored the use of chemical modifications that optimize RNA lipophilicity,
increase duplex stability, or impart nuclease resistance to achieve these aims.
Although improving pharmacological efficacy through chemical modification is
important for the realization of RNAi therapeutics, less progress has been made with
respect to spatial and temporal control over gene silencing. One technique to control
RNAi is to use a chemically-inducible endogenous expression of hairpin RNA (Gossen
and Bujard 1995; Gossen, Freundlieb et al. 1995; No, Yao et al. 1996; Gupta, Schoer
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et al. 2004). While this approach does add a level of temporal control, light-based
triggers are potentially much faster and may allow for spatial resolution on the
nanometer scale (Betzig, Patterson et al. 2006). One way to achieve photo-control is
to introduce a temporary chemical modification which blocks silencing activity and can
be removed with an external trigger. Two research groups have recently explored
using photolabile protection groups in siRNA toward spatial, temporal, and dosing
control of gene knockdown using light (Shah, Rangarajan et al. 2005; Nguyen, Chavli
et al. 2006; Shah and Friedman 2007). Coupling this light-activation technique with
chemically-stabilized siRNAs may allow RNAi spatiotemporal targeting in more
complex biological systems.
The use of photolabile protection groups for the light induction of a biological
system was first described by Kaplan in 1978 as caging (Kaplan, Forbush et al. 1978).
Caged nucleic acids (NAs) have been used for a variety of applications [reviewed by
(Monroe and Haselton 2004; Mayer and Heckel 2006; Ellis-Davies 2007; Tang and
Dmochowski 2007; Young and Deiters 2007)]. Photo-caged RNA has been used to
control ribozyme activity through sugar caging (Chaulk and MacMillan 1998; Chaulk
and MacMillan 2007), RNA folding through base caging (Hobartner and Silverman
2005), as well as mRNA translation (Ando, Furuta et al. 2001; Ando, Furuta et al.
2004) and siRNA silencing through phosphate caging (Shah, Rangarajan et al. 2005;
Nguyen, Chavli et al. 2006; Shah and Friedman 2007). However, phosphate caging of
RNAs may lead to unstable products due to the potential for self-meditated hydrolysis
of the phosphotriester by the neighboring 2’-hydroxyl in aqueous solution (Breslow and
Xu).

Additionally, multiple attachment sites of cage groups to siRNAs may be

necessary to achieve full inactivation.
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For practical applications of caged RNAi effectors, the combination of
chemical-stabilization

and

photoprotection

might

be

advantageous.

Chemical

modifications of the sugar-phosphate backbone of RNAi effectors are widely used to
increase resistance of the RNA to hydrolytic and enzymatic degradation (reviewed by
(Manoharan 2004; Zhang, Du et al. 2006)). In addition to nuclease resistance, some
of these modifications maintain or improve other desired characteristics such as
preference for a certain helix formation or increased thermal stability (Kurreck 2003;
Manoharan 2004). To achieve RNAi that meets all the desired characteristics, many
types of modified siRNAs have been evaluated for their ability to elicit target mRNA
degradation and subsequent gene knockdown. These studies have yielded highly
variable results between different modification types and sometimes even among
siRNAs of differing sequence that have the same chemical modification. Of all the
modifications tested, 2’-deoxy-2’-fluoro modifications seem to be the best-tolerated
alteration for maintaining silencing activity. Partially flouro-modified siRNA in which the
2’-F substitutions are limited to pyrimidine moieties are common in the literature, so to
achieve completely modified siRNAs other chemical substitutions are sometimes used
in combination with the 2’-halide (Braasch, Jensen et al. 2003; Chiu and Rana 2003;
Harborth, Elbashir et al. 2003; Layzer, McCaffrey et al. 2004; Soutschek, Akinc et al.
2004; Allerson, Sioufi et al. 2005; Morrissey, Blanchard et al.). Recent results from our
group indicate that fully 2’-deoxy-2’-fluoro modified siRNA (siFNA) induces RNAi with
similar activity to unmodified RNA (chapter 2).

Despite the advances made in

chemical stability of siRNA, RNAi is still limited with respect to temporal and spatial
regulation.
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In this study, statistical (non site-specific) caging of the phosphate backbone
was performed on a chemically stabilized RNAi effector, using 1-(4,5-dimethoxy-2nitrophenyl)diazoethane (DMNPE). To allow the random attachment of multiple caging
groups to a single siRNA molecule, the following chapter presents a combination of
RNA 2’-OH chemical modification with the random attachment of DMNPE to achieve
siRNA with multiple sites caged. The nucleic acid has been fully substituted with 2’deoxy-2’-fluoro modified nucleotides to eliminate the possibility of 2’-OH mediated self
hydrolysis of the phosphotriester in aqueous solution.

These caged species were

evaluated in mammalian cell culture and developing zebrafish embryos for lightinduced RNAi activity.

4.2

Materials and Methods

4.2.1

2’-Deoxy-2’-Fluoro Nucleic Acid Synthesis and Caging

Synthetic

sense

(5’-GGUGAACUUCAAGAUCCGCUU-3’)

and

antisense

(5’-

GCGGAUCAUGAAGUU-CACCUU-3’) 2’-deoxy-2’-fluoro nucleic acids were generated
through solid phase synthesis as previously described (chapter 3), where the resulting
chemically-modified siFNAs effectively silenced GFP transgene expression through
RNAi. Each FNA strand was suspended in 100 μL of 10 mmol Bis-Tris buffer (pH 5.5)
at 1 μg/μL, (150 μM). 4,5-Dimethoxy-2-nitroacetophenone hydrazone precursor (5 mg,
22 μmol) (Molecular Probes, Inc., Eugene, OR) was oxidized with MnO2 (50 mg, 557
μmol) in 1.0 mL acetonitrile at room temperature under agitation for 20 minutes. MnO2
was removed by filtration through an acetonitrile-wetted Celite (Sigma Aldrich, St.
Louis, MO) syringe filter. The activated diazo-cage solution was mixed with the FNA
solution to achieve a 2:1 acetonitrile:aqueous buffer and 300 molar equivalents of the
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active diazo compound. A process control sample without nucleic acid and a process
control sample without active caging compound were simultaneously run with
experimental samples in order to rule out downstream effects resulting from caging
reaction processing. The reaction solutions were agitated at 4°C for 18 hours. Excess
cage compound was removed by size exclusion chromatography through a gravity
column of preswollen (1:2 acetonitrile:water) solvent-resistant LH-20 sephadex (GE
Healthcare Bio-Sciences Corp., Piscataway, NJ). The product was further purified by
4 X 500 μL washes through a YM-3 nitrocellulose spin filter (Millipore, Billerica, MA) to
remove any residual cage compound, buffer, and organic solvent. The products were
dried, and resuspended in TE buffer (10 mM Tris, 1mM EDTA, pH 8.0) or nuclease
free water. All products were stored at 4°C and protected from light.

4.2.2

Evaluation of Caged Nucleic Acids In Vitro
FNA concentration and degree of cage attachment was determined through

spectrophotometric analysis.

Absorbance spectra of the caged products were

measured from 230 nm to 500 nm. The molar concentrations of the covalently bound
cage sample and nucleic acid were calculated from the absorbance of incident light at
260 nm and 355 nm. Reverse phase high performance liquid chromatography (RPHPLC) was used to evaluate the control, caged, and photo-released FNAs. Each
sample type was injected (1.25 μg, 25 μL) in HPLC-grade water into a C18 analytical
column, ODS2 spherisorb 5 μm (Waters Corporation, Milford, MA). Separation was
obtained using a gradient of 1% TEAA in HPLC water to 1% TEAA in 80% acetonitrile
over 20 minutes.
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4.2.3

Nuclease Digestions
Bal-31 nuclease (Promega Corporation, Madison, WI) was used to evaluate

nuclease resistance of control and caged FNAs. Final digestion conditions were as
follows: 2.5 units Bal-31 nuclease, 2 μg 21mer FNA samples, 20 mM Tris-HCl (pH 8.1),
12.5 mM CaCl2, 12.5 mM MgCl2, 600 mM NaCl, 6.25 nM EDTA, 0.625% (v/v) glycerol,
50 μL total reaction volume at 30°C. At various time intervals, 5 μL volumes were
removed and were heated to 80°C for 10mins to halt digestion and immediately frozen
at -20°C for subsequent analysis. These fractions were collected and inactivated at 0,
5, 10, 20, 40, 80, and 160 minute discrete time intervals. Digestion of each FNA
sample was evaluated via PAGE using 15% polyacrylamide precast gel (BioRad,
Hercules, CA, USA) stained with Sybr Gold (Molecular Probes, Inc., Eugene, OR).
Band densitometry analysis was performed was using Metaview software (Universal
Imaging Corporation, West Chester, PA). Briefly, regions of equal size were drawn
around each band and band density was recorded as intensity integration over the
area.

In the cases where no bands were visible, regions were drawn over the

expected location of the bands. Background intensities of each gel were measured
and subtracted from the band measurements and each lane was then normalized to
the undigested product.

4.2.4

Photoexposure
A GreenSpot photocuring system (American Ultraviolet, Lebannon, IN) was

used for exposing nucleic acids, cell cultures, and zebrafish embryos to UVA light
doses. Light was delivered through an inverted liquid-filled light guide for bottom-up

99

exposure of cell-culture wells or microcentrifuge tubes. Infrared, UVC, and UVB light
was filtered out using a short bandpass filter (SWP-2502U-400) and an IR-filter (KG-2IR) (Lambda Research Optics, Costa Mesa, CA). Delivered light had a maximum
output at 365 ± 8 nm with a fluence rate of 0.705 W/cm2 at 4.5 cm or 0.950 W/cm2 at
3.2 cm (Forman, Dietrich et al. 2007). Total light delivered was 40 J/cm2 for cell
cultures and zebrafish and 200 J/cm2 for nucleic acid solutions. Adjacent wells in a BD
FalconTM 12-well tissue culture plate (BD Bioscience, Franklin Lakes, NJ) were
protected from light by using an aluminum mask with a 2.25 cm diameter opening.

4.2.5

Cell Culture and Transfection
BHK-21 (Baby Hamster Kidney) cells were cultured in reduced serum

Dulbecco’s

Modified

Eagle’s

Medium

(DMEM-RS)

(HyClone,

Logan,

UT)

supplemented with 3% heat inactivated fetal bovine serum (HyClone, Logan, UT) at
37°C under 5% CO2 in a humidified chamber and regularly passaged at
subconfluence. Cells were seeded on 12-well plates 18 hours prior to transfection at
approximately 20K cells/cm2. Cotransfections of pAcGFP-N1 (Clontech, Carlsbad, CA)
and process control or caged siFNAs were mediated with lipofectamine (Invitrogen,
Carlsbad, CA). Transfection mixtures containing 0.1 μg of pAcGFP-N1, 3 pmol siFNA
sample, and lipid (3:1 ratio of lipid to total nucleic acid) were complexed in 100 μL of
reduced protein medium (OPTI-MEM®, Invitrogen, Carlsbad, CA) and incubated at
room temperature for 30 minutes. Cells were rinsed with 500 μL of OPTI-MEM prior to
transfection, and the transfection mixtures diluted in 500 μL of OPTI-MEM giving final
siFNA concentrations of 5 nM in 600 μL and were added to the appropriate wells. The
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cells were incubated at 37°C under 5% CO2 for 6 hours, followed by return to normal
growth media. For light exposure of cell cultures, media was replaced with OPTI-MEM
and cells were photoexposed at 4 hours after the end of the transfection period. To
ensure that photoexposure did not have an effect on GFP expression in cell culture,
GFP positive controls and siFNA knockdown controls were exposed 5, 10, 20, 40, 60,
80 J/cm2 to determine thresholds to UVA light.

After exposure, OPTIMEM was

replaced with cell culture media and cells harvested at 48 hour post-transfection for
expression analysis.

4.2.6

Flow Cytometry RNAi Analysis
Transfected and control cell culture samples were harvested and fixed in

PBS suspension with 0.5% paraformaldehyde prior to GFP expression analysis via
flow cytometry. GFP fluorescence was collected at 530±15 nm (FL1), and cellular
auto-fluorescence was collected at a wavelength greater than or equal to 650 nm (FL3)
on a fluorescence activated cell sorter (FASC-Scan) cytometer (Becton Dickinson, San
Jose, CA) equipped with 488 nm excitation light source. For each culture sample, a
maximum of 30,000 cellular events were collected. Intact cells were gated on a FSC
(forward angle light scatter) versus SSC (90 degrees light scatter) dot plot. An FL1
versus an FL3 display of a GFP-negative control was gated and applied to all samples
and analyzed to yield a percentage of cell events in the GFP-positive region. This
GFP-positive percentage for each sample was normalized to an average of GFPpositive controls for the specific set of experiments and expressed as a mean value ±
standard error
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4.2.7

Zebrafish Embryo RNAi
Wild-type zebrafish purchased from EkkWill Waterlife Resources were kept

at standard laboratory conditions (28°C on a 14 hr light: 10 hr dark photo-period in a
recirculating system). Embryos were collected from group spawns, and rinsed several
times in embryo medium(Westerfield 2000) prior to microinjection procedures.
Microinjection of zebrafish embryos was carried out as previously described
(Westerfield 2000) to deliver plasmid and control or caged siFNAs. Injection needles
were pulled on a Flaming/Brown P-97 micropipette puller using fire-polished
borosilicate glass capillaries with filament (Sutter Instrument Co., Novato, CA). Briefly,
a volume of 1-3 nL of a solution containing GFP plasmids (125 ng/μL), process control
or caged siFNAs (250 ng/μL), Alexa Fluor 546-conjugated 10,000 MW dextran tracking
dye (Molecular Probes, Eugene, OR), and 0.1% phenol red was injected into the
embryo by forcing the pipette through the chorion and the yolk cell and then injected
into the yolk stream at the 1- to 4-cell stage. After injection, embryos were isolated in a
transgenic containment facility and incubated at 28°C until photoactivated at 6-7 hpf.
Embryos were exposed to UVA in 35-mm cell culture dishes containing 1 mL of
embryo medium. Previous UVA dose-response curves (LD50 of UVA in zebrafish ~800
J/cm2) in zebrafish embryos indicate their very high tolerance to UVA exposure,
indicating the safety of these photo-activating light regimens (Dong, Svoboda et al.
2007). After the photoactivation, the embryos were raised to 27-30 hpf and further
analyzed at the behavioral level.

Prior to 27 hpf, mortality and malformation

identifications were used as initial evaluation criteria for UV or siFNA induced toxicity.
At 27 hpf, the touch response behavior of each embryo was assayed. Those exhibiting
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a normal touch response were fixed in 4% paraformaldehyde for three hours at room
temperature.
After fixation, individual embryos were placed in a single drop of PBST on 1mm-thick slides, coverslipped, and viewed with a Zeiss MOT II inverted microscope
with a 20Χ objective equipped with GFP and rhodamine filter cubes. Embryos were
first viewed in bright-field with DIC optics to get a clear view of the trunk region or brain
region. Once a crisp view was obtained with DIC optics, the brain region, as well as
rostral and caudal spinal cords were imaged under epi-fluorescence utilizing the GFP
filter set. Images of the GFP expression were acquired using an ORCA-ER digital
camera (Hamamatsu Inc, Japan). For each experiment, a minimum exposure setting
required to obtain a non-saturating image of GFP expression in control embryos was
first determined. For every experiment, after the control images were acquired, images
of all the subsequent experimental embryos were acquired using the very same
exposure times as controls. To confirm that the embryos were indeed successfully
injected with the various plasmids and molecular reagents, the distribution of the
10,000 MW dextran was visualized. Control embryos and experimental embryos that
did not exhibit even dextran distribution within the embryo were excluded from
analysis.

4.3

Results

4.3.1

Spectrophotometric Evaluation of Caged FNA
Absorbance spectroscopy was used to determine level of cage attachment

to oligonucleotides.

Extinction coefficients for attached cage compounds (1-(4,5-
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dimethoxy-2-nitrophenyl)ethyl phosphoesters) were determined for 260nm (ε260 =
3064 M-1cm-1) and 355nm (ε355 = 4512 M-1cm-1) and were consistent with previously
reported values (Walker, Reid et al. 1988; Ghosn, Haselton et al. 2005).

These

values, accompanied with the known spectral properties of nucleic acids, enabled the
determination of molar concentrations of the cage compound and nucleic acid in a
sample to give a measure of cage attachment. A representative spectrum for a caged
2’-fluoro-substituted nucleic acid is shown in Figure 4.1.

Caged FNAs exhibit a

Process Control NA
41% Caged NA
Caged NA + 365 nm Light

1.0

0.8

0.6

0.4

0.2
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Figure 4.1: Spectrophotometic analysis of FNAs. Processed control (
), and photoexposed caged (
) NAs are overlaid. All samples were
(
processed in parallel. Following photoexposure, released cage was removed from
the solution via filtratation.

characteristic absorbance plateau at 355 nm in addition to an absorbance peak at 260
nm.

Following UVA light exposure and purification, the photocleaved product

resembles the control (non-caged) FNA.

The level of cage attachment could be

altered by adjusting the concentration of the diazo-reactant relative to the nucleic acid
or increasing the reaction duration. Oligonucleotide products with an average number
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of cage groups of approximately 1, 3, 4, and 8 to 9 were generated reproducibly by
varying cage reaction stoichiometry. For all assays reported, a single caging reaction
was utilized and the level of cage attachment for each strand was an average of 7.9
and 9.0 cage groups per 21mer oligonucleotide strand for the sense and antisense
FNA strands, respectively.

4.3.2

HPLC Separation of Caged FNAs.
Single stranded 21nt FNAs were characterized using RP-HPLC.

A

representative HPLC plot is shown in Figure 4.2. FNA control samples eluted quickly
with a sharp peak elution profile. Caged FNAs were retained longer than their process
0.4
Process Control FNA
Caged FNA
Caged FNA + 365 nm Light
0.3

0.2

0.1

0.0
6

8

10

12

Retention Time (minutes)
Figure 4.2: HPLC separation of caged FNAs. Elution profiles for processed control
(
), caged (
), and photoexposed caged (
) FNAs are shown. Peak
broadening of caged sample is indicative of a heterogeneous product mixture of
various degrees of caging. Photoexposure restores mobility to resemble the
process control products.
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Figure 4.3: Nuclease digestion (BAL-31) of control and caged FNAs. Top panel:
PAGE results show that caged FNAs are much more resistant to sugar non-specific
nuclease that control FNA. Bottom panel: graphical representation of banddensitometry normalized to band intensity at time = 0 minutes.
control (non-caged reaction, see methods and Fig. 4.1 results) counterparts and
exhibited a broadened elution profile. Upon exposure to 200 J/cm2 of 365 nm light, the
elution profile of the photo-released species resembled the control FNA elution profile,
suggesting removal of the cage moieties.

4.3.3

Nuclease Digestions of Caged FNAs.
Although FNAs have previously been shown to exhibit nuclease resistance

to sugar specific nucleases (chapter 3) and posses enhanced serum stability (Chiu and
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Rana 2003; Layzer, McCaffrey et al. 2004), here we show that BAL-31 nuclease can
digest the modified oligonucleotides in vitro.

This enzyme is a bidirectional

exonuclease that is able to hydrolyze RNA and DNA (Wei, Alianell et al. 1983). Time
course experiments show improved resistance of caged FNA to BAL-31 nuclease as
illustrated in Figure 4.3. The uncaged, process control FNA products were not visible
after 10 minutes of digestion. The caged products are still detectable at 160 minutes,
indicating that the presence of the cage group acts to slow digestion of the nucleic
acids.

4.3.4

Control of RNAi in Cell Culture with Caged FNAs.
Sense and antisense FNA strands were caged in parallel reactions.

A

process control, in which the caging compound was not added to the reaction with the
FNA, was also prepared simultaneously for each strand.

These products were

matched to provide four siFNA caging schemes; 1) non-caged, 2) only antisense stand
caged, 3) only sense strand caged, and 4) both strands caged. In all cases, the
attachment of DMNPE decreased the observed RNAi silencing when compared to the
activity of the process controls (Fig. 4.4). Exposure of transfected cell cultures to 365
nm light partially restored the RNAi activity for all caged samples. Figure 4.4 illustrates
that the RNAi is more sensitive to the caged antisense strand than the caged sense
strand. Knockdown activities of caged and photoexposed siFNAs were compared to
process control siFNAs. The latter represent fully active RNAi effectors, which were
able to eliminate GFP transgene expression in nearly 90% of the cells at a 5nM dose.
SiFNAs with a caged antisense strand silenced GFP expression in only 15.3 ± 13.7%
of the cell population, whereas sense strand caged siFNAs silenced GFP in 41.9 ±
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14.7 % of cells. A further reduction in RNAi activity to 9.7 ± 1.4 % was observed when
both strands were caged. All caged siFNA species had significantly reduced silencing
activity compared to controls (p <

0.05). Following photoexposure, each of these

Percent Cells with RNAi Response (%)
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S.Caged
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Figure 4.4: RNAi using caged siFNAs in cell culture.
Bars represent treatments
Bars represent equivalent treatments as the
that were protected from light.
paired black bar followed by delivery of 40 J/cm2 365 nm light. A significant
difference exists between all photoexposed and non-photoexposed caged samples
(denoted by †, p < 0.05). No statistical deference was seen for the control siFNA
(left).
caged siFNA samples exhibited an increase in the percentage of GFP negative cells to
57.9 ± 6.9 %, 78.1 ± 4.7 %, and 55.8 ± 3.4 % for the antisense caged, sense caged,
and dual strand caged siFNAs, respectively. While these photoactivated expression
increases are significantly different from the corresponding caged samples (p < 0.05),
they are also significantly different from the controls, indicating incomplete restoration
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of siFNA activity. GFP positive controls were subjected to various doses of 365 nm
light to ensure that photo-treatment did not have a negative impact on transgene
expression. No negative affects on cellular morphology or growth rates were observed
until light doses reached 80 J/cm2. Figure 4.5 shows that percent of GFP-positive cells
GFP Positive Control
siFNA knockdown Control

Normalized GFP Response (%)
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Figure 4.5: Response of cells to various doses of 365 nm light.
Represents GFP
positive controls at various light doses.
Represents siFNA knockdown cultures
exposed to various light doses. No statistical difference could be found by
photoexposing positive controls up to 80 J/cm2 (p < 0.05). A small decrease in GFP
expression was significant (denoted with †, p < 0.05) at light doses > 40 J/cm2
relative to non-photoexposed cultures, but this was the opposite effect observed
from photolysis of caged siFNA treatments. These results indicate that light dosing
in this range does not have noteworthy effect on GFP expression or silencing
activity.

in samples treated with only plasmid or by plasmid and siFNA remained nearly
unchanged through a 80 J/cm2 dose of UVA photoexposure, relative to the
corresponding non-photo-treated cultures.
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4.3.5

In Vivo Control of RNAi in Zebrafish Embryos.
All treatment reagents were co-injected into the yolk stream of zebrafish

embryos in the 1 to 4-cell stage, and a fluorescently labeled dextran tracking dye
allowed for the selection of successful injections and delivery to the cells, as illustrated
Figure 4.6.

Adequate injections exhibited a uniform red-fluorescence signal.

No

differences in mortality or malformation were observed in response to the dextran
tracking dye or the GFP plasmid at the concentrations tested.
Fish Embryo at 28 hpf

Alexa Fluor Dextran

pAcGFP

Merged

Figure 4.6: Zebrafish injection analysis. Fish embryo at 28 hpf development depicts
the region in which image analysis was performed. Left: Dextran tracking dye (red)
was observed throughout the region for successful injections. Middle: GFP positive
cells resulted in mosaic expression (green). Right: Overlaid of the signals from the
labeled dextran and GFP expression in the same fish. This pattern was typically
observed in our injection paradigms and indicates uniform delivery and a mosaic
expression pattern.
Gene knockdown activity of control and caged siFNAs, prior to and after light
exposure, are illustrated in Figures 4.7 and 4.8 with representative fluorescent images.
Co-injections of process control siFNA and GFP plasmid exhibited less green
fluorescence

signal than embryos only injected with GFP plasmid, performed in

parallel. This pattern held true at all concentrations of plasmid and siFNA investigated.
GFP expression levels in embryos injected with caged siFNAs were similar to those
with injections of only GFP plasmid. GFP expression decreased in embryos injected
with caged siFNAs and exposed to UVA light at 7 hpf. Doses utilized (40 J/cm2) had no
effect on zebrafish morphology, plasmid expression, or control siFNA silencing.
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Figure 4.7: GFP expression is unaffected by UVA light exposure (40 J/cm2)

A

GFP-control

siFNA + GFP

siFNA + GFP
+ UVA Light

B

GFP-control

Caged siFNA + GFP

Caged siFNA + GFP
+ UVA Light

Figure 4.8: RNAi of caged versus control siFNA in zebrafish. Each row represents
a complete experimental set of treatments for embryos injected on the same day.
Exposure to 40 J/cm2 UVA light was performed at 7 hpf. A: Uncaged siFNAs reduce
GFP expression relative to controls, and light exposure has no observable effect on
GFP expression. B: Caged siFNA resemble GFP control injections, but light
exposure reduces GFP expression.
The appropriate concentration of siFNAs used for zebrafish injections was
determined through titration assays to determine subtoxic treatment levels. Injections
with siFNA concentrations of 500 ng/μL or greater resulted in an increased incidence
of mortality and noticeable delays in embryonic development. The severity of this
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Fig. 4.9: Toxicity evaluation of control versus caged siFNAs. Panel A: siFNA
concentrations above 250 ng/μL resulted in an increase in mortality. Panel B:
Caging of siFNAs protects the developing embryo from the siFNA induced toxicity.
Panel C: Illustrates a developmental delay at 12 hpf in response to siFNA toxicity at
a concentration of 500 ng/μL. Control (no siFNA) and caged siFNA injected
embryos exhibit a developing tail bud, denoted by white circles. At the same age,
the embryos injected with process control siFNA are several hours behind in
development, and they have not transitioned from gastrulation to the tailbud stage.
developmental delay was proportional to the concentration of siFNA delivered to the
embryo. Treatment with single-stranded antisense FNA of the same sequence (500
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ng/μL) did not result in a noticeable developmental delay or increased mortality rate
(data not shown). Interestingly, caging the siFNA reduced both the motility rate an
observed delay (Fig. 4.9).

4.4

Discussion
RNAi is a widely utilized mechanism for gene silencing, but despite being

highly active and stable in cell culture, challenges still exist for effective silencing in
vivo.

These challenges include improving nuclease stability and siRNA half-life,

designing thermodynamically stable effectors with improved target binding affinity,
achieving efficient biodistribution through idealized pharmacokinetic properties, and
targeting of diseased tissue.

Most attempts to achieve these goals focus on

permanent chemical modification, resulting in a siRNA mimic. These types of siRNA
manipulation have provided much information regarding structural requirements for
RNAi and what types of alterations can be made without disrupting gene silencing. For
instance, a review of 2’-modified siRNAs suggests that the 2’-OH is not necessary for
RNAi, but changes at this location that alter either the global duplex structure or disrupt
the minor groove can abolish interference (Manoharan 2004; Zhang, Du et al. 2006).
Since halide and o-methyl substitutions maintain A-type helical structure by enforcing a
C3’-endo sugar pucker confirmation (Guschlbauer and Jankowski 1980; Chiu and
Rana 2003), and are not large enough to disrupt the major groove, these modifications
have been extensively utilized for RNAi.

In addition, these substitutions improve

resistance to sugar-specific enzymatic degradation and have been shown to reduce
off-target effects normally observed following siRNA delivery (Jackson, Burchard et al.
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2006; Cekaite, Furset et al. 2007). Despite the advances in siRNA stability through
permanent chemical modification, these effectors still lack improved biodistribution and
tissue specific targeting capabilities.
One strategy to achieve tissue specific targeting of RNAi is to utilize
synthetic siRNAs that can be activated by an external inducing agent. This strategy
would utilize the trigger to activate at select sites and times. This has been attempted
by several groups with photo-caging RNA in order to silence gene expression using
controlled light exposure. The first incidence of RNA caging was accomplished by the
incorporation of a 2’-OH photolabile protecting group into RNA for disruption of the
hammerhead ribozyme activity (Chaulk and MacMillan 1998). This system efficiently
provided light-reversible protection of the substrate RNA. Although highly efficient, this
technique required extensive synthetic procedures to produce the protected
oligonucleotide. An alternative approach to caging RNA was demonstrated with the
random attachment of 6-bromo-7-hydroxycourmanrin-4-ylmethyl (Bhc) cage compound
to exogenous mRNA through a reactive diazo-intermediate (Ando, Furuta et al. 2001).
This approach was adopted using a similar attachment chemistry to produce 1-(4,5dimethoxy-2-nitropheynl)ether (DMNPE) caged siRNAs (Shah, Rangarajan et al.
2005). In both incidences the caged RNA effectors demonstrated reduced activity
relative to their respective controls, which was partially restored by exposure to 350365 nm light. Although not proven, it is presumed that caging of nucleic acids with
diazo-intermediates results in phosphate attachment. Therefore, a potential drawback
of these studies was the potential for phosphotriester-mediated hydrolysis of caged
species. RNA phosphotriesters have been shown to be unstable in aqueous solutions
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where the 2’-OH may play a role in hydrolysis (Breslow and Xu). Therefore internally
caged nucleotides might be very susceptible to hydrolytic release of the cage molecule
itself or scissile bond cleavage and degradation of the RNA. Our early attempts to
cage 700bp dsRNA using reactive diazo compounds resulted in fragmentation of the
RNA in aqueous buffer (Chapter 2).
In an effort to reduce the leak activity, improve the efficiency of photoinduction, and avoid RNA hydrolysis, two groups have separately expanded on caged
siRNA by incorporating a single photolabile group onto the 5’-terminal phosphate of the
siRNA antisense strand (Nguyen, Chavli et al. 2006; Shah and Friedman 2007). Each
exploited a commercially-available NPE-derived linker on the 5’-terminal nucleotide
during 3’ to 5’ RNA solid phase synthesis. Based on previous work, this phosphate is
thought to be critical for siRNA incorporation into RISC (Chiu and Rana 2003;
Czauderna, Fechtner et al. 2003; Ma, Yuan et al. 2005). However, the results of these
studies were mixed. Nguyen et al. demonstrated that these caged siRNA had very
little activity and that silencing was efficiently restored with light doses that were
required to remove all cage linkers, which was determined in vitro. Observations of
minute leak activities were explained by N-1 contaminants from RNA synthesis that
had silencing activity due to the absence of the final caged linker. Shah and Friedman
disputed this interpretation since their data shows significant leak RNAi activity in the
caged un-induced state. Additionally Friedman and colleagues tested highly purified
antisense RNA strands with non-photolabile linkers at the 5’-phosphate to verify their
results. Their interpretation was that the RISC components have the ability to interact
with the remaining non-bridging oxygen, allowing some RNAi to proceed. Although the
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5’-phsophate on the antisense strand is known to be required for RNAi activity
(Nykanen, Haley et al. 2001; Martinez, Patkaniowska et al. 2002; Schwarz, Hutvagner
et al. 2002), it has also been shown that various linker modifications to this terminal
location are tolerated if the 5’-phosphoester bond is intact (Schwarz, Hutvagner et al.
2002; Harborth, Elbashir et al. 2003). To avoid this residual activity, light-activated
RNAi might require an alternate site of cage attachment or caging on multiple sites for
each siRNA. Recently the site-specific strategy of caging siRNAs was expanded to
include internally-caged nucleobases with impressive results(Mikat and Heckel 2007).
While photo-caging of siRNAs has demonstrated promise in spatially and temporally
controlling RNAi, this technique does not address some of the other desired
characteristic for improving pharmacological efficiency of RNAi. Results shown here
combine the benefits of 2’F modified siRNAs with DMNPE caging in order to achieve
stable, light-inducible, RNAi.
Fully modified 2’-F RNA was generated through solid-phase synthesis and
caged using a diazonium nitrobenzyl derivative in a batch-style reaction.

While

conditions of this reaction could be altered to produce varying degrees of cage
attachment, the more heavily caged products were used in the model biological
systems to reduce leak RNAi activity. Evaluation of the caged products in several in
vitro characterization assays allowed for qualitative analysis of cage attachment and
photo-release. PAGE separation of caged products was carried out as previously
described (Ghosn, Haselton et al. 2005) and indicated cage attachment (data not
shown).

In this assay a high incidence of cage attachment markedly diminishes

visualization using ethidium-like stains.

This phenomenon could be caused by a
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reduction in the association between the stain and nucleic acid, quenching of the
fluorescent signal, or a combination of the two factors. In addition to gel shift assays,
the products were also evaluated by RP-HLPC, where direct absorbance detection
does not rely on fluorescent staining. The chromatography results (Fig. 4.2) clearly
show separation between the uncaged and caged species. Differences in affinity for
the non-polar stationary phase are believed to arise from the elimination of a negative
charge on the backbone as well as the addition of the non-polar cage moiety. The
observed peak broadening of the caged NAs indicates that the solution was a
heterogeneous mixture of products ranging in the degree of cage attachment.
Therefore, even in samples that are heavily caged, some strands of nucleic acid may
still have a limited number of cage compounds attached. For all assays tested, UVA
photoexposure restored the NA properties to resemble the process control samples.
It has previously been suggested that photo-release of a caged-species with
n multiple adducts requires an irradiation dose that scales to the nth power for
equivalent uncaging (Tang and Dmochowski 2007). However, the observed quantum
yield of DMNPE-caged FNA (n=9) does not support this hypothesis. For instance,
DMNPE-caged ATP quantum yield reported in the literature is between 0.1 and 0.05
(Goeldner and Givens 2006; Ellis-Davies 2007). Assuming similar quantum yields for
DMNPE phosophoesters on FNA, complete photocleavage would require several
orders of magnitude greater light exposure than we observed was necessary for
complete photocleavage (Fig. 4.2).
Caging also provides resistance to enzymatic digestion.

Fully modified

FNAs were previously shown to be impervious to several sugar-specific nucleases
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(chapter 2).

However, these NAs are still susceptible to certain sugar-nonspecific

nucleases, such as BAL-31. Figure 4.3 illustrates that single-stranded FNAs were
rapidly processed by this enzyme at the concentrations tested.

However, the

attachment of DMNPE drastically decreased the BAL-31 degradation of FNA. Since
BAL-31 acts primarily as a bidirectional, single-strand specific, exonuclease (Wei,
Alianell et al. 1983), the enzyme might be able to easily process uncaged end
nucleotides. Once reaching one or multiple adjoining caging sites within the nucleic
acid, the enzyme might be interrupted from its digestive process, similar to the
disruption of Bam H1 digestion of DMNPE-caged plasmid DNA (Monroe and Haselton
2004). It has previously been demonstrated that the 2’F modification increases siRNA
stability in serum and plasma but this does not translate to longer silencing in vivo
(Layzer, McCaffrey et al.). Therefore, intracellular digestion of these modified NAs
might be more efficient than under in vitro conditions.

The combination sugar

modification and backbone caging may provide enough enzymatic resistance to
increase lifetimes of FNA and the duration of RNAi-mediated gene knockdown.
Unfortunately, cell culture assays are not amenable to extended time course
experiments since the RNAi effectors are quickly diluted through cellular proliferation.
Additionally, delayed activation of the caged siFNA could not be tested in these
systems since the fluorescent protein is stable, resulting in a persistent signal. Future
studies utilizing a destabilized or more transient reporter gene in vivo would be useful
in exploring prolonged RNAi lifetimes through cage attachment.
It has been shown above that DMPNE attachment to FNA can affect NA:NA as
well as NA:enzyme interactions. Therefore, caging of siFNAs may have the potential
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to disrupt RNAi in various ways such as: disruption of RISC recognition, helicase
unwinding of the duplex, mRNA target recognition, ejection of the digested target for
RISC recycling, localization of RISC to specialized organelles, and downstream
processing such as chromatin remodeling.

Figure 4.4 demonstrates that caging of

either strand in a siFNA reduces RNAi activity. However, the caged antisense strand
results in greater disruption of RNAi activity even though both strands were evaluated
with similar degrees of cage attachment. This is not unexpected since the sense FNA
strand is discarded early in the RNAi pathway. Reduction of sense strand caged RNAi
is likely caused by improper siFNA formation, reduced delivery of the caged species
through lipid mediated transfection, disruption of RISC recognition, disruption of
helicase removal of the sense strand, or a combination of these factors. A parallel
study carried out by our research group has demonstrated that caging of a
fluorophore-labeled phosphorothioate oligonucleotide resulted in no observable
difference in lipid-mediated cellular delivery (Fabion, in preparation). Additionally, it is
unlikely that cellular delivery is drastically reduced due the attachment of DMNPE
since photoexposure of sense-caged siFNA treated cells restores RNAi activity to
levels that are nearly equivalent to the uncaged-control effectors. This observation
also suggests that when only one strand is caged, FNA duplexes are stable prior to
delivery. Caging of the antisense strand had the benefit of significantly less leak in
RNAi activity.

However, only partial restoration using 365 nm light was achieved.

HPLC evaluation of these products suggests that the caged FNAs may consist of a
heterogeneous mixture of products that vary in the degree of DMNPE attachment.
More lightly caged species may allow for residual RNAi activity, while DMNPE might
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not be fully removed upon photoexposure for heavily caged species. Compounding
the issue of varying amounts of the cage molecule, the location of attachment is likely
variable. Disruption of RNAi might be highly dependant on the location of the cage
species. Since it is carried through the entire RNAi pathway, it is more likely that the
antisense strand has multiple RISC interaction and critical processing locations along
its length and, therefore, it is more likely for a randomly attached cage group to disrupt
silencing. Several potential critical locations for effective RNAi have been identified
through siRNA chemical modification studies as well as structural evaluation of RISC
protein components (Song, Liu et al. 2003; Manoharan 2004; Parker, Roe et al. 2004;
Zhang, Du et al. 2006). Together, these investigations support the observation that the
antisense strand is more sensitive to modification or cage attachment.
Zebrafish embryos were used as an in vivo model to test photo-induced
silencing with caged siFNA to support the cell culture results. The mosaic expression
pattern of the GFP reporter transgene prevented quantitative analysis. This mosaic
expression pattern has been previously reported in other studies (Ando, Furuta et al.
2001). The red-fluorescence signal from injected labeled dextran indicates uniform
delivery by microinjection (Fig. 4.6). Nevertheless, qualitative observations strongly
suggested that caging reduces the silencing activity of these molecules and that this
activity can be restored by photoactivation. The reduction in GFP expression is not
likely due to photoexposure, as the GFP controls are unaffected with similar light
doses. Additionally, the LD50 of UVA in zebrafish (~800 J/cm2) is several orders of
magnitude larger than we have observed in cell cultures (Matsuura, Dong et al. 2005;
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Forman, Dietrich et al. 2007). Thus zebrafish are a particularly appropriate model for
photoactivated gene expression studies.
Another observed benefit of caging these RNAi effectors is protection from
toxicity associated with siFNAs. Several potential causes of this toxicity include offtarget RNAi gene silencing, innate toxicity of siFNAs and their metabolites, or
overwhelming of the RNAi machinery with siRNA substrates. It has been previously
reported that RNAi in zebrafish has a particularly high incidence of off target effects
(Oates, Bruce et al. 2000; Zhao, Cao et al. 2001; Giraldez, Mishima et al. 2006).
Therefore, it is likely that the observed increase in mortality rate and developmental
delay are related to an RNAi phenomenon, rather than toxicity of breakdown products
of FNAs. Additionally, single stranded FNAs injected at high concentrations did not
result in observable toxicity (data not shown). RNAi toxicity might be more dramatic in
a developing system, since endogenous microRNAs are theorized to play a major role
in genetic regulation(Matzke and Matzke 2003). This further supports the conclusion
that caging of the RNAi effector prevents them from entering the RNAi pathway. If this
is true, then the fact that these molecules were activated at 7 hpf demonstrated
intracellular stability of the caged species. Therefore caging of RNAi effectors would
allow delivery to the biological system at concentrations that would otherwise be toxic,
followed by photo-induction of gene silencing at a specific stage of development in a
manner that could be used to control dosing to sub-toxic levels.
Chemically stabilized siFNA was successfully controlled through transient
chemical modifications which can be disassociated with light. The use of 2’-fluoro
modification throughout the NA eliminated the possibility of unstable phosphotriester
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formation. This allowed for multiple attachments of the photolabile compound to the
phosphate backbone of each siRNA strand.

These caged species exhibit increased

resistance to nuclease digestion and reduced RNAi silencing, and these effects were
partially reversible with the application of 365 nm light. Although this strategy was
successful in achieving photo-induced RNAi with chemically stabilized effectors, the
external trigger was not 100% efficient. In order to approach this level of efficiency,
cage groups would likely need to be placed at desired locations, which would need to
be directed through synthetic methods as opposed to random attachment through coincubation with a reactive intermediate.

Despite necessary future improvements, the

results presented here suggest that caging can be used in conjunction with other
siRNA

chemical

modifications

to

achieve

pharmacological properties.
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CHAPTER 5:
Base-Caged ATP: an Alternative to γ-Phosphate Caged ATP
5.1

Introduction
The first example of applying photochemistry to control biological activity of a

substrate was caged ATP [Kaplan, 1978 #60]. In this study, 2-nitrobenzyl and 1-(2nitrophenyl)ethyl groups were attached to the gamma phosphate of ATP to cage its
biological activity. These caged ATPs were used to control the activity of a Na:K
ATPase ion pump. Since this time, ATP has remained the most frequently caged
biomolecule, and is often used a model for different photolabile protecting groups
[Reviewed by Givens review].

For instance, the first biological use of the p-

hydroxyphenacyl demonstrated photo-release of ATP (Givens and Park 1996).
Similarly, the coumarin-derived family of caging compounds was first used to cage
phosphates (Givens and Matuszewski 1984). Nearly a decade later it was used for
caging cAMP in a simulated physiological environment (Furuta, Torigai et al.) and later
was used for ATP caging. Caged-ATP is an excellent model due to the myriad of
biological processes that are dependant on ATP for energy.
Although alkylation of the ATP γ-phosphate restricts kinase activity, this
scheme still has one major flaw. Most applications of caged ATP require an enzyme
interaction to process the substrate ATP.

Caging at the phosphate prevents

dephosphorylation of the ATP, but this does not necessarily prevent protein-ATP
recognition. In many cases, caged ATP substrates have been shown to inhibit the
target systems being studied, as first described by Forbush (Forbush 1984). Other
examples of the gamma-phosphate caged ATP inhibition include actomyosin (Thirlwell,
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Corrie et al. 1995], mitochondrial ADP/ATP carrier protein (Broustovetsky 1997),
kinesin and microtubules (Higuchi 1997), and the classical Na:K ATPase pump
(Geibel, Barth et al.). In the case of actomyosin, the competitive inhibition caused by
the presence of caged ATP slowed the shortening kinetics of muscle fibers. This is
particularly unfavorable since caged-ATP was classically used to measure the kinetics
of this system using a pulse trigger (McCray, Herbette et al.). Since many of these
processes are specific to the adenosine nucleotide triphosphate, another potential
approach would be to cage the nucleobase. This may eliminate competitive binding
and still render the caged ATP biologically inert.

Despite the recent advances in

nucleobase caging of oligonucleotides (Hobartner and Silverman), synthesis and
utilization of base-caged ATP has not been reported to date.
One reason why the generation of base-caged ATP might not have been
attempted is that techniques for caging of a nucleobase often require difficult synthetic
methods. A potential solution to this problem is to utilize a reactive base-modified NTP
as the substrate for caging. This allows for the direct caging of the adenosine through
direct attachment schemes. To avoid the requirement for series of protection and
deprotection steps, the cage intermediate should not be reactive with the phosphates
or the hydroxyl groups on the ribose. A mildly nucleophilic primary amine meets these
requirements.
modified

Additionally this attachment chemistry should be reactive with the

nucleobase,

such

as

6-chloropurine

riboside.

Here,

we

show

2-

nitrobenzylamine and a custom 4,5-dimethoxy-2-nitrobenzyl amine can be used to
cage 6-chloropurine riboside and 6-chloropurine riboside triphosphate to produce
base-caged ATP.
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5.2

Materials and Methods
Ammonia gas was condensed (60 mL) in a pressure vessel cooled in a dry

ice propanol bath to -80oC. Meanwhile, 4,5-dimethoxy-2-nitrobenzyl bromide (DMNBB)
(2.5 gr, 9.06 mMol) was dissolved in acetonitrile (ACN) (24 mL) under continuous
agitation.

The DMNBB solution was added dropwise over 10 minutes to the

condensed ammonia liquid with constant stirring. The pressure vessel was sealed,
shielded from light, and allowed to equilibrate to room temperature.

The reaction

proceeded under constant stirring for 69 hours. The vessel was then re-cooled to 80oC and opened after equalization to atmospheric pressure.

All ammonia was

evaporated and the product was solubilized in 100mL of dichloromethane (DCM). A
10% w/v sodium carbonate aqueous solution was added to the DCM for phase
extraction to separate the nitrobenzylamine product from the ammonium bromide salt.
The aqueous phase was washed 2 more times with DCM. The collected DCM layers
were dried over potassium hydroxide and filtered through Whittman paper funnel. The
product was further purified via silica gel chromatography (1:9 methanol:DCM, Rf =
0.05). The product containing fractions were dried in vacuo, leaving a reddish brown
solid. 4,5-dimethoxy-2-nitrobenzylamine (DMNB-NH2) was verified through NMR, ESIMS, and FTIR spectroscopy.
For nucleoside model studies, chloropurine riboside (CPR) was purchased
from TriLink BioTechnologies (San Diego, CA) and 2-nitrobenzylamine (NB-NH2) was
purchased from Sigma Aldrich (St. Louis, MO). NB-NH2 or DMNB-NH2 (200 μmol) was
dissolved in 1-propanol or methanol (58.2 μL) and triethylamine (41.8 μL). CPR (25
μmol) was added to the solution and the reaction was gently agitated at 42oC for 18
hours. Fractions were taken at various time intervals to monitor the reaction progress
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via reversed phase HPLC on a C18 column (spherisorb ODS2 5 μm bead Waters
Corp., Milford, MA). Separation via HPLC was carried out at a flow rate of 0.5 mL/min
under the following solvent conditions: 90:100 to 50:100 A:B linear gradient over 30
minutes, linear increase to 100% B over 20 minutes, and 5 minute hold at 100% B,
where A is 0.1% triethylammonium acetate (TEAA) in water and B is acetonitrile.
HPLC was also used to purify products for ESI-MS analysis.
For ATP caging, a chloropurine riboside triphosphate (CPR-TP) solution
(100 mM) was purchased from TriLink BioTechnologies. NB-NH2 or DMNB-NH2 (260
μmol) was dissolved in methanol (150 μL) by heating to 60oC in a water bath.
Triethylamine (50 μL) and 16.6 μL of a 100mM CPR-TP aqueous solution (1.66 μmols)
were added to the solution, and the reaction was rocked at 42oC for 18 hours. Once
complete, DCM (500 μL) and deionized water (500 μL) were added to the solution and
phases were mixed by shaking. The aqueous layer was collected and washed twice
more with 500 μL of DCM.

The aqueous layer was passed through an DEAE

sepharose fast-flow anion exchange column (GE Healthcare), which was prewashed
with 1 M NaCl solution and copious amounts of water. The product was eluted using
step increases in concentration of NaCl solutions up to 1 M. The resulting fractions
were dried in vacuo, reconstituted in deionized water, and stored at 4oC and protected
from light for analysis.
A luciferin-luciferase ATP reporter kit was purchased for analysis of the base
caged ATPs (Enliten®, Promega Corp., Madison, WI). Additionally γ-phosphate caged
ATPs (NPE and DMNPE) were purchased for comparative analysis (Molecular Probes,
Eugene, OR). The luciferin-luciferase reagents were reconstituted using the kit buffer
according the manufacturer specifications. These enzyme buffer was further diluted
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(1:5 or 1:10) with HEPES (20mM, pH 7.5). Various concentrations of ATP samples or
mixtures (5 μL total) were added to a 96-well plate. Photoexposures were performed
directly in the plate, before adding the luciferase reagent. The diluted reagent was
added (45 μL per well, 90% of final volume) to the plate immediately before measuring
luminescence on a Fluorstar plate reader. All plates contained several ATP and water
standards for experiment equilibration.
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Figure 5.1: Base-caged adenosine scheme. ATP reaction reaction with 2nitrobenzyl amine caging groups (R = H, n-nitrobenzyl amine, R= OCH3, 4,5dimethoxy-2-nitrobenzyl amine)
Photoexposures were performed using either a transilluminator (TFM-20,
UVP Inc., Upland, CA) (λ = 308 nm, 6.5 mW/cm2) or a GreenSpot Photocuring System
(λ = 365 nm, 0.95 W/cm2) (American Ultraviolet, Lebannon, IN). Light was delivered to
the samples through a bottom-up method using the transilluminator or an inverted
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liquid-filled light guide for the GreenSpot system. Infrared, UVC, and UVB light was
filtered out from the GreenSpot light source using a short bandpass filter (SWP-2502U400) and an IR-filter (KG-2-IR) (Lambda Research Optics, Costa Mesa, CA). Total
light delivered was 60 J/cm2.

Non-photoexposed samples were added to the

appropriate wells following light treatments.

5.3

Results
2-nitrobenzylamine was purchased from Sigma Aldrich (St. Louis, MO),

however the dimethoxy-analogue was synthesized to have a cage suitable for use in
cells and tissues.

The amination of DMNBB was separated on thin layer

chromatography (Rf = 0.15 in 1:4 methanol:DCM or Rf = 0.05 in 1:9 methanol:DCM)

a, b
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e

NH2

f

b

e
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f

Figure 5.2: NMR of DMNBNH2. A labeled chemical structure of the product
correspond to peak labels for H-peak identification.
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and stained using ninhydrin plus heat for detection of amines (data not shown).
Although ammonia was used in vast molar excess, formation of a secondary amine
was detected.

Column silica chromatography yielded a pure product with mass

spectroscopy showing a molecular weight of 213, corresponding to DMNB-NH2 + H+.
The primary amine was difficult to observe using 1H-NMR due to proton exchange with
the solvent (fig. 5.2, peak f). However, the presence of the amine resulted in a signal
shift for the two hydrogen atoms associated with exocyclic carbon (fig.5.2, peak e).
FTIR was used in conjunction with 1H-NMR and ninhydrin staining to verify the
presence of the primary amine.
Both 2-nitrobenzylamine compounds were tested for the ability to convert 6chloropurine riboside to caged amine via substitution of the chloro-modification.
Reactions were carried out separately so that crude fractions could be removed and
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Figure 5.3: HPLC monitoring of CPR and NB-NH2 cage reaction. Overlaid elution
profiles of NBNH2 cage reaction with starting reagents. Red arrow indicates product
formation at 4 hours into reaction. ESI-MS of the product peak correlated to 2nitrobenzylamine caged adenosine (MW: 403.3).
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evaluated by RP-HPLC at hourly intervals. Caging reactions using NB-NH2 gave a
clean product that eluted between the two starting reagents. Figure 5.3 demonstrates
product formation at 1 hour and the elution of the product relative to the starting
reagents. The product peak was collected and verified by ESI-MS (MW = 403.3). The
reaction using DMNB-NH2 resulted in the formation of several side products (Fig 5.4).
3
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Figure 5.4: HPLC monitoring of CPR and DMNB-NH2 cage reaction. Overlaid
elution profiles of DMNB-NH2 cage reaction with starting reagents. Red arrow
indicates product formation of interest, but a significant number of side-product
contaminants are present.
ESI-MS of the product peak correlated to 2nitrobenzylamine caged adenosine (MW: 463.1).

In this reaction, the cage reagent appears to react with the solvent system (methanol
and triethyl amine) or simply breaks down. This results in precipitate formation and a
loss of signal relating to DMNB-NH2 by 4 hours reaction time. However, the product of
interest was generated, collected, and verified by MS (MW = 463.1).
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Once the caging reactions with the CPR nucleoside model were verified, the
same process was used to generate caged ATP from 6-chloropurine riboside
triphosphate. After the 18 hour reaction, a liquid-liquid extraction was used to separate
the unreacted cage from the nucleoside triphosphate products.

Similar to the

nucleoside model studies, a precipitate formed in the reactions and this effect was
more pronounced in the DMNB-NH2 reaction. Additionally, the resulting DMNB-NH2
aqueous phase contained chromophores causing the solution to appear dark blue.
Prior to ion exchange chromatography, the aqueous phase for both products
underwent a colorimetric change during the drying process, suggesting further
reactions by remaining contaminants. During anion exchange, a yellow and green
band eluted at low salt concentrations.

However, the fraction corresponding to

nucleotide triphosphate elution retained a dark blue appearance. Alternatively, the NBNH2 caged yielded in a clear eluent.

The collected fractions were evaluated via

absorbance spectroscopy to determine caged-ATP yield.

Yields of nucleotide

triphosphate crude products were 90% and 62.7% for NB-NH2 and DMNB-NH2,
respectively.
Since 6-chloropurine riboside triphosphate has negligible activity in the
luciferase reporter assay (table 5.1), the crude caged-ATP products could be used
without further purification.

Luminescence was recorded prior to and following

photoexposure using ATP, NPE and DMNPE γ-phosphate caged ATPs, and NB-NH2
and DMNB-NH2 base-caged ATPs. The results using a final ATP concentration of 10
μM, corresponding to the predetermined mid-concentration in the linear range of the
assay (data not shown), are summarized in table 5.1.

All caged ATP analogues

demonstrated photo-activation ability. DMNB-NH2 and γ-phosphate NPE caged ATPs
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exhibited some leak activity. This leak activity approached 10% for γ-phosphate NPE
caged ATP 100 μM and 1 mM concentrations. Alternatively the DMNB-NH2 caged
ATP did not exhibit an increase in leak activity with elevated concentrations,
suggesting this product was free of ATP contamination and/or DMNPE may be more
effective a reducing leak-activity than NPE.
Table 5.1

Luciferase ATP assay with caged effectors
Before UVA
light exposure

After UVA
light exposure

7852 ± 438

N/A

295 ± 13

5623 ± 394

1 ± 1.3

4958 ± 266

0±0

10,939 ± 582

DMNBNH2 base-caged ATP

273 ± 70

3453 ± 178

Unreacted CPR-TP

6 ± 10.9

N/A

Sample
ATP
γNPE-caged ATP
NBNH2 base-caged ATP
γDMNPE-caged ATP

Table 5.2

% of RLU from ATP co-incubated with caged effectors
2-nitrobenzyl

4,5-dimethoxy
2-nitrobenzyl

ATP alone [10 μM]

100.0% ± 32.0%

100.0% ± 12.0%

ATP [10 μM] + γ-phosphate caged ATP [10 μM]

†

†

51.0% ± 6.1%

‡

86.7% ± 6.4%

Sample

23.0% ± 9.0%

‡ 128.1%

ATP [10 μM] + base-caged ATP [10 μM]

± 12.6%

Symbol † denotes statistical difference between caged-ATP and ATP standard
Symbol ‡ denotes statistical difference between γ-phosphate and base caged ATP
(Student’s t-test p < 0.05)
Co-incubation of standard ATP and caged ATP analogues (10 μM final
concentrations, 50 μL) were performed to assess the competitive inhibition properties
of the caged species. Table 3.2 summarizes the percentage of ATP activity of the coiincubations, relative to an ATP standard plus buffer that was run in parallel. Both γ-
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phosphate caged ATPs reduced the observed luminescent signal.

No statistical

difference could be drawn between the ATP standard and the co-incubation of ATP
with either base-caged ATP.

5.4

Discussion
This work demonstrates the facile synthesis of base-caged ATP analogues

without requiring multiple protection and deprotection steps (Pitsch, Weiss et al. 1999;
Hobartner and Silverman 2005). These products are attractive alternatives to classic
examples of caged ATPs, which are caged on the γ-phosphate and act by preventing
enzymatic dephosphorylation(Kaplan, Forbush et al. 1978; McCray, Herbette et al.
1980; Walker, Reid et al. 1988). Phosphate caged ATP has consistently demonstrated
competitive inhibition, which may alter the ATP response of the system being studied
(Forbush 1984). For instance, the presence of caged ATP following flash-photolysis
slows the contraction rate of muscle fibers by transiently blocking the actomyosin
interaction (Thirlwell, Corrie et al.). Based-caged ATPs show very little activity prior to
photo-activation, suggesting that caging on the nucleobase prevents enzyme
recognition since the phosphates are free for kinase processing.
Nucleoside models were initially performed to access the feasibility for
caging CPR on the nucleobase. This system allows for simple reaction analysis and
purification by reverse phase HPLC. For both NB-NH2 and DMNB-NH2, the generation
of base-caged adenosine was observed.

Since the caged product appears to be

relatively stable, the formation of several side products in the DMNB-NH2 caging
reaction is likely the result of interactions between the cage compound and the
solvent/buffer environment.

However, side-products resulting from depurination,
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phosphate hydrolysis, and ring opening can not be ruled out. The conditions of the
substitution reactions were mildly basic to avoid these phenomena.

Colorimetric

changes following caged ATP reconstitution in water from a methanolic solution,
suggests reactivity between 2-nitrobenzylamines and water. Additionally, breakdown
products could be more readily formed in a slightly acidic aqueous solution than in
basic methanol. Differences between the NB-NH2 and DMNB-NH2 groups were likely
caused by the electron donating properties of the O-methyl ring substitutions.
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CHAPTER 6:
Conclusions and Future Directions
6.1 Conclusions
The primary goal of this work was to demonstrate photo-induced RNAi by
caging the effector compounds.

Originally it was hypothesized that statistical

phosphate backbone caging of a long dsRNA transcript would be an ideal means to
control RNAi activity. However, in vitro analysis of these caged products indicated that
the formation of a phosphotriester from the caging process resulted in strand
breakage. This suggests that internal phosphate caging of an otherwise unmodified
RNA is a not a suitable technique for use in aqueous systems. Despite our results,
diazo-mediated cage attachment to RNA has since been used to control mRNA
expression (Ando, Furuta et al. 2001; Ando, Furuta et al. 2004) and siRNA-mediated
gene silencing (Shah, Rangarajan et al. 2005). In the latter case, it is possible that a
significant fraction of the siRNAs were caged on the terminal phosphates only. These
positions may be more readily caged as they have an additional anionic non-bridging
oxygen. In an effort to circumvent the issue of phosphotriester RNA hydrolysis, a
uniform chemically modified RNA mimic was tested to RNAi activity.
Fully 2’-deoxy-2’fluoro modified NA (FNA) was generated for testing of RNAi
silencing activity.

Eliminating all 2’-hydroxyls greatly reduces the probability of

spontaneous intramolecular hydrolysis and protects against 2’-hydroxyl-mediated
enzymatic digestion.

This modification removes this hydroxyl and allows the NA

duplex to form the A-type helical structure through a preferred C3-endo sugar pucker
confirmation without disrupting the major or minor grooves.
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Among all the 2’-

substitutions reported in the literature, the 2’-F modification gives the most consistent
results of unaffected RNAi ability {reviewed by [(Manoharan 2004; Zhang, Du et al.
2006)]}. Fully-modified siFNAs were generated through synthetic methods and by in
vitro transcription.

Transcription gave a crude product contaminated with early

termination products and full length strands with base incorporation errors. Therefore
this technique is somewhat impractical unless considerable improvements are made to
reduce polymerase miscoding.

The synthetic technique worked well using the

corresponding phosphoramidites, which until recently were commercially unavailable
for the purines. These products were verified through mass spectrometry and PAGE
separation.

FNAs demonstrated remarkable resistance to enzymatic digestion by

sugar-specific nucleases.

However, these products could be digested by BAL-31

nuclease, which proceeds through a sugar-nonspecific mechanism. Additionally, NAs
with this substitution exhibited much stronger hybridization properties, as measured by
a dramatic increase in thermal stability.
The observed RNAi ability of siFNA was nearly indistinguishable from
unmodified siRNAs of the same sequence. It was found throughout the course of the
initial cell culture RNAi assay that the hybridization protocol had a significant impact on
the ability to knockdown the reporter gene. Since the melting temperature for the FNA
duplex approached 95oC, it is possible that slightly misaligned siFNAs could be
generated if annealing was rushed or performed at a lower temperature. Extended
annealing times at high temperatures prior to cellular transfection improved the
silencing ability of the siFNAs. However, this phenomenon was not observed using
unmodified siRNAs. In addition to duplex silencing activity, single-stranded antisense
FNAs were tested for their ability to reduce target gene expression. It has previously
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been shown that antisense RNA that is the proper size for RISC association can enter
the RNAi pathway (Martinez, Patkaniowska et al. 2002; Schwarz, Hutvagner et al.
2002; Amarzguioui, Holen et al. 2003; Holen, Amarzguioui et al. 2003). However, the
silencing activity of antisense FNA was much less potent than either duplex siFNA or
single-stranded antisense RNA. This suggests that antisense FNA is not recognized
by RISC, and conversely that duplex siFNA silencing occurs through an enzyme
mediated process rather than simple translational arrest.
Once the RNAi activity of siFNA was verified, the ability to cage these effectors
was revisited. An activated 4,5-dimethoxy-2-nitrophenyl diazonium cage compound
could be used the alkylate the phosphate backbone of each FNA strand individually.
This reaction could easily be adjusted to obtain products with varying degrees of
alkylation. All caged samples, prior to and following photoexposure, were evaluated
using spectroscopy, electrophoresis, and HPLC.

Caging also provided additional

nuclease stability to the FNAs. FNA samples that were not caged were susceptible to
the sugar non-specific nuclease, BAL-31.

However, the attachment of DMNPE

drastically decreased the ability of BAL-31 to degrade the FNA. It is likely that once
this bidirectional exonuclease reaches one or multiple adjoining caging sites, the
enzyme might be interrupted from its digestion process. It has previously been shown
that an increase in serum and plasma stability due to partial 2’-F modification does not
correlate to prolonged RNAi in vivo (Layzer, McCaffrey et al. 2004). It is possible that
these modified nucleic acids are processed either by RNA endonuclease activity or
sugar-nonspecific nucleases. Full modification and caging appears to protect against
both of these possibility.
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The ability to trigger RNAi activity using caged siFNA was evaluated in cell
culture and a zebrafish in vivo model. Taking into account that caging of NAs has
been shown to affect hybridization ability (Ordoukhanian and Taylor 1995; Ghosn,
Haselton et al. 2005) and that it can aide against enzymatic digestion, DMPNE
attachment to FNA should be able to affect NA:NA as well as NA:enzyme interactions.
Therefore, caging of siFNAs has the potential to disrupt RNAi in various ways such as:
disruption of RISC recognition, helicase unwinding of the duplex, mRNA target
recognition, ejection of the digested target for RISC recycling, localization of RISC to
specialized organelles, and downstream processing such as chromatin remodeling. It
was demonstrated that caging of either strand in a siFNA reduces RNAi activity,
however, the caged antisense strand results in a more deleterious effect on RNAi
activity. This is not unexpected since the sense FNA is discarded early in the RNAi
pathway. Reduction of sense strand caged RNAi is likely caused by improper siFNA
formation, reduced delivery of the caged species through lipid mediated transfection,
disruption of RISC recognition, disruption of helicase removal of the sense strand, or a
combination of these factors. A parallel study carried out by our research group has
demonstrated that caging of a fluorophore labeled PS oligonucleotide resulted in no
observable difference in lipid-mediated transfection (Fabion, in preparation).
Additionally, it is unlikely that cellular delivery is drastically reduced due the attachment
of DMNPE since photo-exposure of these treatments restores RNAi activity to levels
that are nearly equivalent to the uncaged-control effectors.

This observation also

suggests that caged FNA duplexes are stable prior to delivery.

Caging of the

antisense strand had the benefit of significantly less leak RNAi activity. However, only
partial restoration using 365 nm light was achieved.
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HPLC evaluation of these

products suggests that the caged FNAs may consist of a heterogeneous mixture of
products that vary in the degree of DMNPE attachment. More lightly caged species
may allow for residual RNAi activity, while DMNPE might not be fully removed upon
photo exposure for heavily caged species. Compounding the issue of varying amounts
of the cage molecule, the location of attachment is random and variable. Disruption of
RNAi might be highly dependant on the location of the cage species. Since it is carried
through the entire RNAi pathway, it is more likely that the antisense strand has multiple
RISC interactions and critical processing locations along its length, and therefore it is
more likely for a randomly attached cage group to disrupt silencing.
Zebrafish embryos were used as an in vivo model to test the photoinduced
silencing ability caged siFNA in support of the cell culture results.

The mosaic

expression pattern of the GFP reporter transgene prevented quantitative analysis.
Nevertheless, qualitative observations strongly suggested that caging reduces the
silencing activity of these molecules and that this activity can be restored by photoactivation. Caging of these effectors also protects the embryo from toxicity associated
with siFNAs. It has been previously reported that RNAi in zebrafish has a particularly
high incidence of off target effects (Oates, Bruce et al. 2000; Zhao, Cao et al. 2001;
Giraldez, Mishima et al. 2006).

Several potential causes of the observed toxicity

include off-target RNAi gene silencing, innate toxicity of siFNAs and their metabolites,
or overwhelming of the RNAi machinery. Since normal RNAi results in toxicity, it is
likely that the observed increase in mortality rate and developmental delay are related
to an RNAi phenomenon, rather than toxicity of breakdown products of FNAs.
Injection of single-stranded FNAs did not result in equivalent toxicity, suggesting that
breakdown products of FNA digestion are not the cause of the observed
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developmental delay. Overwhelming of the RNAi machinery would more critical for a
developing system, since endogenous microRNAs are theorized to play a major role in
genetic regulation (Matzke and Matzke 2003). This further supports the conclusion
that caging of the RNAi effector prevents them from entering the RNAi pathway. If this
is true, than the fact that these molecules were activated at 7 hpf demonstrated
remarkable intracellular stability of the caged species.

Therefore caging of RNAi

effectors would allow delivery to a biological system at concentrations that would
otherwise be toxic, followed by photo-induction of gene silencing at a specific stage of
development in a manner that could control dosing to sub-toxic levels.
In an effort to progress toward site-specifically caged RNAi effectors, we have
generated a scheme to incorporate a single cage molecule within a full length RNA
oligonucleotide using the convertible nucleoside approach.

This requires the

generation and testing of cage precursor containing a primary amine at the site of
attachment for nucleophilic substitution of the internal convertible base placed during
custom synthesis.

4,5-dimethoxy(2-nitrobenzyl)bromide was reacted in pure

condensed ammonia to produce the 4,5-dimethoxy ring substituted 2-nitrobenzylamine
in sufficient yield and purity. Additionally, an unsubstituted 2-nitrobenzylamine was
purchased from a commercial source. These compounds have been tested for the
ability to generate a photolabile N6-caged adenosine derivative. Nucleoside model
studies were carried out by reacting 6-chloropurine ribose with each amine-containing
cage compound. The products were successfully isolated on HPLC and verified by
MS. Building on the success of these models, chloropurine riboside triphosphate was
caged on the nucleobase to generate base-caged ATP. All previous examples of
caged

ATP

have

attached

the

chromophore
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the

γ-phosphate

to

prevent

dephosphorylation.

However, this attachment site does not prevent a NA-protein

association for many of the systems being studied. Therefore γ-phosphate caged ATP
often acts as a competitive inhibitor for uncaged ATP. Our results demonstrate this
competitive inhibition using a luciferase ATP reporter system in vitro. Alternatively, the
base-caged ATP analogs do not appear to act as competitive inhibitors.
compounds are also effectively activated by photoexposure.

These

One last additional

benefit of this system is that the chloropurine riboside reagent is inactive as an ATP in
this reporter system.

Therefore, contamination from the caging reaction does not

cause leak ATP activity, which is a major problem when using γ-phosphate caged
ATP. This is even true when the caged ATP is purchased from a commercial source.

6.2

Future Directions
This work successfully demonstrates using chemically modified NAs that

have been caged to control RNAi-mediated gene silencing. Also demonstrated is the
ability to cage ATP on the nucleobase through nucleophilic substitution. Within each of
these categories, further chemical and photochemical evaluation would strengthen the
foundation built in this work. Additionally, each of these techniques has opened the
possibility for application based investigations. Finally, the study of base-caged ATP
provides a platform toward post-synthetic site-specific caging of oligonucleotides for
use in RNAi or other nucleic acid applications.
This work could readily be extended toward the goal of site-specifically
caged siRNAs. As aforementioned, the ATP study presented here demonstrates the
incorporation of a cage molecule at the N6-position of adenosine. The mechanism of
substitution should be amenable toward caging through the convertible nucleotide
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approach. In this strategy, a full-length RNA oligonucleotide is synthesized with one or
multiple convertible-base modifications inserted during solid phase synthesis. While
still resin bound and protected, the convertible nucleotide is incubated with a
nitrobenzylamine derivative (or another aminated cage compound) for substitution of
the leaving group with the cage compound.

If the primary amine is nucleophilic

enough, this step should also cleave the RNA from its solid support and deprotect the
other nucelobases.

However, treatment with concentrated methanolic ammonia

following the conversion reaction is an alternative to completely cleave the support.
The caged RNA is then 2’-deprotected per normal protocols. One of the initial hurdles
of this study will likely be the removal of unbound cage and side products of the
conversion reaction prior to 2’-deprotection. Our initial attempts of RNA conversion
using NB-NH2 have been unable to circumvent this issue without sacrificing RNA yield.
Additionally, characterization of the caged RNAi product might be difficult if the
conversion reaction is of low yield. Separation techniques will likely be needed to
isolate the properly caged RNAs.
Assuming that site-specific caging of RNA is successful, there are several
immediate phenomena to evaluate.

Clearly, an analysis of RNAi with point cage

insertions should be initiated. This will allow probing into the siRNA to determine the
optimal site(s) for photocaging. Ideally a single cage compound could be inserted into
an siRNA molecule to completely ablate gene silencing activity.

Under these

conditions, caged RNA photoactivation will likely be marked more efficient. Our ATP
studies suggest that some degree of uncaging occurs using a NPE nitrobenzyl with an
intense 365 nm light. If only a single cage compound is inserted per siRNA, the
unsubstituted nitrobenzyl group may be adequately uncaged for photoinduced RNAi
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using this light that is less harmful to biological systems than 308 nm light typically
used to photolyze NPE-caged compounds. The siRNA used in the study was originally
designed for the purpose of site-specific caging. The 11th nucleotide from the 5’-end of
the antisense strand is an adenosine. This was chosen so that a “convertible A” could
be incorporated and post-synthetically caged. Chapter 1 illustrates that this site is
sensitive to base and sugar modifications, and therefore is hypothesized that this is an
ideal site for cage incorporation to disrupt RNAi.
Site-specific caging may also make 2-photon excitation (TPE) of RNAi
effectors more feasible.

Currently these compounds require a large number of

siRNA/siFNA alkylation to prevent significant leak activity. However, TPE requires a
very high intensity of incident light for uncaging.

Concentrating the number a

chromophores in this region by attaching multiple cages per oligonucleotide may push
the required light intensity for uncaging to unsafe limits. A comparison of two-photon
uncaging with discrete increases in the number of attached cage molecules (1, 2, 3,
etc.) will be a worthwhile endeavor to determine the relationship between required light
energy and the number of bound cage compounds. Additionally, the distance between
two cage molecules within a single strand may also affect the efficiency of TPE.
Chromophores in close proximity may be able to interact with the excited electron state
of a neighboring cage compound.
Another application for site-specifically caged RNAs is to improve upon
nuclease resistance assays. By incorporating a cage compound at a specific location,
the interruption of catalytic activity can investigated for various nucleases that act
through different mechanisms. For example, caging at the 5’-terminus may protect
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exonucleases that digest in the 5’ to 3’ direction. However this may be ineffectual
against 3’ to 5’ exonucleases or endonucleases.
One of the more recent observations uncovered in this study was the
developmental delay caused by high concentrations of siFNA and the associated
reversal of this phenomenon by effector caging. The cause of this delay is currently
unknown, but it likely occurs through either RNAi off-target gene silencing or
overwhelming the RNAi machinery. Positional caging may provide a means to explore
this effect.

For instance, caging at site 11 may inhibit target recognition and

degradation but still allow for RISC assembly. If the developmental delay is caused by
overloading the RISC machinery, caging at this site might result in observed toxicity
but little reporter-gene silencing. This would allow for modeling of the optimal locations
for disrupting hybridization and/or target recognition versus the disruption of RISC
assembly. Additionally, this might reveal how many cage molecules are needed to
disrupt all RNAi processes.
Protection from siFNA-induced delayed development in zebrafish highlights
an important potential application for caging. Since the degree of uncaging can be
controlled by adjusting total exposure, dosing of an RNAi effector or some other
therapeutic agent can be modulated with light. This is a promising tool for determining
safe dosing of therapeutic agents. Initially, this phenomenon could be investigated by
caging compounds with known upper limits of toxicity and introducing the caged
analogues in excess of this dose. If the quantum yield is adequately determined, light
dosing could be calculated for corresponding therapeutic doses and this could be
tested against traditional toxicity experiments that can be clouded by transport and
breakdown of the therapeutic agent.
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